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The (in)visible microbial world
More than 300 years ago, the Dutch Antonie van Leeuwenhoek stared through his self-made 
microscope and discovered the first microbes colonizing human body surfaces. Since van 
Leeuwenhoek’s pioneering work on microbial life, microbiota research has revolutionized the 
area of biology, and at this moment microbiology is one of the fastest growing fields in science. 
The role of microorganisms in non-communicable and infectious diseases has been emphasized 
ever since. These discoveries all challenged our fundamental view on the microbiota and its 
complexity, and enormously increased the awareness for our resident microbes as part of 
ourselves. Here, I will outline the size and complexity of the microbiota in our intestinal tract, 
its importance in health and disease and its developmental origin in early life. In addition, I 
highlight the methodologies used to study the microbiota and define the aims of this thesis. 
 We harbor thousands of different microbial species and trillions of cells in our 
gut, including archaea, bacteria and eukaryotic microorganisms [1]. Collectively, the 
microbial cells even exceed the number of human cells. Recent calculations suggest that 
we are composed of approximately 44% human cells [2] [3], albeit the small size of these 
microbial cells only add a few kilograms to the adult body weight. Although our usual 
thought considers the human genome to characterize us as a Homo sapiens, our own 
genes are outnumbered at least 100 times by the 2 to 20 million microbial genes and thus 
comprise only a minor portion of the total gene pool within our body. In contrast to the 
human genome, this metagenome only starts to settle from birth onwards [1, 4, 5]. As 
such, we actually are holobionts: hosts that are accompanied with a living microbiome. 
 The different genes of the gut microbiota encode for molecules involved in pathways 
and functions that affect a wide range of regulatory circuits such as immunity, nutrition and 
metabolism [6-8]. No other microbiome in the human body is as numerous and diverse as 
the gut microbiome. The complex interactions of the gut microbiome with the continuous 
flow of environmental microorganisms, the wide variety of dietary compounds and host 
factors is a research field of high interest. The gut microbiota is able to provide a competitive 
barrier and thereby protect against infections. The gut microbiota is also of importance 
in food fermentation and involved in the maturation of the immune system. Additionally, 
increasing evidence suggests that the gut microbiota profoundly influences the etiology 
and progression of immune-mediated disorders like allergies, neurological disorders like 
Alzheimer’s disease and autism, and metabolic disorders such as diabetes and obesity [9]. 







rising incidence of many non-communicable diseases over the past 50 years in industrialized 
countries. His initial hypothesis attributed the lower allergy risk among children with older 
siblings to their increased exposure to childhood infections. In the following decades this 
hypothesis has been revisited multiple times and led to more rational explanations for the link 
between microbial exposure and inflammatory diseases, such as the old friends hypothesis 
introduced by Graham Rook [10]. The lack of exposure to all kinds of microbes, as a result of 
e.g. antibiotic (over)use, rising cesarean sections rates and western (dietary) lifestyle, has been 
suggested to make young people nowadays more susceptible to non-communicable diseases, 
particularly allergies. Moreover, the observation, that certain conditions are associated with 
specific changes in the intestinal microbiota composition makes it an intriguing target for new 
treatments. Whereas a lot of research has focused on adults, there is more and more interest 
in the development of the early-life microbiota. In contrast to the microbiota of healthy 
adults, which is quite stable and resilient over time (e.g. due to colonization resistance), this 
early age-window is characterized by profound changes in indigenous microbial composition. 
Moreover, the microbiota in early life seems to be particularly crucial for immune development 
and maturation and perturbations have been associated with adverse outcome. As such, 
the neonatal window may provide the best opportunity for targeted manipulation of the 
microbiota, potentially even with long-lasting positive health consequences. 
Studying the microbiota: methodologies and study designs
Until the 1990s, knowledge of the gut microbiota was limited because traditional culturing 
of microorganisms represented the main approach to study its composition [11]. Since 
then, the scientific community has developed innovative, mainly molecular, methods to 
investigate the microbial world. The human gut mainly harbors strictly anaerobic microbial 
species that are difficult to culture and to date only a minor part of the microbiota has 
been cultured and thus functionally investigated. Instead, several culture-independent 
techniques have been introduced in recent decades to analyze composition and complexity 
of the intestinal microbiota. These techniques include (quantitative) polymerase chain 
reaction PCR [(q)PCR], PCR followed by denaturing gradient gel electrophoresis (DGGE), 
fluorescent in situ hybridization (FISH), and DNA microarrays that hybridize ribosomal 
RNA (rRNA) gene sequences with oligonucleotide probes. Although these methods are 
useful for microbial profiling, they usually do not provide detailed taxonomic data. For that 
reason, the most important techniques nowadays are high-throughput next-generation 
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sequencing followed by in-depth bioinformatic analysis. These sequence-based methods 
are commonly based on the analysis of the 16S rRNA gene, present in all bacteria and 
archaea, consisting of nine unique hypervariable regions (V1–V9) flanked by highly conserved 
regions [12]. Despite the fact that other genes have been proposed, sequencing of 16S 
rRNA gene regions remains the gold standard to analyze the microbiota in view of the 
completeness of reference databases, low costs, and advanced bioinformatics software 
available. Different next-generation sequence equipment can be used to analyze 16S rRNA 
gene amplicons. However, to date Illumina sequencing (Illumina Inc., San Diego, CA) is the 
most commonly used platform. This widely popular approach has high coverage and a low cost 
per sample [13]. It should be noted that the selection of primers, the number of sequences 
per sample, costs, and aim of the experiment are strongly interdependent. Therefore, it 
is essential to balance these factors to achieve the optimum amount of information [14]. 
  As opposed to sequencing of marker genes such as the 16S rRNA gene, sequencing 
of the entire genomic content of microorganisms (the ‘microbiome’) within the microbiota 
provides more specific information on their potential functional roles. These metagenomic 
or metatranscriptomic (when sequencing mRNA rather than DNA) analyses, referred to 
as shotgun sequencing, are especially appropriate for linking microbial communities with 
functional potential and activity. In addition, metabolomics—the quantitative assessment of 
metabolic responses of organisms to genetic or pathophysiological changes—is a powerful 
approach and also key to unraveling specific host-microbe interactions. Metagenomic 
approaches relate to the microbiome, and metabolomic approaches to the metabolic profile 
with disease phenotypes [15]. The latter analyses are principally based on proton nuclear 
magnetic resonance (1H-NMR) spectroscopy and mass spectrometry methods. Ideally, 
these analytical techniques should be complemented for the most detailed characterization 
of microbial metabolites obtained from feces, blood, urine, or intestinal tissues. 
 As for the design of studies, experimental studies and large-scale well-defined prospective 
cohorts of patients that have been carefully phenotyped are essential. In these studies, factors 
known to influence gut microbiota composition should be carefully taken into account. In 
particular, dietary aspects and use of antibiotics or probiotics should be well-documented and 
should be considered when setting up microbiota studies. Cross-sectional studies are neither 
able to unravel if exposure to determinants precede changes in the microbiome nor if changes 
in the microbiome occur prior to disease manifestation. Longitudinal studies are therefore 







the (in)stability of the microbiome within individuals and differences between subjects and 
allow us to investigate how the microbiota changes over time. These study designs are able 
to determine the development of the microbiome and to unravel associated determinants 
as well as diseases. In contrast to the majority of other microbiome publications, my thesis is 
solely based on studies with a longitudinal design, involving both animal models and human 
studies and provides more insight on the development of the microbiome in early life and 
its role for the onset of inflammatory diseases.
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Aims and outline of the thesis
A better understanding of the interplay between the gut microbiota, us as a host and 
the factors that contribute to changes in the microbial composition may provide novel 
interventional strategies to support human health. Early childhood appears to represent 
a critical age-window, since major alterations occur during this time and the microbiota 
establishes to form a life-long stable ecological system. To this end, this thesis aimed 
to unravel environmental and host-related determinants that drive development and 
inter-individual variations in the infant microbiota. Identifying these determinants is 
pivotal in order to better understand the role of the microbiota in health and disease. 
 
To achieve this aim, the following objectives have been addressed:
(1) Identify (metabolic and nutritional) factors that influence the establishment of the 
microbiota in the neonate host;
(2) examine how changes in the microbial composition during early life relate to the onset 
of allergic diseases, and;
(3) explore if manipulation of the neonatal microbiota can be achieved in order to improve 
health. 
In chapter 2, the literature on the current knowledge of pioneer bacteria and the evolutionary 
factors that influence the development of the gut microbiota in infants is reviewed. In addition, 
future perspectives including techniques to manipulate and promote the succession of 
the microbiota for prevention and treatment of disorders during infancy will be discussed. 
 The postnatal development of both the intestine and liver is accompanied by 
increased enzymatic, absorptive and metabolic capacity [16, 17]. The related changes 
may contribute to luminal substrate availability and could thereby influence the bacterial 
succession and overall composition [18]. Although it is known that metabolites impact 
the microbial environment in the gut, data on how and when metabolites affect the 
colonization of the microbiota are lacking. In chapter 3, we present a study on the impact 
of the developing host metabolism, in particular the hepatic synthesis of bile acids, on 
the site-specific gut microbiota composition. First, we determined the gut microbiota 
development in the small intestine and colon from birth, early infancy and weaning until 
adulthood in mice. Subsequently, we screened the metabolites followed by correlation 







oral administration of bile acids was performed to confirm their causal role herein. 
 Although a variety of microbes have been studied within the human infant gut, important 
members that are often ignored are the methanogenic archaea despite their potential role 
in the promotion of a number of gastrointestinal and metabolic diseases [19]. Archaea 
have been shown to be mostly absent during infancy while omnipresent in school-aged 
children [20], suggesting that colonization may result from environmental exposure during 
childhood. Therefore, in chapter 4, we explored potential determinants associated with the 
acquisition of methanogenic archaea in children by analyzing fecal samples combined with 
extensive data on environmental factors within the context of the KOALA Birth Cohort Study. 
 Asthma and allergic diseases are the most common pediatric chronic disorders affecting 
more than 300 million children globally. Recently, the influence of microbial changes in the gut 
on the onset of asthma gained widespread attention. However, it is of particular importance 
taking both early samples and potential confounders into account with a longitudinal design. 
For instance, it remains unknown when and which microbes could potentially influence the 
onset of allergies, asthma or atopic dermatitis. In chapter 5 we therefore investigated the 
dynamics of the infant’s microbiome by monitoring the development of the gastrointestinal 
microbiota during infancy at several timepoints in the first year of life and once at school-
age and examined a possible association with subsequent onset of asthma and allergies. 
 Continuing on allergic diseases, little is known on the association between the gut 
microbiome and the progression to asthma in wheezing preschool children. As reliable 
biomarkers to predict which preschool children with wheezing symptoms will ultimately 
develop asthma are currently lacking, the identification of potential gut microbial biomarkers 
is of particular relevance. In chapter 6, we examined the gut microbiome in wheezing children 
and healthy controls aged 2-4 years and the link with immune modulators, sensitization and 
asthma at the age of 6 years within the Asthma DEtection and Monitoring (ADEM) study. 
 Oral administration of specific beneficial bacteria, so-called probiotics, might represent a 
way for targeted manipulation of the gut microbiota. Following preterm birth, the neonate host 
is more susceptible to infections and overwhelming inflammatory diseases such as necrotizing 
enterocolitis (NEC), an inflammatory disease of the intestinal tissue associated with high 
morbidity and mortality [21-23]. Although supplementation of probiotics has been reported 
to decrease the incidence of NEC [24], the precise influence on the microbiota during and 
following the intervention has remained incompletely understood. In particular, the question 
whether and to what extend orally administered probiotics persistently colonize in preterm 
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neonates and how they impact the microbial ecosystem and the development of this disease 
has not been fully addressed. In chapter 7, we examined these questions by comparing the 
microbiome of preterm neonates in the absence of as well as before, during and after oral 
supplementation of two different probiotic regimens within the context of a natural experiment. 
 Finally, in chapter 8, all findings and results of the studies are summarized and discussed. 
In addition, the contribution of this research to our knowledge of the basic mechanisms of the 
gut microbiome establishment in early life and maintenance of the life-long host microbial 
interactions is evaluated. Moreover, future perspectives and novel strategies for medical 
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Chapter 2
On the origin of species: factors shaping the establishment of 
infant’s gut microbiota
Niels van Best, Mathias Hornef, Paul H.M. Savelkoul, John Penders




The human gut microbiota is a complex and dynamic ecosystem, which naturally lives in a 
symbiotic relationship with the host. Perturbations of the microbial composition (dysbiosis) 
and reduced diversity may promote disease susceptibility and recurrence. In contrast to the 
mature intestinal microbiota of healthy adults, which appears relatively stable over time, 
the infant’s  microbiome only establishes and matures during the first years of life. In this 
respect, early childhood seems to represent a crucial age-window in disease prevention since 
microbial diversification and maturation of the microbiome primarily occurs during this period 
of life. A better understanding of ecological processes and pioneer consortia in microbial 
development is crucial in order to support the development of a beneficial microbiota. Various 
deterministic and stochastic aspects seem to shape the microbiome in early life, including 
maternal, environmental and host factors. Here, we review the current understanding of 
the origin of pioneer bacteria and the evolutionary factors that influence the development 
of the gut microbiota in infants. In addition, future perspectives including manipulating and 
promoting the succession of initial bacteria during infancy will be highlighted. 





The human gut microbiota is a complex and dynamic ecosystem consisting of hundreds to 
thousands of distinct bacterial species, as well as microbial eukaryotes, viruses, phages and a 
limited number of Archaea, which naturally live in a symbiotic relationship with the host [1]. 
In the past decades, the knowledge on the role of the gut microbiota and its development 
as well as host-microbial interactions in human health and disease has rapidly increased due 
to the advancement of modern  molecular technologies. On one hand, the microbiota has a 
profound impact on its host by providing a competitive barrier against invading pathogens, 
utilizing undigested food components and producing essential metabolites, modulating 
immune responses and stimulating intestinal maturation [2, 3]. On the other hand, the host’s 
immune system needs to tolerate the luminal microbiota, but avoid their overgrowth and 
translocation of bacteria into the subepithelial tissue. As such, a perturbation of the microbial 
communities (dysbiosis) has the ability to promote disease susceptibility and progression. 
Indeed, alterations in microbiota composition and function have been associated with many 
diseases, including metabolic diseases (i.e. obesity, non-alcoholic fatty liver disease) [4, 5] 
and immune-related diseases (i.e. inflammatory bowel disease, allergies) [6-8]. Moreover, 
dysbiosis has also been linked to neoplastic diseases [9], mental disorders and autism-spectrum 
disorder [10], although it has to be noted that for many of these diseases causality has still 
to be proven. The prevalence of many of these inflammatory non-communicable diseases 
(NCD’s) has increased rapidly over the past few decades, especially in western countries. 
As such, microbiota perturbations as a consequence of modern lifestyle have often held (in 
part) accountable for the rise in prevalence of NCD’s [11]. 
Our knowledge on the intestinal microbial ecophysiology and the processes contributing 
to microbial dysbiosis has a direct impact on our ability to manage and maintain human 
health. In this respect, early childhood appears a crucial age-window since diversification 
and maturation of the microbiota primarily occurs during this period of life. In contrast to the 
mature intestinal microbiota of healthy adults, which seems to be relatively stable over time, 
the infant microbiota waxes and wanes as diet changes and the host develops. Longitudinal 
studies monitoring the dynamics of the newborn microbiota [12-14] showed that periods of 
relative stability were interrupted by abrupt changes in microbial community structure and 
diversity.  In some, but not all cases, these changes can be linked to preceding life events 
(e.g. weaning, fever, medication), indicating that both deterministic and stochastic aspects 
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shape the microbiota in early life.
 Here, we review the origin of pioneer bacteria and evolutionary factors that influence 
the development of the gut microbiota in infants. In addition, the potential of manipulating 
the microbiota for prevention and treatment of disorders in early life will be discussed.  




Factors influencing the intestinal microbiota development
Maternal exposure
In utero transmission
Until recently, the initial microbial colonizers of the neonatal intestine were supposed to 
originate from the maternal perineal, vaginal and fecal microbiota. However, the development 
of the microbiota composition might already start before birth by microbial transfer through 
the placental barrier. Recent sequencing studies revealed the presence of DNA derived from a 
wide variety of microbial taxa in the human placenta, umbilical cord blood, amniotic fluid and 
meconium [15-18]. Although the presence of bacteria such as Mycoplasma and Ureaplasma 
have long been implicated in invasion of the amniotic cavity and detrimental health effects, 
such as preterm birth and necrotizing enterocolitis [18-20], these recent findings suggest 
that normal colonization may already start before rupture of membranes and birth. The 
placental microbiota has been suggested to resemble the oral microbiota from the Firmicutes, 
Tenericutes, Proteobacteria, Bacteroidetes and Fusobacteria phyla, indicating a possible 
mode of bacterial transmission to the fetus [15]. This evidence is, however, indirect as the 
investigators did not compare the placental and oral microbiota of the same subjects but 
rather examined the oral microbiota in non-pregnant individuals. An experimental animal 
study using labeled Enterococcus faecium further evidenced that maternal bacteria can be 
transferred to fetuses in utero via the gastrointestinal tract [16]. The underlying mechanism 
for this bacterial translocation remains unclear, but several possibilities have been proposed, 
i.e. via penetration of dendritic cells through the gut epithelium [17]. Interestingly, bacterial 
translocation of the intestinal mucosa seems to be highly increased in pregnant mice in 
comparison to non-pregnant animals [21]. 
Moreover, a number of studies detected a low abundant microbiota in the meconium of 
preterm and term infants using culture as well as molecular methods [16, 22], implying that 
the neonatal gut may not be sterile at birth. Culture techniques revealed that Staphylococcus 
and Enterococcus predominated in the meconium [16]. DNA-based techniques confirmed the 
predominance of these genera together with Enterobacteriaceae [22]. The source of meconial 
bacteria remains unidentified, but they might have an intrauterine origin and be derived from 
swallowed amniotic fluid. The observation that the major genera observed in meconium are 
similar to those detected in amniotic fluid [18] and less related to the bacteria prevailing in 
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the maternal oral or vaginal microbiome, is supportive for an intrauterine origin [22]. 
Although these studies indicate that the neonatal gut might already become colonized 
with bacteria before birth, the majority of studies relied on culture-independent techniques 
and therefore culture-based methods are ultimately required to establish a prepartum 
microbiota. The detected bacterial DNA sequences may originate from dead bacteria or free 
bacterial DNA in amniotic fluid, placenta and meconium specimens. Moreover, not birth, i.e. 
transit through the birth canal, but rather rupture of the membranes exposes the fetus to the 
environment and thus needs to be considered as critical endpoint. Finally, the actual origin 
of these bacteria or bacterial remnants needs to be considered. Sampling of material from 
the same pregnant women at multiple sites may help to exclude local infection or sample 
contamination. Clearly, further research is necessary to clarify whether the potential in utero 
bacterial transmission of a low abundant inoculum truly contributes to the development of 
a healthy neonatal microbiome, immune maturation and metabolism or merely reflects the 
vulnerability that pregnancy inflicts to the maternal host. 
Mode of delivery 
The microbial colonization of the human intestine has been traditionally assumed to begin at 
birth and further develop during early life to a diverse and mature adult microbiota. Within 
a couple of days after birth, the neonatal intestine becomes rapidly colonized by maternal 
and environmental bacteria, strongly affected by the delivery mode [23, 24]. Infants born 
vaginally (i.e. passing the birth canal in intimate contact with the vaginal mucosa) display 
a microbiota similar to that of the maternal vagina while infants delivered by cesarean 
(C-) section demonstrate a microbiota mainly consisting of commensal skin bacteria [23]. 
Accordingly, the initial microbiota in vaginally delivered newborns is determined by the 
vaginal milieu of the mother, which is predominated by Lactobacillus as well as by a high 
abundance of Prevotella and Sneathia spp. [23, 25, 26]. Infants born by C-section seem to have 
in general delayed and decreased colonization of Bifidobacterium spp. and Bacteroides spp. 
and increased rates of Clostridium difficile and typical skin bacteria such as Staphyloccocus, 
Corynebacterium, and Propionibacterium spp. compared to vaginally delivered infants [23, 
24, 27-30]. Increased rates of C. difficile may result from environmental exposure since C. 
difficile spores can be found widespread in the hospital setting. Consistently, C. difficile has 
been shown to be more prevalent in neonates delivered in the hospital as compared to 
those born at home. Moreover, the risk of colonization by this bacterium increased with each 




additional day of hospitalization [24]. Lacking the inoculum of the maternal microbiota, the 
hospital environment and staff may represent an important source of bacteria colonizing the 
intestinal tract of C-section delivered infants. Longitudinal studies showed that the delayed 
and altered colonization pattern in C-section delivered infants persisted at least to the age 
of one year [28, 30], and even after seven years of age minor differences could be detected 
[31]. However, a potential functional impact on infant’s development and wellbeing has not 
been examined. In addition, Salminen et al. visualized specific bacteria by fluorescent in situ 
hybridization (FISH) and therefore comprehensive data on a fully established microbiota in 
later childhood in relation to the mode of delivery are still lacking.
Given the profound impact of the mode of delivery on the establishment of the neonatal 
microbiome and its potential consequences, the continuously increasing C-section rates in 
many part of the world are worrisome. Recent findings based on the ecological association of 
cesarean delivery rates and perinatal outcomes from 19 developed countries [32], corroborated 
previous suggestions of the WHO expert panel that population-level C-section delivery 
rates above 10–15 percent are hardly justified by medical reasoning.  Yet, during the past 
decades C-section rates have rapidly increased far above 10-15% in many countries mainly 
attributable to non-evidence-based indications, professional convenience, maternal request, 
and over-medication of child-birth [33]. In many European countries, the United States, the 
larger cities in China and Australia rates have risen up to above 30%, while rates as high as 
45% have been reported for Brazil [34].
The increased risk of obesity [35] and childhood asthma [36] in children born by C-section 
has been attributed to an altered intestinal colonization pattern in these children. Indeed, 
within the context of two birth cohort studies, mode of delivery was shown to strongly 
impact the infant microbiota and affect the risk of allergies and asthma [37]. Moreover, the 
decreased abundance of Bifidobacterium and higher numbers of S. aureus in the intestine 
during early life has been associated with subsequent overweight and obesity in childhood 
[38], emphasizing the critical role of the first exposure.
Infant feeding
Breastfeeding plays both directly, by containing living bacteria, and indirectly, by providing 
prebiotic nutrients and bioactive components, an important role in the establishment of 
the neonatal microbiota. The first abundant bacteria of the newborn’s gut are generally 
facultative anaerobes such as Escherichia, Streptococcus and Enterococcus probably due 
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to the oxygen-rich environment in the neonatal gut lumen [30, 39]. Although some studies 
observed a gradual shift in microbial composition and increase in diversity [40], other studies 
demonstrated chaotic shifts over time including a transient drop in diversity within the first 
week of life [39, 41]. The lack of extensive bacterial competition results in high population 
levels in neonates, exceeding the numbers found in adults [42]. Facultative anaerobes utilize 
oxygen and thereby create a reduced environment, making it more favorable for subsequent 
colonization of strict anaerobe bacteria. Therefore, the microbiota development continues in 
the first weeks with proliferation of strictly anaerobic bacteria that are able to convert lactic 
acid derived from to the milk-rich diet. Infants that are exclusively breast-fed in general harbor 
a microbiota dominated by bifidobacteria, while exclusively formula-fed infants harbor a more 
diverse microbiota with increased abundance of Escherichia coli, Clostridia and Bacteroides 
[24, 27, 29, 30, 43]. A recent study revealed by deep sequencing that formula-fed infants 
displayed enhanced populations of Ganulicatella, Citrobacter, Enterobacter and Bilophila 
whereas breast-fed infants showed increased Lactobacillus species apart from bifidobacteria 
[30]. The beneficial effects of human milk oligosaccharides (HMO’s), a structurally diverse 
family of unconjugated glycans that are highly abundant in human milk and absent in formula 
nutrition, might cause the differences in the microbiota composition between formula-fed 
and breast-fed infants. The maternal HMO’s have a prebiotic role and promote the growth 
of Bifidobacterium, increase microbial diversity and are able to protect the infant against a 
number of enteropathogenic microorganisms [44]. The quantity and composition of these 
oligosaccharides varies over the course of the lactation period, but also between individual 
women, mainly driven by their genotype [45, 46]. 
Additionally, breastmilk contains other immunologic compounds, i.e. IgA, lactoferrin, 
lysozyme [47]. All these factors are able to interact with pathogens, reduce their viability 
and prevent their attachment to the intestinal mucosal surface, assisting the expansion of 
commensal bacteria. Therefore, factors such as the IgA repertoire might shape a distinct 
neonatal microbiota [48]. Vitamin D, which is part of infant formulas and recommended 
supplement in breastfed infants, is another compound that has been suggested to influence 
the developing microbiome [49], given its role in the development of regulatory T-cells and 
dendritic cells [50]. Direct evidence, however, is limited to a single study correlating a lower 
vitamin D intake to a different microbiota composition in adult African Americans as compared 
to Caucasian Americans [51]. The results need to be confirmed in larger longitudinal studies.
Interestingly, recent studies also revealed the presence of a microbiota in maternal 




breastmilk. With concentrations of 102-104 viable bacterial per mL breast milk, an exclusively 
breastfed infant will consume the significant amount of about 105-107 commensal bacteria 
per day [52]. A study on variations in the breastmilk microbiome over the course of lactation 
indicated that staphylococci, streptococci, and lactobacilli derived from the milk ducts and 
skin predominated in colostrum, whereas after six months a higher abundance of oral taxa, 
including Veillonella and Prevotella, were found in breastmilk [45]. Other studies hypothesize 
an entero-mammary pathway, postulating that maternal gut bacteria could translocate 
through the intestinal epithelial barrier, migrate to the mammary gland and subsequently 
become secreted with the milk and colonize the breastfed neonate [53]. Using a combination 
of culture-dependent and -independent methods, Jost et al. examined whether viable strains 
of gut-associated obligate anaerobes were shared between the maternal and neonatal gut 
microbiota and transferred via breastfeeding. Next to facultative anaerobes, obligate anaerobic 
genera, including Bifidobacterium, Bacteroides and Clostridia were detected in maternal 
faeces, breast milk and neonatal feces. Moreover, pulse-field gel electrophoreses (PFGE) of 
Bifidobacterium breve isolates from maternal feces, breast milk and neonatal feces of a single 
mother-child pair revealed identical restriction profiles, suggesting transfer of these strains 
from the maternal to the neonatal gut via breast milk [54]. Alternatively, the maternal gut 
might represent a common source for both the mammary skin/gland duct bacteria as well 
as the neonatal intestine. 
The third stage in the development of the microbiota is defined by alterations of the 
microbial composition and function due to the introduction of solid food 4-6 months post-
partum (weaning). Upon weaning, the microbiota functionally maturates by a decrease in the 
relative abundance of genes involved in the degradation of sugars from breast milk and towards 
enrichment of genes involved in the degradation of complex sugars and starch. The major 
pectin-degrading enzyme, pectinesterase, has been shown to be enriched in infants by the 
age of 12 months, likely in response to the increased intake of foods rich in pectin by this age 
[30]. The particular effects of solid foods, however, strongly depend on the geography linked 
to major differences in dietary habits around the world. In western countries, the introduction 
of a more complex diet rapidly increases the levels of Bacteroides and Clostridium, alters 
the lactobacilli communities and decreases the Bifidobacterium levels [30, 39, 41, 55]. The 
intestinal microbiota closely resembles the diverse adult-like composition at the age of three 
years [41, 55], even though older data indicated that microbial stability is already achieved 
at the age of one year [12, 40]. Interestingly, a longitudinal study of 98 Swedish mothers and 
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their infants also compared the bacterial composition between the introduction of solid food 
with and without continuation of breastfeeding [30]. This comparison suggested that the 
cessation of breastfeeding rather than the introduction of solid food represents the major 
factor driving the microbiota composition towards a more adult-like ecology. Altogether, 
these data emphasize the role of breastmilk and diet in the succession and shaping of the 
intestinal microbiota in early life.
Environmental Exposure
Besides the influence of the mother and the associated exposures during delivery, the child’s 
living environment, including the indoor home environment, pets and older siblings as sources 
for microbial exposure, has been shown to affect the intestinal microbial development. A 
recent longitudinal study by the Home Microbiome Consortium, showed substantial interaction 
among the human, home and pet microbiota [56]. Moreover, strikingly similar dynamics in 
the development of the enteric microbiota of a fraternal twin pair, including the coincidental 
transient appearance of specific organisms in both twins, suggest that stochastic environmental 
influences can also play an important role during the assembly of microbial communities [12].
Siblings
Singletons seem to have a distinct colonization pattern in comparison to infants that grow 
up together with older siblings, although data are scarce and not always consistent. The 
Canadian Healthy Infant Longitudinal Development (CHILD) cohort showed a lower abundance 
of C. difficile and its family Peptostreptococcaceae [27], whereas a German study reported 
decreased colonization rates of Clostridium cluster I in newborns with older siblings as 
compared to singletons [57]. The higher levels of Clostridium species in singletons are in 
accordance with another study comprising three European birth cohorts [58]. A decrease 
in bifidobacteria in infants without older siblings has also been reported [24]. Moreover, a 
higher microbial richness and diversity has recently been observed in infants with older siblings 
[59]. Altogether, these data suggests that firstborn infants harbor a less mature microbiota 
than infants with older siblings at a certain age, which may impact the risk on allergies [37]. 
Whether this occurs due to direct or indirect bacterial transfer between siblings or due to 
other factors, such as altered vaginal microbiota and breastmilk composition in multiparous 
as compared to primiparous women, remains to be elucidated. 




Pets & house dust
There is limited data available on the role of in-house microbial exposure in humans, but 
an association between the bacteria found in house dust and in children has recently been 
reported [60]. Moreover, Azad et al. observed that the presence of pets might affect infant 
colonization [61], in contrast to studies which did not find a relation between the presence of 
household pets and the human gut microbiota [24, 60]. Pets might also cause the occurrence 
of certain bacteria in house dust and transfer of specific communities to humans. Infants 
living with pets showed mainly increased Peptostrepococcaceae (C. difficile) and decreased 
abundance of bifidobacteria at 4 months of age. The discrepancy between studies might 
indicate the minor role of pets and more research is necessary to confirm the association 
and identify transfer pathways. 
Geography
The microbial ecology also differs between infants from various geographical habitats. Children 
born in developing countries are characterized by enhanced levels of Prevotella and decreased 
abundance of Bacteroides in early life as compared to infants living in western countries 
[41, 62-64]. The geographical variation in colonization patterns might mainly result from 
differences in diet, as segregation of the microbiota composition into distinct geographic 
clusters becomes apparent only after weaning, i.e. the start of consumption of solid food 
[62]. The food in developing countries is low in fat and protein, and rich in fibers compared 
to the typical western diet. In addition, the advanced sanitary conditions in western countries 
compared to a less advanced infrastructure and crowded settings in developmental countries 
could also influence differences in indigenous microbial community structures. Furthermore, 
intra-continental differences between western countries have also been reported with 
lower proportions of Bifidobacterium and higher proportions of Akkermansia, Clostridium 
and Bacteroides in German infants than Finish infants [65]. The latter is in line with another 
European study that showed overrepresentation of Bifidobacterium in Northern European 
infants whereas increased diversity was detected in Southern European infants [29]. However, 
whether these differences are driven by environmental exposure, genetic make-up, or dietary 
factors is currently unclear. 
Host genetics
Host genotype is another factor with a major impact on the microbial composition, as shown 
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by studies comparing the microbiota of individuals with varying degrees of relatedness, in 
particular monozygotic as compared to dizygotic twins. Several studies using traditional 
microbial fingerprinting techniques in both children and adults reported host genetic effects 
on the microbiota composition [66-68]. A recent study analyzing the microbiota development 
by next-generation sequencing in three dichorionic triplet sets showed that at the age of one 
month the monozygotic twin pairs shared a more similar microbiota as compared to their 
fraternal siblings. By month 12 however, the profile became more uniform between the three 
infants, suggesting that host genetics initially play a significant role, while environmental 
determinants dominate by the age of 12 months [69].
By far the most comprehensive study to date examined the influence of host genetics on 
the microbiota using fecal samples of 416 pairs of adult twins from the TwinsUK cohort [70]. 
The microbiota were more similar between twin pairs as compared to unrelated individuals 
and were also more similar between monozygotic twins than dizygotic twins. By estimating 
the heritability of individual microbial taxa, it was shown that the community structure 
within the phylum Bacteroidetes was mainly shaped by environmental factors. Heritability 
appeared strongest for families within the phylum Firmicutes, including Ruminococcaceae and 
Lachnospiraceae, with Christensenellaceae being the most heritable family. Christensenellaceae 
formed a co-occurrence network with other microbes such as methanogenic Archaea and was 
associated with lean BMI. The functional relevance was illustrated by subsequent transfer of 
Christensenellaceae species to germ-free mice resulting in reduced body weight. Interestingly, 
the authors were able to validate their findings of heritability of the above-mentioned bacterial 
families by applying their statistical models to the data of two studies that had previously 
failed to reveal significant genotype effects on the microbiota [41, 71].
Furthermore, studies using a candidate gene approach examined the involvement 
of individual genes. For instance, individuals that have a functional fucosyltransferase 2 
(FUT2) gene, referred as secretors, displayed different microbial communities compared to 
non-secretors [72]. The secretor-status regulates the existence of mucosal ABH and Lewis 
blood group antigens, but also the glycosylation of the intestinal mucus and breastmilk 
oligosaccharides. In addition, fucosyltransferase 3 (FUT3) produces the Lewis A antigens in 
non-secretors and B antigens in secretors. The profiles of the human milk oligosaccharides has 
been shown to differ in accordance to maternal secretor status as well as Lewis blood group 
antigen due to genetic variations of FUT2 and FUT3 respectively [73]. In accordance, a recent 
study observed earlier colonization and higher levels of bifidobacteria in breastfed infants 




of maternal secretors [74]. Many other candidate genes have been suggested to influence 
microbiota composition. Among them in particular genes encoding immune mediators such as 
NOD2 and MEFV – reviewed in detail elsewhere [75]. The nucleotide-binding oligomerization 
domain 2 (NOD2) receptor recognizes bacterial cell wall-derived muramyl dipeptide fragments 
and regulates the release of α-defensins by Paneth cells. Consistent with an influence of 
enteric antimicrobial peptides on microbiota composition [76], expression of NOD2  has 
been shown to affect the microbial ecology in mice [77]. In humans, NOD2 mutations are 
a risk factor for the development of inflammatory bowel disease and are associated with 
microbial dysbiosis [78]. Mutations in the human gene MEFV that encodes pyrin results in 
familial Mediterranean fever, an autoimmune disease with uncontrolled interleukin (IL)-1 
release. Mutations in MEFV are associated with changes in the gut microbiota including lower 
bacterial diversity [79]. These findings highlight that the genotype of the host influences the 
intestinal microbiota composition, which in turn, may influence host metabolism. 
Antibiotics
Although the majority of common pediatric infections, e.g. upper respiratory tract infections, 
are self-limiting and caused by viruses, large volumes of broad-spectrum antibiotics are still 
being prescribed for these conditions in primary care settings [80] with little evidence for 
clinical benefit [81]. Next to being the main factor driving the development and dissemination 
of antimicrobial resistance, (over)use of antibiotics has profound and direct effects on the 
indigenous microbiota. The exact effects on the microbiota composition are dependent on 
the specific type of antibiotic, but also differ between individuals as was demonstrated in a 
study on the effects of ciprofloxacin treatment in healthy volunteers [82]. This latter study 
showed that the microbiota is relatively resilient to perturbations induced by a single course 
of antibiotics. A subsequent study, however, indicated that the microbiota composition 
may permanently shift to an alternative state upon multiple courses of ciprofloxacin [83]. 
In newborns exposed to antibiotics, obligate anaerobic genera such as Bacteroides spp. and 
Bifidobacterium spp. and Lactobacillus spp. are depleted, whereas levels of Proteobacteria 
increase [24, 84, 85]. Not surprisingly, also maternal antibiotic use during pregnancy or 
breastfeeding has been shown to affect the infant’s microbiota composition with decreased 
levels of Bacteroides spp. and Atopbium spp. [29]. Interestingly, the maternal vaginal microbiota 




To date, few studies have examined the effect of intrapartum antibiotic prophylaxis (IAP), 
a practice routinely used in pregnant women positive for group B streptococci (GBS) on the 
vaginal mucosa, on the establishment of the neonatal microbiome. GBS represents the most 
important causative agent of neonatal sepsis with often fatal outcome. In the absence of an 
available vaccine, prophylactic antibiotic treatment represents the recommended measure 
to prevent infection. Two recent studies, quantifying a selected group of bacterial genera, 
revealed a decrease in bifidobacterial abundance as well as a shift in bifidobacterial species 
composition in newborns whose mothers did receive IAP as compared to newborns without 
maternal IAP exposure [87, 88]. In addition, newborns are (indirectly) exposed to antibiotics 
during labor as prophylaxes prior to C-section. The effects on the neonatal microbiome have, 
however, not been characterized. 
Although there is little direct evidence from human studies, it is highly likely that the 
developing infant microbiota is far less resilient to antibiotic-induced perturbations than the 
microbiota of adults.  This is supported by a recent study mimicking pediatric antibiotic use 
in a mouse-model by providing early-life administration of antibiotics at therapeutic doses 
(beta-lactam and macrolides). Progressive and long-term alterations in the gut microbiota 
composition and metagenomic content were observed, varying with the number of courses 
and class of antibiotic treatment [89]. Moreover, murine antibiotic exposure in early life 
showed an altered host metabolism regarding energy harvesting and fat storage [89, 90]. 
Therefore, antibiotic use during infancy has been suggested to increase subsequent weight 
gain and enhance the risk of childhood overweight [91-93]. The latter studies indicate that 
perturbation of the microbiota in early life results in different metabolic effects even in the 
presence of a similar diet. The lack of acquisition or the extinction of specific species during 
the neonatal period might therefore represent a critical factor, emphasizing the key role of 
pioneer bacteria.




Data from human infants are commonly based on stool samples which deviate considerably 
from colonic mucosal microbiota [94]. Recent high-throughput microbial profiling also 
showed that the mucosal microbiota even varies along the complete length of the gut [95]. 
Therefore, data from animals of small intestinal and colonic microbiota provides additional 
insight on the development as well as specific host-microbe interactions. Although mice and 
rats have an increased exposure to environmental and fecal microbiota, the essence of the 
initial succession of gut bacteria in rodents reflects that in humans. In mice, the neonatal 
gut is mainly dominated by Lactobacillaceae, Streptococcus and Enterobacteriaceae [96, 
97]. The colon in mice is first established by bacteria that resemble the vaginal microbiota, 
followed by a decrease in microbial diversity and shift in dominance from Streptococcus 
to Lactobacillus [97]. The microbial abundance seems to be related to the anatomical 
complexity of the intestine, resulting in very low microbial diversity in a simple and small 
gut after birth [96]. After the introduction of solid food, the murine microbiota increases 
in strictly anaerobes such as Bacteroides, Lachnospiraceae and Clostridium. Altogether, 
animal studies further indicate that the microbiota development is multiple-phasic and 
are pivotal in unraveling host-microbiota relationships.
Window of opportunity for microbiota manipulation
The therapeutic manipulation of the gut microbiota is promising since the microbiota plays 
a crucial role in human health. For instance, fecal transplantation is a procedure that has 
recently raised a lot of scientific awareness and many intervention studies are currently 
ongoing to treat a variety of diseases. However, this method has so far only been clinically 
accepted as an effective method to eradicate C. difficile infection [98]. Moreover, numerous 
randomized placebo-controlled trials have been conducted on the efficacy of pre- and probiotic 
supplementation in pregnant women and newborns in the primary prevention of diseases 
such as necrotizing enterocolitis (NEC), atopic diseases, and (extra)intestinal infections. For 
most clinical outcomes the efficacy of pre- and probiotic supplementation is inconclusive, 
although there is evidence that probiotics might reduce the risk of atopic eczema in infants 
[99] and NEC in preterm neonates [100]. Yet, there is great heterogeneity between studies 
in terms of the probiotic strains used, dosing, duration and timing of probiotic therapy. 
The understanding and selection of the appropriate probiotics is crucial and should be 
determined by fundamental host-microbiota interactions.  Importantly, a better knowledge 
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on the bacteria that are essential for specific health effects might also stimulate the use of 
selected diets or drugs as a way to modify the microbiota. Further research is necessary to 
identify not only beneficial bacteria, but also other microbes such as Archaea and viruses 
and their interactions. This may include approaches that use phage therapy as a tool against 
specific bacteria or pathogens [101]. 
In addition, a better understanding of ecological processes and pioneer consortia 
in microbial development will be crucial to design efficacious therapies and standardized 
manipulations. The microbial maturation relies on the succession of initial bacteria during 
infancy, making early life a particular suitable period to modify the microbiota in favor of 
health-promoting bacteria. The identification of specific neonatal populations that will 
benefit most from microbiota manipulation could also be relevant in terms of personalized 
strategies e.g. following C-section delivery, intra-partum antibiotic prophylaxis or neonatal 
infections. In this respect, trials are under way in which newborns delivered via C-section 
are being exposed to the maternal vaginal microbiota directly after birth. However, further 
studies are needed to unravel the critical shaping factors of intestinal bacteria in early life in 
order to support future targeted microbial therapies to reduce the risk of disease. 
Figure 1 - Main maternal, environmental and host determinants that impact the establishment of the intestinal 
microbiota during the first year of life.  A non-exclusive listing of bacterial taxa affected by these determinants is 
depicted at the bottom of the figure. Note: the timeline is colored ranging from white to blue corresponding to a 
change in microbial diversity from low to high, respectively. Perinatal starts at rupture of the membranes.




Conclusion and future perspectives
Our knowledge on the maturation dynamics of the gut microbiota during infancy has advanced 
considerably during the past decades. The microbiota develops from the initial inoculum to 
a complex and diverse ecosystem during the first years of life and is influenced by a large 
number of perinatal environmental and maternal factors. The colonization of essential bacteria 
in the neonatal gut is important, since their lack might result in increased risk of metabolic or 
immune-associated disorders such as obesity or allergy, respectively. The establishment of 
the microbiota and its function during early life is strongly affected by the mode of delivery, 
breastmilk versus formula, and diet. Studies also emphasize the destructive role of antibiotic 
exposure in the succession of initial bacteria. In addition, the child’s living location, including 
the indoor home environment, the presence of pets and older siblings as sources for microbial 
exposure, have been suggested to impact the infant microbiota. Further studies highlighted 
the critical role of the host’s genotype in the intestinal microbiota composition, although 
these results were mostly derived from animal studies. Importantly, besides the determinants 
that select or shape the microbiota, the order of acquiring specific bacteria – the historical 
contingency - should also be taken into account. The historical contingency might be crucial 
because it defines how bacteria interact with each other and with the host, and may in turn 
influence the entire community [102]. However, the order of microbial arrivals is mainly 
stochastic and unknown, resulting in highly unpredictable microbial interactions. Therefore, 
experimental studies providing insight in the extent to which historical contingency contributes 
to microbial assembly are pivotal. Large-scale birth cohort studies generally assess the 
growth or stability of the microbiome by sampling at intervals ranging from months or 
years, but whether these dynamics sufficiently reflect the variability over a shorter period is 
unclear. As such, more regular sampling moments (weekly or even daily) within the context 
of longitudinal birth cohort studies is warranted. Moreover, further research is needed to 
unravel the functional and metabolic development of the neonatal microbiome. The integration 
of metatranscriptomics and metabolomics in future longitudinal human studies will greatly 
improve our understanding of the role of the infant’s microbiome. It will also be crucial to 
determine the impact of early microbial changes on the incidence and severity of certain 
diseases in infancy as well as in later life. Consequently, new longitudinal studies should define 
in more detail the host-microbe interactions in regard to infant’s health and provide sufficient 
follow-up to monitor the onset of non-communicable diseases. For instance, C-section may 
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have a long-term impact on child’s health, regarding immune-mediated disorders [37, 103] 
as well as increased BMI in offspring and obesity in adulthood [104]. The latter emphasizes 
the crucial role of the first inoculum and suggests that the vaginal microbiota has the ability 
to induce metabolic and immune maturation in the newborn over a prolonged time period. 
Insight into the multifaceted interactions between the microbiota and ecological as well 
as host factors are still in its infancy and need to be expanded to facilitate therapeutic or 
prophylactic microbiota manipulations. Altogether, the overall challenge will be to promote 
certain bacterial populations in early life, prevent their eradication by antibiotics, and in this 
way prevent the development of non-communicable diseases. 
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Following birth, the neonatal intestine is exposed to maternal and environmental bacteria that 
successively form a dense and highly dynamic intestinal microbiota. Whereas the effect of 
exogenous factors has been extensively investigated, endogenous, host-mediated mechanisms 
have remained largely unexplored. Concomitantly with microbial colonization, the liver 
undergoes functional transition from a hematopoietic organ to a central organ of metabolic 
regulation and immune surveillance. The aim of the present study was to analyze the influence 
of the developing hepatic function and liver metabolism on the early intestinal microbiota. 
Using metabolomic and microbial profiling in combination with multivariate analysis we 
characterized the colonization dynamics and liver metabolism in the murine gastrointestinal 
tract (n=6-10 per age group). We observed major age-dependent microbial and metabolic 
changes and identified bile acids as potent drivers of the early intestinal microbiota maturation. 
Consistently, oral administration of tauro-cholic acid or β-tauro-murocholic acid to newborn 
mice (n= 7-14 per group) accelerated postnatal microbiota maturation.




All mammalian host body surfaces and in particular the intestinal tract are colonized by 
a variety of microorganisms. The intestinal microbiota of the healthy host represents a 
dense and competitive microbial ecosystem and provides a core set of metabolic activities 
and immunostimulatory molecules, which together significantly contribute to the host’s 
metabolism, tissue development and immune maturation and protect from infection with 
enteropathogenic microorganisms [1]. Perturbations of the human intestinal microbiota 
composition have been associated with highly prevalent metabolic and immune-mediated 
diseases. Therefore, a detailed understanding of the mechanisms that establish and maintain 
a beneficial microbiota composition in the healthy host is fundamental. In particularly, this 
relates to the immediate postnatal and early infant period during which initial bacterial 
colonization accompanies dynamic fluctuations in the microbiota composition [2-5]. Notably, 
the early postnatal colonization process is of critical importance for the long-term microbiota 
composition [6], and immune maturation and thereby the susceptibility to highly prevalent 
non-communicable diseases [7]. Microbiota alterations during this time window have been 
associated with adverse consequences and an enhanced susceptibility to disease [8, 9]. 
 The fetal mucosal surfaces are sterile [10]. With birth, exposure to the maternal vaginal, 
fecal and skin microbiota establishes an early set of bacteria. With time, additional bacteria are 
incorporated generating an increasingly diverse bacterial ecosystem with significant resilience to 
exogenous perturbations [11]. The process of intestinal bacterial colonization after birth has been 
intensively studied during the last years and exogenous factors which significantly impact the 
early microbiota composition have been identified [3, 5, 12-15]. However, exogenous factors can 
explain only a limited amount of the inter-individual variation in microbiota composition [5, 16]. 
 Few studies have attempted to characterize host-mediated endogenous mechanisms 
such as for example genetic factors that shape the microbial ecosystem early after birth [17-
19]. The identification and characterization of such endogenous mechanisms is expected 
to provide insight in the functional relevance of particular aspects of the microbiota since 
they result from a long process of host-microbial coevolution [20]. In the present study, 
we aimed to unravel the impact of the developing host hepatic metabolism on the murine 
intestinal microbiota composition. To characterize the intestinal microbiota maturation, we 
first profiled the microbial composition of the small and large intestine obtained from animals 
within the same litter during the immediate postnatal period, early infancy and weaning until 
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adulthood. Subsequently, we performed a global metabolic screen in the liver tissue of the 
same animals to provide information on the site-specific metabolites. Multi-omics analysis 
identified specific bile acids associated with maturation of the early intestinal microbiota and 
subsequent interventional studies functionally confirmed and specified the role of specific 
bile acids as important drivers of microbiota development.





All animal experiments were performed in compliance with the German animal protection 
law (TierSchG) and approved by the local animal welfare committees, the Landesamt für 
Natur, Umwelt und Verbraucherschutz, North Rhine Westfalia (84-02.04.2016.A207 and 
84-02.04.2015.A293). All C57BL6J wildtype mice were bred locally and held under specific 
pathogen-free conditions at the Institute of Laboratory Animal Science at RWTH Aachen 
University Hospital. The day of birth was considered day 0, i.e. animals screened at day 1 
were approximately 24 h old and verified to have ingested breast milk (abdominal milk spot). 
Mice were weaned at PND21.
In vivo study design
To monitor microbiota and host metabolic development throughout the neonatal period into 
adulthood, intestinal and hepatic tissues were obtained from C57BL/6J mice in two different 
approaches. First, total small intestinal, colon and liver tissues were obtained from C57BL/6J 
mice aged 1, 7, 14, 21, 28, and 56 days (n=6 per timepoint). In a separate set of experiments, 
similar tissues were obtained from mice aged 0, 6, 12, 18 and 24 hours (n=10 per timepoint). 
To rule out potential litter and cage effects, we obtained tissues from a single animal of one 
litter for a given age group and repeated this by selecting a new animal from the same litter 
for every other age group (Fig. 1a). Every animal was only examined once at the indicated 
age (PND). For oral bile acid administration, PND7 animals received the indicated bile acid 
(Sigma-Aldrich, Biomol) at a concentration of 70 µg/g body weight or PBS daily for 3 days by 
oral gavage (average 5µl) with 100% succession (Lorenzo-Zuniga et al, 2003). Body weight 
and food/water consumption was monitored daily. To determine the effect of bile acid 
administration, the intestine was aseptically cut into 10-20 parts and alternately assigned 
to two collections for microbial profiling and assessment of metabolites. Samples from an 
additional group of adult 8-12 week old animals (n=5) were processed in parallel to provide 
an adult microbiota control. Tissues were transferred into sterile micro-centrifuge tubes and 
stored at -80°C before analysis. Liver tissues of 7-, 14-, 21- and 56-day-old germ-free mice 
were obtained from the Institute for Laboratory Animal Science at Hannover Medical School. 
Tissues were collected and stored in sterile tubes stored at -80°C until further analysis.
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DNA isolation and generation of sequence data
Total metagenomic DNA was isolated from snap frozen small intestinal and colonic tissues 
by repeated-bead-beating combined with chemical lysis plus a column-based purification 
method as described in detail elsewhere [21]. For each DNA isolation batch, additional 
isolation was performed on PCR-grade water as a negative control. Generation of amplicon 
libraries and sequencing was performed according to a previously published protocol [22]. 
Briefly, the V4 region of the 16S rRNA gene was PCR amplified from each DNA sample in 
duplicate. Pooled amplicons from the duplicate reactions were purified using AMPure XP 
purification (Agencourt, Massachusetts, USA) according to the manufacturer’s instructions 
and subsequently quantified by Quant-iT PicoGreen dsDNA reagent kit (Invitrogen, New York, 
USA). Amplicons were mixed in equimolar concentrations, to ensure equal representation of 
each sample, and sequenced on an Illumina MiSeq instrument using the V3 reagent kit (2x 
250 cycles). All V4 16S rDNA bacterial sequences generated in this study have been submitted 
to the Qiita and ENA databases under accession No. 10719 and ERP116798 respectively.
Sequence analysis
Data demultiplexing, length and quality filtering, pairing of reads and clustering of reads 
into Operational Taxonomic Units (OTUs) at 97% sequence identity was performed using the 
online Integrated Microbial Next Generation Sequencing (IMNGS, www.imngs.org) platform 
using default settings [23]. Removal of primers and technical reads resulted in fragments of 
approximately 250 bases. Sequencing was performed from both the 3’ and 5’ side resulting in 
sufficient resolution. IMNGS is a UPARSE based analysis pipeline [24]. Pairing, quality filtering 
and OTU clustering (97% identity) was done by USEARCH 8.0 [25]. The analysis was based on 
OTUs rather than amplicon sequence variants (ASVs) since we aimed at aggregating taxa at a 
higher level and wanted to avoid overestimation of prokaryotic diversity due to Intragenomic 
heterogeneity of 16S rRNA genes [26]. Chimera filtering was performed by UCHIME (with 
RDP set 15 as a reference database [27]. Taxonomic classification was done by RDP classifier 
version 2.11 training set 15.8 Sequence alignment was performed by MUSCLE and treeing 
by FastTree [28, 29]. A total of 21,372,397 V4 reads were generated over two runs. After 
trimming, quality filtering, removal of potential chimeric reads, de-multiplexing and removal 
of low abundant operational taxonomic units (OTUs), 15,692,587 sequences belonging to 478 
OTUs were retained for downstream analysis. Negative controls were evaluated based on 
their number of sequences and composition compared to other samples. We used for each 
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batch, sampling blank controls, DNA blank extraction controls and no-template amplification 
controls, and monitored the lack of contaminant bacterial DNA load herein by a gel-based 
principle. Moreover, we compared the acquired OTUs composition from the negative controls 
to our low abundant microbial samples to ensure that our findings were not driven by potential 
contaminant taxa. Subsequently, samples of the negative controls and with low sequencing 
depth (less than 6,749 sequences/sample) were excluded from subsequent analysis. For 
the remaining samples, the number of sequences per sample ranged from 6,749 to 239,395 
(median 87,227). 
Richness, diversity, taxonomy and enterotype analyses
Data normalization, diversity, taxonomical binning and group comparisons were performed 
using the Rhea package [30]. In order to not discard informative data, normalization in Rhea 
was performed by dividing OTU counts per sample for their total count (sample depth) followed 
by multiplying all of the obtained relative abundance for the lowest sample depth (6,749 
reads/sample). Alpha- (observed species and Shannon index) and the generalized Unifrac 
beta-diversity index were calculated using the Rhea package [31]. Additional beta-diversity 
indices (weighted Unifrac, unweighted Unifrac, and Bray-Curtis distance) were calculated 
using the R package Phyloseq [32]. Ordination of samples according to their microbial 
composition expressed as Hellinger transformed genus abundance data or beta-diversity 
indices was visualized using Principal Component Analysis (PCA) and Principal Coordinate 
Analysis (PCoA), respectively. All ordinations were constructed using the R package Phyloseq 
and included 95% confidence ellipses. Dirichlet multinomial mixtures models (DMM) were 
used to calculate genus-level enterotypes [33]. When including samples from all time-points, 
Laplace approximation revealed an optimal number of three clusters.
Downstream microbial analyses and presentation
Smoothing of the kinetic for dominant taxa (Fig. 1e and f as well as Fig. S1d and e) was 
generated using the geom_smooth function of the ggplot package with default settings. The 
lines reflect the mean values of the relative abundance. The appearance and disappearance 
of OTUs of the dominant phyla (Actinobacteria, Proteobacteria, Firmicutes, Bacteroidetes) 
with age was visualized in Sankey-plots (SankeyMATIC.com). For readability of Sankey-plots, 
only OTUs present in >10% of all samples per timepoint and with a prevalence of >20% in 
the entire dataset, were included. Ecosystem specific functional metagenome predictions 
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were created by the novel PICRUSt-iMGMC workflow with the de novo picked OTUs and using 
mouse metagenome-assembled genomes linked to 16S rRNA genes [34]. The derived KEGG 
orthologs were mapped into multiple pathways or modules. Differentially changed KEGG 
modules were identified using the pathways enrichment analyses from MicrobiomeAnalyst 
with default settings [35]. The identification of lactobacillus-related OTUs were performed 
using EZbiocloud and used to construct a phylogentic tree of lactobacilli by MEGA7 (MUSCLE) 
for alignment and iTOL v4 for the final annotations (itol.embl.de) with default settings.
Liver metabolomics and bile acid analyses
The metabolome analyses were carried out with the AbsoluteIDQ® p180 Kit (Biocrates Life 
Science AG, Austria. The kit allowed identification and quantification of 188 metabolites 
from 5 compound classes (acyl carnitines, amino acids, glycerophospho- and sphingolipids, 
biogenic amines and hexoses). The kit used flow injection tandem mass spectrometry (FIA) 
for the non-polar metabolites and LC-MS/MS for the more polar compounds. The integrated 
MetIDQ Software streamlined the data analysis by automated calculation of metabolite 
concentrations. Quantification of analytes utilized stable isotope-labelled or chemically 
homologous internal standards (IS). Controls were included for 3 different concentration 
levels. For calibration, the kit contained a calibrator mix at 7 different concentrations. The 
measurements were carried out with an ABI Sciex API5500 Q-TRAP mass spectrometer via 
Electrospray ionization (ESI) by Multi Reaction Monitoring (MRM) mode for high specificity 
and sensitivity. 158 MRM pairs were measured in positive ion mode (13 IS) and 2 MRM pairs 
were measured in negative mode (1 IS). The following additional chemicals for LC-MS were 
used: water, Millipore; PITC, Fluka; pyridine, Fluka (p.a.); methanol, Merck; Lichrosolv for LC/
MS; acetonitrile, Merck; formic acid, Sigma Aldrich. Metabolites were extracted from liver 
samples by adding H2O/acetonitrile (1:1,v:v) per mg sample followed by homogenization 
with a tissue disruptor (10 min, 30Hz, 4 steel balls). The samples were centrifuged (1400g, 
2 min) and the supernatant analysed. The targeted analysis was performed by adding 10 μL 
of extracted liver sample to the AbsoluteIDQ® p180 Kit (Biocrates Life Science AG, Innsbruck, 
Austria), following the vendor’s instructions [36]. For bile acid measurements the MS-based 
Bile Acids Kit (Biocrates Life Sciences AG, Innsbruck, Austria), a 96-well plate format assay, was 
used as described in the manufacturer´s instructions with normalization based on mass [37]. 
 The contribution of each metabolite to metabolomic variation was derived from age-
constrained redundancy analysis (RDA) based on all metabolites stratified in group levels with 
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additional scaling by normalization based on z-scores (Phyloseq package). Moreover, PCA 
was used to illustrate changes in the composition of the different metabolic groups during 
the postnatal period for both PC1 and PC2, and PC2 and PC3. For the bile acids the 2nd and 
3rd component were chosen for plotting, since the first component was mainly driven by 
the strong separation observed between the first and subsequent time points (PND1 vs. 
PND7-56).
Multi-omics analyses
Regularized canonical correlation analyses (rCCA) were performed (Mixomics package) [38] to 
unravel specific correlations between bile acids and OTUs with a minimal presence of 20% in all 
samples. Samples were excluded from the microbiota-data if they were not measured in the bile 
acid analyses (i.e. PND1 of litter 1 & 2). Prior to rCCA a hyperbolic sine transformation was used 
on OTU-counts and a log-transformation for the bile acids. For the estimation of regularization 
(penalization) parameters  λ1 and λ2, the cross-validation procedure [39] method was used. 
We used a λ1 =  0.0001, λ2 =  1 with a CV-score =  0.4779644 and 2 components. OTUs with a 
correlation between -0.3 and 0.3 on the first 2 components were filtered out to optimize the rCCA. 
 The Spearman’s rank correlation coefficient was calculated between bile acids (weight 
corrected) and bacterial genera (relative abundances) with a minimal presence of 20% in all 
samples. Benjamini & Hochberg FDR correction was performed to correct for multiple testing 
(p>0.05). For the heatmap only significant correlations with adjusted p-value of <0.05 are 
shown and sorted according to their PCA loading scores. 
Hepatic gene expression analyses
Total RNA was isolated from liver tissue using an RNeasy Plus Universal Kit (Qiagen). RNA 
concentration and purity were assessed by UV absorption measurement, and integrity was 
checked using agarose gel electrophoresis. 750 ng of total RNA was converted into single-
stranded cDNA using a SensiFAST™ cDNA Synthesis Kit (Bioline). cDNA equivalent to ca. 16 ng 
of total RNA was used as input for real-time PCR analysis, employing Sybr Green chemistry 
(SensiMix™ SYBR® Hi-ROX Kit, Bioline) and a LightCycler® 480 System [10]. All primer pairs 
(Sigma-Aldrich) were designed using PrimerBlast, and correct amplicon size was verified by 
agarose gel electrophoresis. LinRegPCR was used for analysis of real-time qPCR data. Gene 
expression data was normalized to the geometric mean of two reference genes, viz. 36b4 
and Hprt [40]. 
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Absolute abundances (16S rDNA gene qPCR)
The 16S rDNA gene copy number was determined to quantify the amount of bacterial 
genomes present in the samples and convert the relative OTU abundances into absolute 
bacterial numbers. The PCR primers 5’-CCTACGGGNGGCWGCAG-3’ (16S_341_F) and 
5’-GACTACHVGGGTATCTAATCC-3’ (16S_805_R) were used as described earlier [41]. In short, 
the real-time PCR was performed on a MyiQTM System (BioRad, USA) in a reaction-volume 
of 25 µl with 12.5 µl iQTM SYBR Green (Biorad), 2 µl template DNA and 0.75 µl primers (10 
µM). The cycling conditions were 95°C for 3 min followed by 35 cycles of 95°C for 15 s; 55°C 
for 20 s and 72°C for 30 s. Total 16S gene copy numbers were calculated by comparing the 
CT value to a standard curve with known concentrations of a plasmid encoding the target 
16S gene sequences. Absolute OTU numbers were calculated by multiplying the relative 
abundances with the 16S rDNA gene copy numbers per sample. 
In vitro culture assays
Lactobacillus johnsonii DSM 100219 similar to BA-OTU 4, Lactobacillus reuteri DSM 32035 
similar to BA-OTUs 7 & 364, Lactobacillus murinus DSM 100193 similar to the BA-OTUs 2 & 
798 and Escherichia coli DSM 28618 previously isolated from the intestine of mice [42] were 
employed for in vitro growth assays. Lactobacillus and E. coli strains were cultured overnight 
in MRS (Merck, Germany) and BHI (Sigma-Aldrich) medium, respectively. Cultures were 
diluted 1:100 and incubated in a 96-well plate (at 100 µl/well) in the absence or presence of 
1% (w/v) UDCA, TCA, GCA or βTMCA (Sigma-Aldrich, Taufenkirchen and Biomol, Hamburg) 
and incubated at 37° C for 24h under anaerobic conditions. Bacterial growth was determined 
by optical density (OD) measurements at 570 nm (OD570) and expressed as OD570 in medium 
with 1% bile acid/OD570 in medium with no bile acid supplement.
Statistical analysis
A permutational multivariate analysis of variance (PERMANOVA) using distance matrices 
(vegan::adonis) was performed in each case to determine if the separation of groups was 
significant. The Kruskal-Wallis or Mann-Whitney U test were used to test for differences 
with respect to the relative abundance of bacterial phyla, families and genera, as well as for 
differences in microbial richness and diversity. For these analyses, apart from the default 
settings we used no cutoff for relative abundance, no cutoff for median abundance, and zero 
values were included in statistics. In addition, significance of a trend was evaluated to test for 
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differences in alpha-diversity with age, by including it as a continuous variable in a regression 
model. All statistical tests were performed by two-sided approaches. Data analyses were 
performed with R and GraphPad Prism software. p values are indicated as follows: ****, 
p<0.0001; ***, p<0.001; **, p<0.01; and *, p<0.05. 
Results
Postnatal kinetic of the intestinal microbiota composition 
To investigate the postnatal gut microbial development, we obtained the complete small 
intestinal and colonic tissue from mice aged 0, 6, 12, 18 and 24 h (n=10/age group) as well as 
1, 7, 14, 28 and 56 days (n=6/age group) after birth to cover the early developmental stages 
until adulthood. To avoid litter effects, tissues for all time points in a given kinetic were taken 
consecutively from animals from one litter (Fig. 1a and Fig. S1a – schematic overview of study 
design). Amplicon sequencing of the 16S rRNA V4 gene region of these samples generated 
in total 15,692,587 high-quality sequences with a median of 87,227 [IQR 77,784] reads per 
sample. All sequences were subsequently clustered based on de novo assembly into 478 
operational taxonomic units (OTUs) that were taxonomically classified to the genus level. 
 No substantial changes in the general community structure were observed during 
the first 24 hours (Figure S1b). The bacterial richness and diversity decreased significantly 
in both small intestine and colon during the first 24 h after birth (Fig. S1c and d, Fig. S2a). 
In line with the reduced diversity, the relative abundance of almost all genera decreased 
during this early time window in both the small intestine and colon. Only the abundance of 
the genera Corynebacterium and Mannheimia increased temporarily with a peak at 6-18h 
and 24h or PND1, respectively. (Figure S1e and f). The initial decrease in richness most likely 
indicates the transient passage of bacterial species ingested during birth and shortly thereafter 
which were unable to permanently colonize the intestinal tract (e.g. Corynebacterium). The 
developmental phase thus starts as indicated by the diversification from 24 h onwards (Fig. 
1b-f) and we therefore decided to focus all subsequent analyses on these later time points. 
 Microbial richness increased from PND7 onwards in both small intestine and colon 
(Fig. 1b and c). While the bacterial richness was similar in both organs at birth (PND1), 
a significantly higher colonic richness was detected after weaning (i.e. PND28, FDRadjusted 
p=1.7x10-5, Mann-Whitney U test). Similar findings were observed for microbial diversity 
using the Shannon index (Fig. S2b). The presence, origin and loss of OTUs in small intestinal 
Chapter 3
56
and colon tissue were visualized in Sankey plots for all postnatal time points as well as for the 
maternal source (Fig. S3a and b). This analysis illustrated the contribution of OTUs from all 
four major phyla to the microbial ecosystem at the different time points after birth. Notably, 
it revealed that a significant proportion of Proteobacteria originating from an environmental 
(non-maternal) source (78.2% of colonic and 73.2% of small intestinal OTUs) contributed to the 
microbiota early after birth (PND1). In contrast, the majority of OTUs from the Actinobacteria, 
Bacteroidetes and Firmicutes phylum persisted throughout the examined time window and 
were shared with the mother (53.3-94.2% and 45.0-86.5% for the colon and small intestine, 
respectively). The early (PND1) Proteobacteria contribution was most evident in the colon, 
whereas the small intestine was most strongly influenced by Proteobacteria and Actinobacteria.
 Clear separation of the small intestinal and colonic microbial composition according to 
age was detected by principal coordinate analysis (PCoA) (Fig. 1d). The general microbiota 
community structure of the small intestine and colon was indistinguishable at the early time 
points (PND 1-21) but diverged significantly after weaning leading to a site-specific intestinal 
microbiota. This result was supported by the Dirichlet multinomial mixtures (DMM) modelling 
in which small intestinal and colonic samples from PND 1 and 7 clustered together, whereas 
two distinct clusters dominated the small intestinal and colonic microbiota from PND 21 
onwards (Fig. S2c). The taxonomic changes confirmed the late emergence of an organ-specific 
microbiota. Whereas the abundance of the most prevalent genera Mannheimia, Streptococcus, 
Escherichia, Staphylococcus and Enterococcus gradually decreased in small intestine and colon 
during the postnatal period, a relative enrichment in Lactobacillus abundance was observed 
in both organs (Fig. 1e and f).  After weaning, the relative increase in lactobacilli continued 
in the small intestine whereas a more complex composition, with expansion of Bacteroides 
and members of the Porphyromonadaceae (a.o. Muribaculum) and Lachnospiraceae families, 
developed in the colon.
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Metabolic factors with potential influence on the microbiota
The enzymatic and absorptive capacity of the intestine and the metabolic capacity of the liver 
mature significantly during the postnatal period [43-45]. The associated changes contribute 
to luminal substrate availability and could thereby influence the bacterial succession and 
overall composition [3]. To allow analysis of the same mice used for the long-term microbiota 
analysis presented above we investigated a panel of hepatic metabolites as a proxy for the 
small intestinal metabolome [46]. Major age-dependent differences were noted in particular 
between PND7 and PND21, 28 and 56 (Fig. 2a-d). Amino acids, biogenic amines, acylcarnitines 
and some glycerophospholipids showed a moderate but significant decrease between these 
timepoints, most likely due to the switch in diet during weaning (Fig. 2b-d), which is normally 
completed after day PND21. In contrast, a number of bile acids increased significantly 
after weaning in particular at PND7 vs. PND28 as well as PND7 vs. PND56 (Fig. 2c and d). 
 Constraining the ordination of all metabolites at the group level for age using Redundancy 
Analysis (RDA) indicated that variation in acylcarnitines, amino acids, glycerophospholipids, 
and sphingolipids was mainly the result of the marked differences between PND1 and all other 
age-groups (Fig. S4a-c, Fig. S5). In contrast, enterohepatic bile acids explained a major part of 
the age-dependent metabolic variation thereafter as depicted by RDA2 and RDA3 (Fig. S4d 
and e). These age-dependent metabolic shifts were further supported using unconstrained 
ordination of all metabolic groups separately, illustrating the compositional changes (Fig. 
S5a-i). 
Postnatal maturation of bile acid synthesis, modification and reabsorption
Consistently, the bile acid composition revealed a clear separation according to age along the 
second and third component with strong differences between birth and adulthood based on 
PCA (Fig. 2e). The global compositional shifts were supported by transcriptional changes of 
genes involved in bile acid synthesis in hepatic tissue. Transcripts for key enzymes of the classic 
pathway of bile acid synthesis involved in cholic acid and chenodeoxycholic acid formation such 
as Cyp7a1 and Cyp27a1 increased early (PND7-14) followed by increased Cyp8b1 mRNA (Fig. 
2f). Moreover, the key enzyme of the alternative pathway leading to chenodeoxycholic acid 
formation, Cyp7b1, was barely expressed until PND28 and unlikely to significantly contribute 
to synthesis of this bile acid within this time period. In contrast, the early elevation of Cyp2c70 
mRNA may in particular drive increased conversion of chenodeoxycholic acid to muricholic 
acids, along with cholic acid major bile acid species in mice (Fig. 2g). Notably, postnatal 
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upregulation of the key enzyme of the classical bile acid synthesis pathway Cyp7a1 was also 
observed in germ-free animals. Germ-free animals are bred and raised in the absence of 
viable bacteria and thus this postnatal upregulation occurred in a developmental, microbiota-
independent fashion (Fig. 2h). 
Age-dependent changes in the concentration of bile acids were noted within the time 
window of major alterations in the microbiota composition. Since the metabolome analysis 
was performed on liver tissue to reflect the situation in the small intestine, these changes 
throughout the postnatal time period primarily reflected the abundance of primary bile acids. 
Nevertheless, prediction of the metabolic capacity of the developing microbiota by means 
of Phylogenetic Investigation of Communities by Reconstruction (PICRUSt) using the novel 
integrated Mouse Gut Metagenomic Catalog (iMGMC) revealed an age-dependent enrichment 
of bacteria encoding for genes involved in bile acid metabolism in adults (PND56) compared 
to neonates (Fig. S6). More specifically, the predicted abundance of genes for the key enzyme 
involved in bacterial bile acid metabolism, the bile salt hydrolase (BSH, KO1442), increased 
steadily with age reaching the highest small intestinal levels approximately at PND 21-28 (Fig. 
3a). Notably, much higher abundances of BSH activity harboring bacterial taxa are observed 
in the large intestine. In addition, enhanced expression of genes encoding proteins involved 
in the hepatobiliary transport of bile acids such as Ntcp (Slc10A1), Abcb11, and Abcb4 as well 
as proteins involved in the Fxr-Fgf15-Fgfr4 negative feedback loop regulating de novo hepatic 
bile acid synthesis was observed after birth in total liver tissue as measured by RT-PCR (Fig. 
S7). Consistent with enhanced BSH activity and maturation of the hepatobiliary transport 
system, the hepatic concentration of bacterially modified secondary bile acids increased 
with age, whereas the concentration of primary bile acids decreased (Fig. 3b). Thus, the 
maturation of the host’s bile acid biosynthetic capacity and hepatobiliary transport system 
in combination with an enhanced bacterial bile acid metabolism led to a marked change 
of the total bile acid pool as well its composition after weaning. The small intestine during 
the immediate postnatal period, however, was characterized by the presence of mainly 
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Figure 3 - Enterohepatic cooperation in the maturation of the microbiota. (A) Relative abundance of the predicted 
bacterial bile salt hydrolyses (KO1442) in the small intestinal microbiota (n=5 per group, means connected and 
replicates). (B) Total concentration [µmol / gram] of primary (blue) and secondary (red) bile acids (n=3-5 per 
group, means connected and replicates). (C-D) Coefficients of the regularized canonical correlation analyses (rCCA) 
indicating the relationship between primary bile acids and small intestinal OTUs on the first component (C) and 
second component (D) (selected bile acids are highlighted in red). (E) Correlation heatmap based on the coefficients 
of the rCCA between hepatic primary bile acid concentrations and relative abundances of small intestinal OTUs 
indicated a strong positive effect (red) of GCA and UDCA on many Lactobacillus OTUs.
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Integrative analysis of metabolomic and microbiota data
To investigate the potential influence of bile acid exposure on the composition of the small 
intestinal microbiota, we next characterized the relationship between individual bile acids 
and microbial OTUs using regularized canonical correlation analysis (rCCA). rCCA aims at 
maximizing the correlation of two data sets obtained from the same animals. The first two 
components explained most of the variance with canonical correlations >0.3 (27.1% of 
variation in OTUs and 54.1% of variation in bile acids). Ursodeoxycholic acid (UDCA) and 
glycine-conjugated cholic acid (GCA) obtained the highest canonical coefficient on the first 
and second component, respectively (Fig. 3c and d). Taurine-conjugated a/b-muricholic acid 
(TMCA) and taurine-conjugated cholic acid [5] exhibited the strongest negative coefficient. 
Consistently, UDCA and GCA negatively correlated with early colonizers such as Mannheimia 
and Streptococcus and positively correlated with bacteria capable to metabolize bile acids 
such as Enterorhabdus and Lactobacillus (Fig. 3e and Fig. S8). In contrast, TMCA showed the 
opposite effect exhibiting a negative correlation with members of the Coriobacteriaceae family 
and a positive correlation with Mannheimia and Streptococcus. Notably, these patterns are in 
line with the observed changes in the concentration of specific bile acids between pre- and 
post-weaning but also early after birth and after weaning (Fig. S9). Whereas UDCA and GCA 
increased in molarity towards adulthood, the concentration of TMCA and TCA decreased over 
time. Thus, UDCA, GCA, TMCA and TCA are significantly associated with the compositional 
changes of the microbiota with age and represent good candidates of host-derived factors 
that drive postnatal establishment of the enteric microbiota.
Bile salt-mediated maturation of the neonatal gut microbiota
Next, we therefore administrated the four bile acids UDCA, GCA, bTMCA and TCA orally to 
neonate mice and evaluated the impact on the developing small intestinal microbiota. Neonate 
mice received the indicated bile acid or PBS as control by oral gavage for three consecutive 
days between PND7-PND9. At PND9, the site-specific small intestinal microbiota composition 
was determined. PCoA revealed that both TCA and bTMCA shifted the global microbiota 
composition towards a more adult-like microbiota composition (Fig. 4a-b). Consistently, 
administration of TCA and bTMCA significantly increased the richness of the small intestinal 
microbiota (Fig. 4c) and decreased the distance to the adult microbiota composition based 
on the Bray-Curtis dissimilarity analysis (Fig. 4d).  
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Figure 4 - Oral administration of bile acids to neonate mice accelerates microbial maturation. (A-B) PCoA and scores of 
the 1st axis based on Bray-Curtis dissimilarity indicating shifts in microbial community structure in the small intestine of 
adult mice (Adult), untreated neonate mice (Control) and neonate mice after oral administration of (A) GCA or TCA and 
(B) βTMCA or UDCA (Kruskal-Wallis test to controls with Dunn’s post-test and correction for multiple comparisons, median 
and interquartile range; *, p<0.05; ***, p<0.001. n=7-14, and for subsequent analyses). (C). Richness (observed species) 
of the intestinal microbiota of untreated mice (Control) and mice after oral administration of GCA, TCA, βTMCA or UDCA 
(Kruskal-Wallis test to controls with Dunn’s post-test and correction for multiple comparisons, mean and SD; *, p<0.05; **, 
p<0.01). (D). Bray-Curtis distance of untreated neonate mice (Control) and neonate mice after oral administration of GCA, 
TCA, βTMCA or UDCA compared to adult animals (Kruskal-Wallis test to controls with Dunn’s post-test and correction for 
multiple comparisons, mean and SD; **, p<0.01; ****, p<0.0001). (E-G) Relative abundance of the two most abundant 
genera Lactobacillus and Escherichia (E, F) and ratio of the abundance of Lactobacillus OTUs to Escherichia OTUs (G) in 
the microbiota of untreated neonate mice (Control) as compared to neonate mice after oral administration of GCA, TCA, 
βTMCA or UDCA (Kruskal-Wallis test to controls with Dunn’s post-test and correction for multiple comparisons, mean and 
SD; *, p<0.05; ****, p<0.0001). The abundance of these genera (E, F) and the ratio of the abundance of Lactobaccillus OTUs 




In contrast, GCA and UDCA had no impact on bacterial richness (Fig. 4c) 
or microbiota maturity i.e. the similarity to the adult microbiota (Fig. 4d). 
 A bile acid-induced shift of the small intestinal microbiota composition towards 
a more mature phenotype was further supported by the relative abundances of 
the two most abundant genera in the small intestine, Lactobacillus and Escherichia 
(Fig. 4e-f). Here, inoculation of bTMCA and UDCA enhanced the abundance of 
Lactobacillus whereas bTMCA significantly decreased the abundance of Escherichia. 
Using the Lactobacillus:Escherichia ratio as a proxy for microbiota maturity, bTMCA 
administration led to the highest ratio with a value similar to adult animals (Fig. 4g). 
 Interestingly, members (OTUs) of the lactobacillus genus responded differently to 
individual bile acids. Whereas bTMCA enhanced OTUs that were found abundantly in adults 
(Fig. 5a-c), UDCA influenced only OTUs with a minor contribution of the adult microbiota 
(Fig. 5d, e). Moreover, the annotation of these OTUs into a phylogenetic tree with their 
closely related Lactobacillus ancestors clearly indicated a genetic distinction between the 
‘UDCA-responders’ and ‘bTMCA-responders’ by falling into two separated key branches 
(Fig. 5f). Transformation of the OTU abundance in absolute bacterial numbers confirmed 
that bTMCA increased the colonization density of Lactobacillus OTUs found abundantly in 
the adult microbiota (Fig. S10a-c) and decreased the colonization of Escherichia (Fig. S10e). 
Although UDCA also decreased the absolute abundance of Escherichia (Fig. S10e), it increased 
the colonization density of Lactobacillus OTUs not typically found abundantly in the adult 
microbiota (Fig. S10a-c). This finding may explain why UDCA does not enhance the similarity 
of the neonatal microbial composition to the adult microbiota (Fig. 4d). Notably, in vitro 
analysis of the effect of UDCA, GCA, bTMCA and TCA on murine Lactobacillus isolates revealed 
a direct growth promoting effect of bTMCA on the ‘bTMCA-responders’ L. johnsonii (BA_OTU 
4) and L. reuteri (BA_OTU 7 & 364) but not on the ‘UDCA-responder’ L. murinus (BA_OTU 
796 & 2) consistent with our in vivo results (Fig. S11). UDCA exerted an inhibitory effect on 
the murine Escherichia isolate both in vitro and in vivo (Fig. S10e, Fig. S11). In contrast, an 
inhibitory effect of UDCA on Lactobacillus isolates was observed in vitro but not in vivo (Fig. 
S10 and Fig. S11). 














































































































































































































































































































































































































































































































































































































































































































































Figure 5. Differences in the impact of bile acids on the phylogenetic lactobacillus clusters. (A-E) Relative abundance 
of the Lactobacillus OTUs (A) BA OTU 7, (B) BA_OTU 364, (C) BA_OTU 4, (D) BA_OTU 798, and (E) BA_OTU 2 (Kruskal-
Wallis test to controls with Dunn’s post-test and correction for multiple comparisons, mean and SD; *, p<0.05; **, 
p<0.01; ***, p<0.001) in the small intestinal microbiota of adult mice (Adult), untreated neonate mice (Control) 
and neonate mice after oral administration of GCA, TCA, βTMCA or UDCA. (F) Phylogenetic tree of lactobacilli 
(Ezbiocloud) based on the 16S rDNA gene. The three colored branches indicate the main clusters; identified OTUs 
are assigned to the clusters and highlighted in red (purple, BA_OTU 4; green, BA_OTU 798 and BA_OTU 2; orange, 




Together, our results identify bile acids as host factors driving the postnatal small 
intestinal microbiota composition. They are in accordance with the results of a recent 
large human twin study that associated metabolic genes with the intestinal bacterial 
colonization [18]. The postnatal increase in hepatic bile acid synthesis and maturation 
of the enterohepatic cycle might therefore significantly contribute to shape the early 
intestinal microbiota. Alterations in the intestinal microbiota composition have previously 
been observed when supplementing bile acids to adult mice [47], following bile duct 
ligation in mice [48] as well as in human adults with cholestasis [49]. Yet, these changes 
have not been linked to any microbiota-driven functional benefit for the host. In contrast, 
our results in mice identify specific bile acids that promote characteristics of a mature 
and beneficial microbiota during the particularly important immediate postnatal period. 
 Careful microbiota profiling throughout the postnatal period revealed major age-
dependent compositional changes. Consistent with previous reports, monitoring the immediate 
postnatal time window revealed an initial reduction of microbial richness within the first 
24 hours after birth [2, 50, 51]. The reduction in microbial diversity immediately after birth 
most likely illustrates the inability of many bacterial species ingested during or shortly after 
birth to find their niche in the neonatal intestine and thrive. Alternatively, it may reflect 
the perinatal ingestion and intestinal passage of bacterial DNA remnants. Although not 
studied in detail so far, it is consistent with the results from previous studies in animals 
and humans that included samples from this early time window after birth [2, 52, 53]. Few 
bacterial genera such as Mannheimia and Corynebacterium exhibited a transient increase 
in abundance early after birth. The underlying mechanisms are unclear but might involve 
changes in exposure or altering environmental conditions in the gut lumen such as oxygen 
concentration, changes in substrate availability and bacterial competition as well as the 
induction of mucosal host responses. Global bacterial diversification and increasing richness 
started only thereafter and continued until after weaning in both small intestine and colon. 
 We analyzed the hepatic metabolome of the identical animals with the goal to reveal the 
site-specific spectrum of metabolites. This strategy has previously been shown to reliably reflect 
the metabolic situation in the small intestine [46, 54]. The complexity and inter-individual 
variation of both the metabolome and the gut microbiota prompted us to perform an integrative 
analytical approach by rCCR analysis. This analysis identified bile acids as potential drivers of 
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the microbiota composition. Concomitant with the transition from a hematopoietic tissue to a 
central metabolic organ, the capacity of the human liver for bile acid biosynthesis increases [45]. 
Our metabolomic and transcriptional analyses are consistent with the previous notion that the 
human neonatal liver is able to produce and secrete a significant amount of bile acids into the 
small intestine [55]. Conjugated primary bile acids dominate during the immediate postnatal 
period and also after weaning are present at high concentrations in the small intestine. They 
may well exert a significant influence particularly on the small intestine where a critical 
influence of the microbiota composition on the maturation of the mucosal immune system 
in the neonate has been demonstrated [39, 56]. Continuous maturation of the microbiota 
composition subsequently initiates the well-described bacteria-mediated modification of bile 
acids as illustrated by the rise in bile salt hydrolyse (BSH) encoding genes during weaning. 
 Bile acids due to their amphipathic character compromise the bacterial cell wall integrity 
and thereby exert a potential direct antibacterial effect, consistent with our results for 
UDCA [57]. In vivo, they might additionally synergize with other antibacterial molecules 
such as bacteriocins or host-derived antimicrobial peptides present in the mammalian 
intestinal lumen that also target the bacterial surface [58, 59]. In accordance with our 
results, a great species-specific variability in the bile acid tolerance has been reported, 
although some general phylogenetic differences exist [60] [57]. Additionally, specific bile 
acids in mice and men act as agonists or antagonists of mucosal receptor molecules that 
regulate the secretion of soluble mediators and influence the mucosal immune system and 
the global host metabolism. Induced changes may in turn indirectly influence the postnatal 
intestinal microbiota [61]. Specific direct or indirect effects might explain why the overall 
effect size of a given bile acid might not primarily depend on the concentration. Also, the 
described activities are expected to differentially affect bacterial taxa and thus, bile acids 
via a number of mechanisms could influence the composition of the intestinal microbiota. 
 Oral administration of two major conjugated bile acids, bTMCA and TCA confirmed 
their functional activity. Both taurine-conjugated bile acids enhanced the richness of the 
neonatal small intestinal microbiota and rendered it more similar to an adult composition. 
bTMCA and TCA may suppress bacteria of the neonatal microbiota thereby generating new 
niches for incoming bacteria and foster the abundance of members of the adult microbiota. 
Consistently, bTMCA lowered the abundance of Escherichia and enhanced the abundance 
of lactobacilli inverting the Lactobacillus:Escherichia ratio in an adult-like manner. Notably, 
bile acid administration did not influence all members of the Lactobacillus genus in a uniform 
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manner. bTMCA administration in vivo enhanced the abundance Lactobacillus OTUs that 
according to available databases contain BSHs and were closely related to dominant murine 
Lactobacillus species, including L. reuteri (BA_OTU 7 and 364) and L. johnsonii (BA_OTU 4) 
[62]. In contrast, OTUs related to species not containing BSHs (L. fermentum and L. pontis) 
remained unaffected [63]. BSHs have different catalytic efficiencies and substrate preferences 
[64]. Some species are known to contain multiple BSHs with different substrate specificity 
whereas others only carry a single BSH (e.g. L. reuteri) [63]. The carriage of multiple BSHs 
by the majority of L. johnsonii strains might explain why TCA also enhanced the abundance 
of BA_OTU 4 in vivo while it did not affect the OTUs related to L. reuteri. Indeed, it has 
recently been shown that BSHs from L. johnsonii significantly vary in substrate specificity [65]. 
Consistently, bTMCA exposure in vitro strongly promoted the growth of L. johnsonii and, to a 
lesser extent, L. reueri. In contrast, the growth of the BSH-negative bacteria L. murinus and 
E. coli remained unaffected.
Notably, the administered bile acid may exert its effect not only directly but also following 
bacterial modification to CA or DCA or via the induction of metabolic host changes as discussed 
above. In contrast to bTMCA and TCA, UDCA and GCA had no influence on richness and 
microbiota maturation. UDCA is highly soluble and generally considered a non-toxic bile acid 
with little activity on the host’s bile acid receptors. GCA is a representative of the glycine-
conjugated bile acids, which are common in humans but rare in mice. Substrate specificity and 
low glycine-deconjugating enzymatic capacity in the murine host’s microbiota may therefore 
explain the lack of a significant effect of GCA on microbiota richness and maturation [66]. 
 However, associations between microbial and bile acid species as observed in our multi-
omics rCCR analysis did not completely match with the microbial changes induced upon oral 
bile acid administration. These differences may reflect the time course of bile acid exposure, 
the circadian luminal concentration and the dosing. In addition, the metabolic transformation 
of administered bile acids e.g. by deconjugation or transformation of GCA and TCA to CA and 
DCA may contribute. Although human neonates other than human adults were shown to 
produce a more taurine-dominated bile acid conjugation (similar to what is seen in mice), 
differences exist between the dominant bile acid species in mice and men and our findings may 
not completely reflect the human setting. For instance, the classic pathway is the predominant 
pathway for synthesis of bile acids in human liver, whereas all pathways including the mural 
pathway contribute about equally to bile acid synthesis in rodents. However, ethical concerns 
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impede the analysis of healthy neonatal liver and small intestinal tissue samples in human 
neonates. Human fecal samples cannot be used since they mainly contain deconjugated 
and secondary bile acids [55]. Likewise, the fecal bacterial composition does not reflect the 
small intestinal microbiota [55]. Future studies need to find ways to analyse human neonatal 
liver and small intestinal tissue samples and extend the analysis to rare bile acid species. 
Moreover, further insight in the underlying mechanisms through which bile acids influence 
the microbiota maturation at the various anatomical sites of the intestinal tract is needed. 
 Insight into the ecological factors that shape the microbiome during early life 
is particularly important. These factors act during the non-redundant time-window 
after birth that critically primes the host’s immune system with life-long consequences 
on the susceptibility to inflammatory and immune-mediated diseases [7, 13]. From 
the perspective of ecological theory, bile acid concentrations and species profiles 
could potentially promote processes such as environmental filtering or niche-
based interactions. The extent to which bile acids contribute to the inter-individual 
variation in microbiota composition in humans should be the focus of future research. 
 In conclusion, we identify bile acids as host factors that shape the postnatal intestinal 
microbiota composition. The transition of the liver from a hematopoietic tissue to a central 
organ of metabolic regulation after birth might therefore significantly contribute to the 
postnatal establishment of host-microbial homeostasis. Our results might help to identify 
strategies to compensate for the adverse effects of necessary medical interventions such 
as early-life antibiotic treatment and to promote a microbial composition that is consistent 
with a beneficial host-microbial homeostasis.  
Acknowledgment




1. Integrative, H.M.P.R.N.C., The Integrative Human Microbiome Project. Nature, 2019. 569(7758): p. 641-648.
2. Palmer, C., et al., Development of the human infant intestinal microbiota. PLoS Biol, 2007. 5(7): p. e177.
3. Backhed, F., et al., Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life. Cell 
Host Microbe, 2015. 17(5): p. 690-703.
4. Hill, C.J., et al., Evolution of gut microbiota composition from birth to 24 weeks in the INFANTMET Cohort. 
Microbiome, 2017. 5(1): p. 4.
5. Stewart, C.J., et al., Temporal development of the gut microbiome in early childhood from the TEDDY study. 
Nature, 2018. 562(7728): p. 583-588.
6. Martinez, I., et al., Experimental evaluation of the importance of colonization history in early-life gut 
microbiota assembly. Elife, 2018. 7.
7. Torow, N. and M.W. Hornef, The Neonatal Window of Opportunity: Setting the Stage for Life-Long Host-
Microbial Interaction and Immune Homeostasis. J Immunol, 2017. 198(2): p. 557-563.
8. Ahmadizar, F., et al., Early-life antibiotic exposure increases the risk of developing allergic symptoms later in 
life: A meta-analysis. Allergy, 2018. 73(5): p. 971-986.
9. Cox, L.M., et al., Altering the intestinal microbiota during a critical developmental window has lasting 
metabolic consequences. Cell, 2014. 158(4): p. 705-721.
10. Leiby, J.S., et al., Lack of detection of a human placenta microbiome in samples from preterm and term 
deliveries. Microbiome, 2018. 6(1): p. 196.
11. Lozupone, C.A., et al., Diversity, stability and resilience of the human gut microbiota. Nature, 2012. 489(7415): 
p. 220-30.
12. van Best, N., et al., On the origin of species: Factors shaping the establishment of infant’s gut microbiota. 
Birth Defects Res C Embryo Today, 2015. 105(4): p. 240-51.
13. Tamburini, S., et al., The microbiome in early life: implications for health outcomes. Nat Med, 2016. 22(7): p. 
713-22.
14. Chu, D.M., et al., Maturation of the infant microbiome community structure and function across multiple 
body sites and in relation to mode of delivery. Nat Med, 2017. 23(3): p. 314-326.
15. Vatanen, T., et al., Genomic variation and strain-specific functional adaptation in the human gut microbiome 
during early life. Nat Microbiol, 2019. 4(3): p. 470-479.
16. Falony, G., et al., Population-level analysis of gut microbiome variation. Science, 2016. 352(6285): p. 560-4.
17. Benson, A.K., et al., Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple 
environmental and host genetic factors. Proc Natl Acad Sci U S A, 2010. 107(44): p. 18933-8.
18. Goodrich, J.K., et al., Genetic Determinants of the Gut Microbiome in UK Twins. Cell Host Microbe, 2016. 
19(5): p. 731-43.
19. Fulde, M., et al., Neonatal selection by Toll-like receptor 5 influences long-term gut microbiota composition. 
Nature, 2018. 560(7719): p. 489-493.
20. Dominguez-Bello, M.G., et al., Role of the microbiome in human development. Gut, 2019. 68(6): p. 1108-
1114.
21. Salonen, A., et al., Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: 
effective recovery of bacterial and archaeal DNA using mechanical cell lysis. J Microbiol Methods, 2010. 




22. Caporaso, J.G., et al., Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq 
platforms. ISME J, 2012. 6(8): p. 1621-4.
23. Lagkouvardos, I., et al., IMNGS: A comprehensive open resource of processed 16S rRNA microbial profiles for 
ecology and diversity studies. Sci Rep, 2016. 6: p. 33721.
24. Edgar, R.C., UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods, 2013. 
10(10): p. 996-8.
25. Edgar, R.C., Search and clustering orders of magnitude faster than BLAST. Bioinformatics, 2010. 26(19): p. 
2460-1.
26. Sun, D.L., et al., Intragenomic heterogeneity of 16S rRNA genes causes overestimation of prokaryotic diversity. 
Appl Environ Microbiol, 2013. 79(19): p. 5962-9.
27. Edgar, R.C., et al., UCHIME improves sensitivity and speed of chimera detection. Bioinformatics, 2011. 27(16): 
p. 2194-200.
28. Edgar, R.C., MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids 
Res, 2004. 32(5): p. 1792-7.
29. Price, M.N., P.S. Dehal, and A.P. Arkin, FastTree 2--approximately maximum-likelihood trees for large 
alignments. PLoS One, 2010. 5(3): p. e9490.
30. Lagkouvardos, I., et al., Rhea: a transparent and modular R pipeline for microbial profiling based on 16S rRNA 
gene amplicons. PeerJ, 2017. 5: p. e2836.
31. Chen, J., et al., Associating microbiome composition with environmental covariates using generalized UniFrac 
distances. Bioinformatics, 2012. 28(16): p. 2106-13.
32. McMurdie, P.J. and S. Holmes, Phyloseq: a bioconductor package for handling and analysis of high-throughput 
phylogenetic sequence data. Pac Symp Biocomput, 2012: p. 235-46.
33. Holmes, I., K. Harris, and C. Quince, Dirichlet multinomial mixtures: generative models for microbial 
metagenomics. PLoS One, 2012. 7(2): p. e30126.
34. Lesker, T.R., et al., An Integrated Metagenome Catalog Reveals New Insights into the Murine Gut Microbiome. 
Cell Rep, 2020. 30(9): p. 2909-2922 e6.
35. Chong, J., et al., Using MicrobiomeAnalyst for comprehensive statistical, functional, and meta-analysis of 
microbiome data. Nat Protoc, 2020. 15(3): p. 799-821.
36. Kenéz, Á., et al., A metabolomics approach to characterize phenotypes of metabolic transition from late 
pregnancy to early lactation in dairy cows. Metabolomics, 2016. 12(11): p. 165.
37. Pham, H.T., et al., Inter-Laboratory Robustness of Next-Generation Bile Acid Study in Mice and Humans: 
International Ring Trial Involving 12 Laboratories. The Journal of Applied Laboratory Medicine, 2019. 1(2): 
p. 129-142.
38. Rohart, F., et al., mixOmics: An R package for ‘omics feature selection and multiple data integration. PLoS 
Comput Biol, 2017. 13(11): p. e1005752.
39. Constantinides, M.G., et al., MAIT cells are imprinted by the microbiota in early life and promote tissue repair. 
Science, 2019. 366(6464).
40. Ruijter, J.M., et al., Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. 
Nucleic Acids Res, 2009. 37(6): p. e45.
41. Klindworth, A., et al., Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-
generation sequencing-based diversity studies. Nucleic Acids Res, 2013. 41(1): p. e1.
Chapter 3
72
42. Lagkouvardos, I., et al., The Mouse Intestinal Bacterial Collection (miBC) provides host-specific insight into 
cultured diversity and functional potential of the gut microbiota. Nat Microbiol, 2016. 1(10): p. 16131.
43. Muncan, V., et al., Blimp1 regulates the transition of neonatal to adult intestinal epithelium. Nat Commun, 
2011. 2: p. 452.
44. Henning, S.J., Ontogeny of enzymes in the small intestine. Annu Rev Physiol, 1985. 47: p. 231-45.
45. Grijalva, J. and K. Vakili, Neonatal liver physiology. Semin Pediatr Surg, 2013. 22(4): p. 185-9.
46. Quinn, R.A., et al., Global chemical effects of the microbiome include new bile-acid conjugations. Nature, 
2020. 579(7797): p. 123-129.
47. Van den Bossche, L., et al., Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce 
Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice. Appl Environ Microbiol, 2017. 83(7).
48. Cabrera-Rubio, R., et al., Cholestasis induced by bile duct ligation promotes changes in the intestinal 
microbiome in mice. Sci Rep, 2019. 9(1): p. 12324.
49. Li, Y., et al., Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases. Autoimmun Rev, 
2017. 16(9): p. 885-896.
50. Mueller, N.T., et al., Delivery Mode and the Transition of Pioneering Gut-Microbiota Structure, Composition 
and Predicted Metabolic Function. Genes (Basel), 2017. 8(12).
51. Wampach, L., et al., Colonization and Succession within the Human Gut Microbiome by Archaea, Bacteria, 
and Microeukaryotes during the First Year of Life. Front Microbiol, 2017. 8: p. 738.
52. Pantoja-Feliciano, I.G., et al., Biphasic assembly of the murine intestinal microbiota during early development. 
ISME J, 2013. 7(6): p. 1112-5.
53. Costa, M.C., et al., Development of the faecal microbiota in foals. Equine Vet J, 2016. 48(6): p. 681-688.
54. Sayin, S.I., et al., Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic 
acid, a naturally occurring FXR antagonist. Cell Metab, 2013. 17(2): p. 225-35.
55. Tanaka, M., et al., The association between gut microbiota development and maturation of intestinal bile acid 
metabolism in the first 3 y of healthy Japanese infants. Gut Microbes, 2020. 11(2): p. 205-216.
56. Cahenzli, J., et al., Intestinal microbial diversity during early-life colonization shapes long-term IgE levels. Cell 
Host Microbe, 2013. 14(5): p. 559-70.
57. Watanabe, M., S. Fukiya, and A. Yokota, Comprehensive evaluation of the bactericidal activities of free bile 
acids in the large intestine of humans and rodents. J Lipid Res, 2017. 58(6): p. 1143-1152.
58. Tremblay, S., et al., Bile Acid Administration Elicits an Intestinal Antimicrobial Program and Reduces the 
Bacterial Burden in Two Mouse Models of Enteric Infection. Infect Immun, 2017. 85(6).
59. Aymeric, L., et al., Colorectal cancer specific conditions promote Streptococcus gallolyticus gut colonization. 
Proc Natl Acad Sci U S A, 2018. 115(2): p. E283-E291.
60. Ridlon, J.M., et al., Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes, 2016. 
7(1): p. 22-39.
61. Wahlstrom, A., et al., Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host 
Metabolism. Cell Metab, 2016. 24(1): p. 41-50.
62. Schwab, C., et al., Gene expression of lactobacilli in murine forestomach biofilms. Microb Biotechnol, 2014. 
7(4): p. 347-59.
63. O’Flaherty, S., et al., The Lactobacillus Bile Salt Hydrolase Repertoire Reveals Niche-Specific Adaptation. 
mSphere, 2018. 3(3).
64. Foley, M.H., et al., Bile salt hydrolases: Gatekeepers of bile acid metabolism and host-microbiome crosstalk in 
Bile acids drive the newborn’s gut microbiota maturation
73
3
the gastrointestinal tract. PLoS Pathog, 2019. 15(3): p. e1007581.
65. DiMarzio, M., et al., Identification of a mouse Lactobacillus johnsonii strain with deconjugase activity against 
the FXR antagonist T-beta-MCA. PLoS One, 2017. 12(9): p. e0183564.
66. Dong, Z. and B.H. Lee, Bile salt hydrolases: Structure and function, substrate preference, and inhibitor 





















































































































































Figure S1 - Dynamics of the intestinal microbiota composition during the first 24 h after birth. (A) Im ge illustr ting 
the study outline; one mouse from each one litter was analyzed for each individual time point (Hours). (B) PCoA 
based on Bray-Curtis dissimilarity illustrating the small intestinal (SI) and colonic (C) microbial community structure 
along PC1 and PC2 during the first 24 hours (n=6-10 per group , also for subsequent analyses). (C and D) Richness 
(observed species) of the (C) small intestinal (p<0.0001, linear regression R2=0.3548) and (D) colonic (p<0.0001, 
linear regression R2=0.5360) microbiota during the first 24 hours after birth. (E-F) Changes in the relative abundance 
of the 10 most abundant genera for both the small intestine (E) and colon (F) during the first 24 h after birth.





































































































Figure S2: Postnatal dynamics in microbial diversity. (A-B) Shannon index for the small intestinal (blue) and colonic 
(red) microbiota (A) between 0-24 h after birth (n=6-10 per group) and (B) between 1-56 days (PND1-56) after birth 
(n=5 per group). (C) Three DMM-clustering profiles confirming the distinct microbial community structures of mainly 
small intestine and colon PND1-14 (C1, green symbols), small intestine PND21-56 (C2, orange symbols) and colon 










































































Figure S3 - Sankey plot tracking OTUs between PND1-PND56. (A and B) Sankey plot illustrating the origin and 
transmission of OTUs between mother and offsprings at the indicated time points after birth (postnatal day, PND). 
All OTUs shared by at least by 20 percent of the population in small intestinal (A) and colonic (B) microbiota were 
tracked and are shown individually for the four major phyla. The rectangle height indicates the relative number of 
OTUs (number of observed OTUs at a given time-point divided by the total number of OTUs within a phylum across 
all time-points) and the rectangle color reflects the age of the animals. Light grey rectangles represent the fecal 
microbiota of maternal animals. Lines represent the transfer of OTUs between different time points; the thickness 
of the line is indicative of the number of OTUs transferred. 



















































































































































































































































Figure S4 - The contribution of metabolic groups to age-dependent shifts in the metabolome. (A and B) Age-
constrained ordination using redundancy analysis (RDA) of metabolomic groups colored according to age depicting 
(A) RDA1 and RDA2 and (B) RDA2 and RDA3. (C-E) Mean contribution of individual metabolic groups to explain the 
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Figure S6 - Age-dependent metagenomic enrichment analyses. Mouse-PICRUSt based prediction of metagenomic 
information functionally annotated using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. Enrichment 
analysis of the age-dependent increases and decreases with the corresponding p-values for the top 10 differentiatially 
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Figure S7 - Maturation of the enterohepatic cycle. (A-F) Expression analysis by RT-PCR for key factors in bile acid 
transport and signaling such as (A) the sodium/bile acid co-transporter Na+-taurocholate cotransporting polypeptide 
(Ntcp), (B) the bile salt export pump ATP-binding cassette, sub-family B member (Abcb)11, (C) the lipid transport 
molecule ATP-binding cassette, sub-family B member (Abcb)4, (D) the bile acid receptor farnesoid X receptor (Fxr), 
(E) the fibroblast growth factor receptor (Fgfr)4, and (F) the Fgfr associated protein b-Klotho (bKl) in total liver tissue 

























































































































































































































































































































































Figure S8 - Correlation heatmap of primary bile acids and individual OTUs. Correlation heatmap based on the rCCA 
with significant pairs of small intestinal OTUs/bile acids (Spearman, *p<0.05, **p<0.01, ***p<0.001).





























































































Figure S9 - Changes in bile acids according to age. A-D, Concentration [µmol/gram] of the four primary bile acids 
(A) UDCA, (B) bTMCA, (C) GCA, and (D) TCA in total liver tissue (n=3-5 per group, (Kruskal-Wallis test to controls 




























































































































































































Figure S10 - Impact of orally administered bile acids on the absolute abundance of lactobacilli in the small intestinal 
microbiota. (A-F) Absolute abundances of the dominant lactobacillus OTUs (A) BA_OTU 7, (B) BA_OTU 364, (C) 
BA_OTU 4, (D) BA_OTU 798,  (E) Escherichia and (F) BA_OTU 2 following oral administration of the indicated bile acids 
calculated based on the results of a quantitative analysis of the total 16S rDNA gene copy number (Kruskal-Wallis test 




















































Figure S11: Direct influence of bile acids on bacterial survival and growth. Influence of UDCA, TCA, GCA and 
bTMCA at a concentration of 1% on the anaerobic growth of representative murine lactobacillus and E. coli isolates 
as illustrated by the relative growth in the presence/absence of bile acid supplementation over 24 h (ΔOD570 in 
medium with 1% bile acid/ΔOD570 in medium with 0% bile acid). 
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The gut microbiota represents a complex and diverse ecosystem with a profound impact on 
human health, promoting immune maturation, and host metabolism as well as colonization 
resistance. Important members that have often been disregarded are the methanogenic 
archaea. Methanogenic archaea reduce hydrogen levels via the production of methane, thereby 
stimulating food fermentation by saccharolytic bacteria. On the other hand, colonization by 
archaea has been suggested to promote a number of gastrointestinal and metabolic diseases 
such as colorectal cancer, inflammatory bowel disease, and obesity. Archaea have been 
shown to be absent during infancy while omnipresent in school-aged children, suggesting 
that colonization may result from environmental exposure during childhood. The factors that 
determine the acquisition of methanogenic archaea, however, have remained undefined. 
Therefore, we aimed to explore determinants associated with the acquisition of the two 
main gastrointestinal archaeal species, Methanobrevibacter smithii and Methanosphaera 
stadtmanae, in children. Within the context of the KOALA Birth Cohort Study, fecal samples 
from 472 children aged 6-10 years were analyzed for the abundance of M. smithii and M. 
stadtmanae using qPCR. Environmental factors such as diet, lifestyle, hygiene, child rearing 
and medication were recorded by repeated questionnaires. The relationship between these 
determinants and the presence and abundance of archaea was analyzed by logistic and linear 
regression respectively. 369 out of the 472 children (78.2%) were colonized by M. smithii, 
and 39 out of the 472 children (8.3%) by M. stadtmanae. The consumption of organic yogurt 
(odds ratio: 4.25, CI95: 1.51; 11.95) and the consumption of organic milk (odds ratio: 5.58, 
CI95: 1.83; 17.01) were positively associated with the presence of M. smithii. We subsequently 
screened raw milk, processed milk and yogurt samples for methanogens. We identified 
milk products as possible source for M. smithii, but not M. stadtmanae. In conclusion, M. 
smithii seems present in milk products and their consumption may determine archaeal gut 
colonization in children. For the first time, a large variety of determinants have been explored 
in association with gut colonization by methanogenic archaea. Although more information is 
needed to confirm and unravel the mechanisms in detail, it provides new insights on microbial 
colonization processes in early life. 




The human gut contains a complex and diverse ecosystem consisting of hundreds of 
microbial species that are acquired during the first years of life [2]. Although a myriad 
of bacterial species has been studied within the human infant gut, important colonizers 
that are often disregarded are the methanogenic archaea [3]. At present, 5 methanogenic 
archaea species and two halophilic archaea have been isolated from human feces from 
which only the Methanobrevibacter smithii (M. smithii), Methanosphaera stadtmanae 
(M. stadtmanae) and Methanomassiliicoccus luminyensis (M. luminyensis) have been 
detected more than once [4-9]. A previous study from Dridi et al. showed that the most 
dominant archaeal gut inhabitant is M. smithii with a prevalence of 88% in children 
of 0 to 10 years of age. In contrast, M. stadtmanae and M. luminyensis tend to colonize 
the child’s gut less frequently with a prevalence of 11% and 1%, respectively [10]. 
 Upon colonization, methanogenic archaea are responsible for producing the 
majority of methane in the gut by reducing carbon dioxide into methane in the presence 
of hydrogen [11]. The hydrogen in the gut is mainly the result of bacterial fermentation, 
and accumulation of hydrogen subsequently inhibits this process of breaking down food 
components for energy. Therefore, reduction of hydrogen levels by methanogens stimulates 
food fermentation by saccarolytic bacteria [12, 13]. On the other hand, colonization 
by archaea has been suggested to be potentially detrimental for host health due to 
alterations in gut metabolism and syntrophic interactions with other microbes [11, 14-
17]. For instance, in previous studies higher levels of archaea and excreted methane were 
found in patients with gastrointestinal and metabolic diseases such as colorectal cancer, 
inflammatory bowel disease, irritable bowel syndrome, constipation and obesity [18-24]. 
 Methanogenic archaea have been shown to be absent during infancy while omnipresent 
in school-aged children and their presence seems to increase with age [10]. The latter suggests 
that colonization may result either through exposure to sources of archaea during childhood, 
or through factors shaping the gastrointestinal ecophysiology to make the gut more favorable 
for archaeal colonization during this time period. The factors that determine the acquisition 
of methanogenic archaea, however, have remained undefined. Although the rumen of beef 
cattle has been shown to be a carrier for M. smithii and M. stadtmanae [25], these human 
gut colonizers have not been identified in selected food products so far [26]. Moreover, no 
study has conducted a comprehensive analysis on potential lifestyle and dietary determinants 
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of human gut colonization by these methanogenic archaea. Therefore, we aimed to explore 
a wide variety of potential determinants associated with the acquisition of the two main 
archaeal species, M. smithii and M. stadtmanae, in children. To this end, we used extensive 
data on determinants prospectively gathered through repeated questionnaires within the 
KOALA Birth Cohort Study in combination with data on presence and abundance of M. smithii 
and M. stadtmanae obtained from fecal samples in children of 6 to 10 years. 





This study was conducted within the KOALA Birth Cohort Study in the Netherlands. The 
study design has been described in detail elsewhere [27]. In summary, 2834 pregnant 
women were recruited between October 2000 and December 2002. Pregnant women 
with a conventional lifestyle (N=2343) were recruited from an ongoing cohort study on 
pregnancy-related pelvic girdle pain in the Netherlands. In addition, pregnant women with 
an ‘alternative’ lifestyle (N=491) were recruited through organic shops, anthroposophical 
doctors and midwives, anthroposophical under-five clinics, Steiner schools and 
magazines for special interest groups. The ‘alternative’ lifestyle was expected to differ 
from the ‘conventional’ lifestyle in vaccination practices, use of antibiotics, dietary habits 
(breastfeeding, organic foods, and vegetarian diet) and child rearing practices [27].  
 Parents of a subgroup of children (N=1204) were approached for the collection of 
a fecal sample of their child at age 6-10 (Figure 1). Fecal samples were provided by 669 
children. Transport time exceeded 4 days for 197 samples, which were therefore excluded 
from analyses. As a result, quantitative real-time PCR analysis was performed on 472 fecal 
samples. Informed consent was given by all parents, and the study was approved by the 





Figure 1 -  Flowchart illustrating how the population under study (n=472) was obtained from the KOALA Birth 
Cohort Study population
Fecal sampling
Parents received a stool sample kit consisting of a feces collection tube with a spoon attached 
to the lid (Sarstedt, Nürnbrecht, Germany) together with an instruction form on fecal collection. 
After collection, the fecal sample was sent to the Department of Medical Microbiology at 
the Maastricht University Medical Center+ by mail. Upon arrival fecal samples were 10-fold 
diluted in Peptone Water (Oxoid CM0009) containing 20% (vol/vol) glycerol (Merck, Darmstadt, 
Germany) and stored at -80ºC until further analysis.
Fecal DNA isolation and quantitative real time PCR 
Repeated-Bead-Beating (RBB) plus a column-based purification method was used to isolate 
DNA as described in detail elsewhere [28, 29]. Afterwards, DNA concentration and purity were 
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determined by the Nanodrop 1000 spectrophotometer (Thermo Fisher Scientific, Wilmington, 
USA). For the enumeration of M. smithii and M. stadtmanae all fecal samples were subjected 
to 5’-nuclease based real-time PCR assays. Primers and probes employed for PCR and the 
amplification and quantification process as performed on an Applied Biosystems Prism 7000 
sequence detection system (Applied Biosystems) have been described in detail elsewhere 
[20]. In short, quantification of the abundance of M. smithii and M. stadtmanae in fecal 
samples was achieved by comparing the cycle threshold (Ct) values to a standard curve. The 
standard curves were constructed by subjecting serial tenfold dilutions of positive plasmid 
constructs containing the target sequences of M. smithii and M. stadtmanae to the same 
qPCR assays. The lower limit of detection was 3.81 log10 copies/g feces for M. smithii and 
4.82 log10 copies/g feces for M. stadtmanae. Further details on qPCR assays and conditions 
can be found elsewhere [20].
Determinants
Information on potential determinants was collected by repeated questionnaires in the KOALA 
Birth Cohort Study. Information was requested from 34 weeks of gestation until 6-7 years of age. 
Questionnaires covered multiple topics including dietary habits (food frequency questionnaires 
(FFQ)), lifestyle characteristics, hygiene, child rearing practices, diseases and medication use. 
Determinants of interest were selected based on findings from previous research on the 
establishment of the microbiota and the availability of information in repeated questionnaires. 
 Determinants selected for analysis were: age of the child at time of fecal sample 
(continuous in years), recruitment group (conventional cohort, alternative cohort), child’s 
gender, maternal education (low: primary school, preparatory vocational or lower general 
secondary school; middle: vocational, higher general secondary or pre-university; high: 
higher vocational or academic education), maternal diet during pregnancy (conventional; 
organic/biodynamic), place and mode of delivery (vaginal delivery at home; vaginal delivery 
in hospital; artificially induced delivery in hospital; caesarean section in hospital), gestational 
age (continuous [weeks]), birth weight (continuous [grams]), regularly cleaning of pacifier in 
boiling water (no, yes), duration of pacifier use (never, short [until 7 months], long [at least 
until 12 months]), first time exposure to antibiotics during the first 2 years of life (Never, at 
0-3 months, at 3-7 months, at 7-12 months, at 12-24 months), number of siblings at 1 year 
of age (0, 1, ≥2), regular stay at daycare during the first 2 years of life (never; at host parent 
or daycare; host parent and daycare combined), vitamin D/AD supplementation during the 
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first 2 years of life (no; yes), number of siblings at 4-5 years of age (0; 1; ≥2), type of pets 
kept during life of the child (none; dog; cat; other; combination), exposure to farm (animals) 
during the last 12 months at 6-7 years of age (never; pigs; chicken/pigeons; ox/goat/sheep/
horse; children’s farm visits; combination), antibiotic use within 1 year prior to fecal sampling 
(no; yes), child’s diet at 6-7 years (conventional; >25% organic/biodynamic), vegetarian diet 
of child (no; yes), total energy intake (continuous [kcal]), carbohydrate intake (continuous 
[en%]), protein intake (continuous [en%]), animal protein intake (continuous [en%]), fiber 
intake (continuous [grams]), regular intake of organic raw vegetables (no; yes), regular intake 
of organic fruit  (no, yes), regular milk consumption (at least once per week; no, yes), regular 
organic milk consumption (at least once per week; no, yes), regular cheese consumption (at 
least once per week; no, yes), regular organic cheese consumption (at least once per week; 
no, yes), regular yogurt consumption (at least once per week; no, yes), regular organic yogurt 
consumption (at least once per week; no, yes).
Statistical analysis
Characteristics of the present study population (N=472) and the total KOALA birth cohort 
(N=2834) are presented as median plus range for continuous variables and as frequency (n 
(%)) for categorical variables.
 Multivariable logistic regression models were used to assess the association between 
potential determinants and the presence of M. smithii and M. stadmanae, respectively. 
Multivariable linear regression models were used to assess the association with M. smithii 
abundance. Variable selection for the regression models was based on purposeful selection 
as described by Hosmer & Lemeshow (Hosmer and Lemeshow, 2000). A multivariable model 
was fitted including all determinants identified from univariable models with a p-value 
of < 0.25. This model was further reduced to only include variables with either a p-value 
lower than 0.10 or variables that affected the parameter estimate (β) of other variables 
in the model by more than 20%, as recommended by Bursac, Gauss [30]. This model was 
subsequently refitted with variables that were not statistically significant (i.e. p > 0.25) in 
univariable analyses. Afterwards, the model was reduced as described before (p < 0.10), but 
only for the added variables. As a result, all variables included in the main effects model were 
statistically significant or made an important contribution based on the presence of other 
variables in the model [30]. After completion of purposeful selection the resulting main effects 
model was additionally adjusted for the following covariables of prior interest: age at time of 
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fecal sampling (years), gender (male, female), total energy intake (kcal), recruitment group 
(conventional, alternative) and BMI (z-score). For determinants with more than 30 missing 
values a missing value group was constructed. Models were checked for multicollinearity 
through Variance Inflation Factor (VIF) scores. If VIF scores exceeded 10, determinants causing 
multicollinearity were separated into independent models to obtain effect estimates without 
multicollinearity for the affected determinants. To limit the number of spurious associations, 
results from multivariable analyses were corrected for multiple comparisons by adjusting 
α by Benjamini-Hochberg procedure at a false discovery rate (FDR) level of q=0.05 [31]. 
 In secondary analyses, the impact of the number of consumed organic dairy products, 
and organic as well as raw vegetable and fruit products on the presence and abundance of 
M. smithii and M. stadtmanae was examined. For this purpose the individual variables for 
organic dairy (cheese, milk and yogurt) and organic fruit and raw vegetables were grouped 
into index variables as follows: number of different organic dairy products (0; 1; 2; 3), number 
of different organic raw vegetable and fruit products (0; 1; 2). Since organic dairy products 
were significantly associated with the presence of M. smithii, analyses were extended to 
yogurt, milk and cheese, irrespective of organic or conventional origin. For all statistical 
analyses IBM SPSS version 23 (SPSS Inc., Chicago, IL) was used.
Archaeal presence in milk
To validate findings from this study, publicly available data from another study was used 
to identify archaea in 975 raw milk samples collected from 899 tanker trucks [1]. These 
individual trucks arrived at two dairy processors in San Joaquin Valley of California for 
product manufacturing during three seasons between October 2013 and September 
2014. The sequences of the 16S rRNA V4 regions were obtained via the Qiita database 
(https://qiita.ucsd.edu) under study ID 10485, and further analyzed within Qiime [32] 
 Processed milk and yoghurt samples were collected from biodynamic, organic and 
non-organic brands from the supermarket (Supplementary Table 1). Raw unprocessed milk 
was obtained from a local farmer via a standard tap-procedure (Brunimat). Metagenomic 
DNA was extracted from dairy products with the PowerFood™ Microbial DNA Isolation kit 
(MoBio Laboratories Inc.) according to manufacturer’s instructions as evaluated in detail 
elsewhere [33]. In short, cell lysis with chaotrophic agents and bead-beating plus a column-




Fecal samples from 472 children with a median age of 7.2 (6.0-12.0) years were analyzed. 
Of these, 369 (78.2%) out of 472 were colonized by M. smithii, while 39 (8.3%) out of 472 
children were colonized by M. stadtmanae. Due to the low colonization rate of M. stadtmanae, 
analyses on its abundance were not performed in this study. Supplementary table 2 shows 
participant characteristics of the KOALA Birth Cohort Study (n=2834) and the study population 
(n=472) for all selected determinants. In general, the distribution of participant characteristics 
of the study population was similar to the population of the entire KOALA Birth Cohort Study.
Methanobrevibacter smithii presence and abundance
The multivariable regression models (Table 1 and Supplementary Table 3) showed a positive 
association between organic yogurt and organic milk consumption and M. smithii colonization. 
Children who regularly consumed organic yogurt were more than four times as likely to 
be colonized by M. smithii as compared to children who did not consume organic yoghurt 
(ORadjusted: 4.25 95% Confidence Interval (CI95): 1.51; 11.95), whereas children consuming 
organic milk were even over 5 times more likely to be colonized by M. smithii as compared to 
children who did not consume organic milk (ORadjusted: 5.58, CI95: 1.83; 17.01). We subsequently 
performed secondary analyses to examine the effect of the number of different organic dairy 
products being consumed on M. smithii colonization (Table 2 and Supplementary Table 4). 
These analyses showed a statistically significant increasing trend between the number of 
dairy products consumed and the chance of colonization by M. smithii (Table 2, p=0.002).
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Table 1. Final multivariable logistic regression model showing the association between potential determinants and 
the presence of Methanobrevibacter smithii. Adjusted main effects model (N=419)a
Determinant OR (CI95%) FDR crit.b p-value
Regular intake of organic milkc, d
No Ref.
Yes 5.58 (1.83; 17.01) 0.006 0.003f
Regular intake organic yogurtc, d
No Ref.




Organic (incl. biodynamic) (>25% organic) 0.36 (0.17; 0.79) 0.011 0.010f
Fiber intake (g)e 0.95 (0.88; 1.03) 0.028 0.250
 
a Model adjusted for: age at fecal sampling (years), gender (male/female), recruitment group (conventional/
alternative), total energy intake (kcal) and BMI (z-score); b critical FDR cut-off level as determined by Benjamini-
Hochberg procedure; c Missing value category omitted (included in FDR correction); d Due to multicollinearity both 
regular intake of organic milk and regular intake of organic yogurt were included in separate models, which included 
all other variables as listed in this table; e Parameter estimates presented for the model containing organic milk 
intake. Parameter estimates did not change substantially when the variable ‘organic milk intake’ was replaced by 
the variable ‘organic yoghurt intake’ (data not shown); f Significant association after correction for FDR by Benjamini-
Hochberg procedure.
Table 2. Secondary multivariable logistic regression model estimating the impact of the number of organic dairy 
products on the presence of Methanobrevibacter smithii.
M. smithii presence
Adjusted main effects model (N=406)a
Determinant OR (CI95%) FDR crit.b p-value
First exposure to antibiotics (during first 2 years of life)
Never Ref.
At 0-7 months 0.61 (0.33; 1.13) 0.020 0.115
At 8-12 months 1.20 (0.58; 2.49) 0.035 0.631
At 13-24 months 0.78 (0.39; 1.57) 0.030 0.490
Regular intake of organic products (cheese, milk and yogurt)




Organic (incl. biodynamic) (>25% organic) 0.30 (0.14; 0.65) 0.010 0.002c
a Model adjusted for: age at fecal sampling (years), gender (male/female), recruitment group (conventional/
alternative), total energy intake (kcal) and BMI (z-score); b Critical FDR cut-off level as determined by Benjamini-
Hochberg procedure; c Significant association after correction for FDR by Benjamini-Hochberg procedure.
For all other potential determinants that have been examined in the present study, no 
relationship with M. smithii colonization was found. Moreover, when examining the relationship 
between M. smithii colonization and the consumption of dairy products, irrespective of organic 
or conventional origin, we did neither find an association for milk nor for yogurt and nor for 
Chapter 4
96
cheese consumption. In contrast to the analyses on the presence of M. smithii, none of the 
determinants assessed in this study were positively associated with the abundance of M. 
smithii (Supplementary Tables 5 & 6). In models for both M. smithii presence and abundance 
the model adjustment by a priori selected covariates did not meaningfully alter parameter 
estimates. The minimal effect of these covariates on parameter estimates indicates that 
models for M. smithii were robust.
Methanosphaera stadtmanae presence
Multivariable regression analyses on the presence of M. stadtmanae showed no significant 
results after FDR correction (Supplementary Table 7). However, after adjustment for a priori 
selected covariables birth by caesarean section (OR: 6.89, CI95: 2.09; 22.67), first exposure 
to antibiotics at 13-24 months (OR: 3.38, CI95: 1.34; 8.50) and organic fruit intake (OR: 4.73, 
CI95: 1.64; 13.62) were associated with an increased M. stadtmanae presence (Table 3). In 
secondary analyses to examine the effect of the number of organic fruit and vegetable products 
consumed on the presence of M. stadtmanae no significant trend was found (p=0.321).
In models for M. stadtmanae presence minor differences in model estimates were found 
after adjustment for a priori selected covariates. These differences may indicate underlying 
relationships between potential determinants and a priori selected covariates or model 
instability of M. stadtmanae models.
Verification of archaeal presence in milk
To evaluate the contribution of milk and yogurt to gut colonization by Archaea, we re-analyzed 
16S sequence-data of raw milk from a previous study [1] as only the bacterial results of 
these samples from 899 tanker trucks were reported in the original publication. The relative 
abundances showed that the vast majority of all recovered archaeal sequences could be 
assigned to the genera Methanobrevibacter (87.70%) and Methanosphaera (3.63%) compared 
to the other 10 (<1.70%) (Figure 2). In addition, 947 out of the 975 milk samples (97.13%) 
were positive for Methanobrevibacter while Methanosphaera sequences were present in 
348 of the milk samples (35.69%). To further assess the absolute counts of methanogens 
in dairy products, we subsequently screened unprocessed raw milk, pasteurized milk, and 
pasteurized yogurt samples (Supplementary Table 1). M. smithii and M. stadtmanae were 
quantified by qPCR on isolated DNA of these samples. Although M. smithii could not be 
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detected in yogurt samples, we found significant levels of M. smithii in milk (Figure 3). The 
average absolute counts in processed milk was highly similar for biodynamic (2.63 log10 
DNA copies/ml), organic (2.88 log10 DNA copies/ml) and conventional milk (2.94 log10 DNA 
copies/ml). However, raw milk (3.73 log10 DNA copies/ml) showed higher M. smithii counts 
compared to processed milk. For M. stadtmanae, no detectable levels could be measured 
in any of the samples. In conclusion, we identified milk as a possible source off M. smithii.
Table 3. Final multivariable logistic regression model showing the association between potential determinants and 
the presence of Methanosphaera stadtmanae.
M. stadtmanae presence
Adjusted main effects model (N=420)a
Determinant OR (CI95%) FDR crit.b p-value
Birthweight (g)c 1.001 (1.000; 1.002) 0.019 0.028
Place and mode of deliveryc
Natural birth at home Ref.
Natural/artificial birth at hospital 1.61 (0.67; 3.88) 0.034 0.288
Caesarean section 6.89 (2.09; 22.67) 0.003 0.002f
First exposure to antibiotics (during first 2 years of life)c
Never Ref.
At 0-7 months 0.54 (0.16; 1.83) 0.038 0.323
At 8-12 months 0.70 (0.21; 2.36) 0.050 0.566
At 13-24 months 3.38 (1.34; 8.50) 0.013 0.010f
Regular intake of organic milkd, e
No Ref.
Yes 3.52 (0.97; 12.73) 0.022 0.056
Regular intake of organic yogurtd, e
No Ref.
Yes 1.690 (0.49; 5.86) - 0.409
Regular intake of organic fruitc
No Ref.
Yes 4.73 (1.64; 13.62) 0.006 0.004f
Animal protein intake (en%)c 0.77 (0.65; 0.92) 0.009 0.004f
 
a Model adjusted for: age at fecal sampling (years), gender (male/female), recruitment group (conventional/
alternative), total energy intake (kcal) and BMI (z-score); b Critical FDR cut-off level as determined by Benjamini-
Hochberg procedure; cParameter estimates presented for the model containing organic milk intake. Parameter 
estimates did not change substantially when the variable ‘organic milk intake’ was replaced by the variable 
‘organic yoghurt intake’ (data not shown); d missing value category omitted (included in FDR correction); e Due to 
multicollinearity both regular intake of organic milk and regular intake of organic yogurt were included in separate 




Figure 2 - Variation in the relative abundances of dominant Archaea taxa in raw milk of re-analyzed 16S sequence-
data from Kable, Srisengfa [1]. Data represent the abundances of the various archaeal taxa (found at 0.1% or greater) 
as proportion of the total archaeal populations in raw tanker milk. Relative abundances of OTU’s rarified at 15,000 
sequences / sample are indicated at their highest identified taxa. (o) order. (f) family. (g) genus.
Figure 3 - Absolute counts of M.smitthii in whole or full-fat dairy products (n=2-3). Replicates (n) denotes repeated 
isolation and quantification of the product. Average counts were calculated from archaea positive samples only.
Discussion
To the best of our knowledge, this is the first large-scale explorative study investigating the 
associations between a wide range of potential determinants and intestinal colonization 
by methanogenic archaea in school-aged children. We found that consumption of organic 
yogurt and milk products is related to colonization of M. smithii in particular. Moreover, we 
identified M. smithii in raw and processed milk, which could therefore be considered as 
potential sources for archaeal colonization.
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 The difference in metabolic activity might be a possible explanation for the large 
difference in the prevalence of the two main intestinal archaea. M. smithii is responsible for 
producing the majority of methane in the gut by reducing carbon dioxide using hydrogen as 
the primary electron donor. Alternatively, M. smithii can use formate as a direct substrate 
to produce methane [11]. In contrast, M. stadtmanae is only able to produce methane from 
hydrogen [12]. Moreover, colonization by M. smithii and M. stadtmanae might originate from 
different environmental sources, which could explain their different prevalence. Factors that 
play a role in the acquisition of methanogenic archaea are largely unknown. However, the 
environment is assumed to play a crucial role in gut colonization. This view is strengthened 
by a twin study that indicated that not genetic factors, but shared and unique environmental 
factors were of importance for the occurrence of methanogens in humans [34]. The prospective 
design and long-term follow-up allowed us to examine a wide range of environmental, dietary 
and life-style associated determinants throughout childhood. Out of the determinants present 
during infancy, caesarean section compared to vaginal delivery at home, first exposure to 
antibiotics in the 2nd year of life compared to no antibiotic treatment during the first two 
years and organic fruit consumption were associated with increased odds of colonization by 
M. stadtmanae. These findings on M. stadtmanae in the present study need however to be 
interpreted with great care. Due to the small group of children colonized by M. stadtmanae 
(n=39), models for M. stadtmanae were prone to instability. Therefore, these factors need to be 
verified in other studies with, preferably, larger sample sizes. In particular, the association with 
birth mode is in contrast with previous findings that intestinal colonization by methanogenic 
archaea in neonates and infants is very rare [35]. However, it could be postulated that the 
pioneer species associated with caesarian section delivery drive a subsequent colonization 
pattern that is more favorable for the establishment of M. stadtmanae at a later stage. As such, 
it is important to study the co-occurrence and co-exclusion of archaea and bacterial taxa in 
future studies, in order to identify microbial networks that might favor archaeal colonization. 
 Although one previous study found females to be more often colonized by 
methanogenic archaea than males [34], the current view is that there is no association 
between methanogenic archaea and gender [36]. In this study, we assessed fecal samples 
of 244 (51.7%) males and 228 (48.3%) females. Of all males under study 187 (76.6%) 
were colonized by M. smithii, while 182 (79.8%) females were colonized by M. smithii. 
Furthermore, 19 (7.8%) males were colonized by M. stadtmanae. This was similar to the 
colonization by M. stadtmanae in females, as 20 (9.6%) females were colonized. Moreover, 
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we also did not find an association between gender and either M. smithii or M. stadtmanae. 
 So far, only one study assessed potential carriers of archaea in food, but yoghurt and 
milk have not been assessed herein [26]. The present study suggests an association between 
dietary factors and archaeal colonization, as organic yogurt and milk were significantly 
associated with the presence of M. smithii. Due to the high correlation between organic 
milk and yoghurt intake, we were however not able to disentangle whether only organic 
milk or organic yoghurt or both were truly responsible for the association with M. smithii 
during multivariable analyses. Cheese was however not associated with M. smithii 
colonization, which is in line with previous findings where no M. smithii or M. stadtmanae 
were detected in different types of cheese [26]. Analyses on the number of dairy products 
consumed, used to address multicollinearity, indicated that the consumption of multiple 
different dairy products might be associated with an increased M. smithii presence. 
 A well-known carrier of M. smithii and M. stadtmanae is the rumen of beef and cows [25, 
37]. Therefore, it is likely that products derived from cows, such as dairy products, may contain 
some of these taxa, which was reflected in our results. Moreover, these specific methanogenic 
archaea have also been found in soil which could be the route of origin to cows as revealed from 
the Integrated Microbial Next Generation Sequencing database [38]. The archaeal presence 
in soil might be the underlying reason that especially organic products were associated with 
colonization. Organic cows have more outdoor access compared to conventionally farmed 
cows and could therefore have increased archaea uptake. Additionally, drugs for organic cows 
are less prescribed whereas conventional cows more often receive antibiotics to prevent 
microbial infections [39]. Methanogens are susceptible to antibiotics such as bacitracin, a 
commonly used antibiotic in cattle, which might eliminate them [40]. Although the screening of 
multiple dairy products indicated the presence of M. smithii in both conventional and organic 
dairy products, the latter could alternatively explain the lack of association of consumption 
of conventional dairy products with M. smithii colonization within our  cohort study. 
 As the culture-independent techniques applied in the present study do not 
distinguish viable microbes from cell-free DNA originating from lysed microorganisms, 
we cannot completely exclude that dairy products only contain archaeal DNA instead 
of viable archaea. However, we used the concentrated pellet of the microbial cells for 
downstream analyses of milk products, thereby minimizing the detection of circulating 
cell-free DNA. It is therefore likely that a living fraction of archaeal cells has been measured. 
 For milk, the typical neutral pH is viable for both M. smithii and M. stadtmanae, 
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which favor an optimal pH of 6.9-7.4 whereas yogurt has a more acidic environment 
[36, 41, 42], which might explain why we could not detect methanogenic archaea in 
yoghurt samples. In addition, methanogens have been discovered in a wide variety of 
extreme environments with temperatures until at least 100°C [43, 44]. The latter might 
indicate that these microbes could resist heat treatments and pasteurization performed 
for milk products. All in all, this strengthens the possibility that viable methanogenic 
archaea could indeed be present in milk products, even after thermal processing. 
 To get definite prove that milk products are a source of archaea, future studies using 
either culture-based methods or molecular methods that enable differentiation between 
intracellular and cell-free DNA, such as the use of propidium monoazide (PMA) as a membrane 
impermeable DNA intercalating dye [45], are warranted. Several studies already identified living 
bacteria with an implemented PMA-assay in both human feces and processed milk [46-49]. 
 In conclusion, dairy products, in particular organic milk products, may play an influential 
role in the colonization of the gut by M. smithii in children. Moreover, M. smithii seems to be 
present in both raw and commonly consumed milk products. For the first time, a large variety 
of determinants have been explored in association with gut colonization by methanogenic 
archaea. Although more information is needed to confirm and unravel the mechanisms of 
archaeal colonization in more detail, it may provide new targets for prevention of diseases 
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Supplementary Table 1. Absolute counts of M. smithii and M. stadmanae in dairy whole/full-fat products (n=2-3). 
*log10 DNA copies/ml, average. Replicates (n) denotes repeated isolation and quantification of the product. Average 
counts were calculated from positive samples only. 







Biodynamic milk 2.63 - Pasteurised 4 Zuiver Zuivel
Organic milk 2.88 - Pasteurised 5 Weerribben Zuivel
Regular milk 2.94 - Pasteurised 1-5 Campina & Plus
Raw milk 3.73 - None - Local Farmer
Organic yogurt - - Pasteurised 14 Weerribben Zuivel
Biodynamic yogurt - - Pasteurised 15 Zuiver Zuivel
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Supplementary Table 2. Patient characteristics of the KOALA birth cohort study and the population under study
Determinants KOALA Birth Cohort Study (n = 2834) Study Population (n = 472)
Continuous variables Median (range) Median (range)
General characteristics
Age at fecal sampling (years) b - 7.2 (6.0 – 10.0)
Birthweight (g) 3500 (780 – 5455) 3570 (2140 – 5000)
Gestational age (weeks) 40 (26 – 43) 40 (35 – 42)
Breastfeeding (months) 4 (0 – 13) 5 (0 – 13)
BMI (z-score) b - -0.2 (-2.7 – 2.8)
Dietary intake (per day)
Total energy intake (kcal) 1437.5 (740.0 – 2844.1) 1419.5 (788.3 – 2415.2)
Carbohydrate intake (en%) 55.7 (37.1 – 74.5) 55.7 (42.3 – 69.5)
Protein intake (en%) 14.6 (8.0 – 21.9) 14.5 (8.8 – 20.4)
Animal protein intake (en%) 9.0 (1.6 – 16.3) 9.0 (2.2 – 15.3)
Fiber intake (g) 15.1 (5.4 – 31.4) 15.4 (6.1 – 28.1)
Categorical variables N (%)a N (%)a
Gender
Male 1451 (51.3) 244 (51.7)
Female 1376 (48.7) 228 (48.3)
Recruitment group
Conventional 2343 (82.7) 354 (75.2)
Alternative 491 (17.3) 117 (24.8)
Maternal education c
Lower education 289 (10.7) 34 (7.5)
Medium education 1060 (39.4) 171 (37.7)
Higher education 1341 (49.9) 248 (54.7)
Older siblings (at 1 year of age)
None 1193 (44.1) 187 (39.7)
One 1110 (41.0) 206 (43.7)
Two or more 404 (14.9) 78 (16.6)
Younger and older siblings (at 4-5 years of age)
None 199 (9.7) 46 (10.3)
One 1162 (56.8) 245 (54.9)
Two or more 685 (33.5) 155 (34.8)
Regular visits to daycare or stay at a host parent (during the first 2 years of life)
No 960 (35.2) 161 (34.3)
Host parent 680 (24.9) 122 (26.0)
Daycare or daycare and host parent 1086 (39.8) 187 (39.8)
Place and mode of delivery
Natural birth at home 1187 (44.9) 219 (47.1)
Natural/artificial birth at hospital 1147 (43.4) 198 (42.6)
Caesarean section 311 (11.8) 48 (10.3)
First exposure to antibiotics (during first 2 years)
Never 1074 (43.5) 212 (46.7)
At 0-7 months 562 (22.8) 92 (20.3)
At 8-12 months 404 (16.4) 75 (16.5)
At 13-24 months 430 (17.4) 75 (16.5)
Use of antibiotic treatments (1 year before fecal sampling) b
No - 396 (85.2)
Yes - 69 (14.8)
Duration of pacifier use by the child d
Never 684 (27.5) 127 (27.6)
Early 587 (23.6) 108 (23.5)
Late 1214 (48.9) 225 (48.9)
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Determinants KOALA Birth Cohort Study (n = 2834) Study Population (n = 472)
Continuous variables Median (range) Median (range)
Cleaning of pacifier in boiling water
Never/Sometimes 458 (22.0) 84 (22.3)
Always 1624 (78.0) 292 (77.7)
Presence of pets at 6 to 7 years of life.
None 928 (47.0) 217 (46.7)
Dog 227 (11.5) 44 (9.5)
Cat 242 (12.3) 58 (12.5)
Other 338 (17.1) 90 (19.4)
Combination 236 (12.0) 56 (12.0)
Monthly exposure to farm (animals) at 6-7 years
No 1309 (72.7) 303 (72.8)
Yes 491 (27.3) 113 (27.2)
Diet of mother
Conventional 1885 (67.1) 294 (62.8)
Organic (incl. biodynamic) 923 (32.9) 174 (37.2)
Diet of child:
Conventional (≤25% organic) 1554 (81.4) 360 (80.2)
Organic (incl. biodynamic) (>25% organic) 355 (18.6) 89 (19.8)
Vitamin D/AD supplementation during the first 2 years of life
No 466 (18.8) 96 (20.6)
Yes 2011 (81.2) 370 (79.4)
Vegetarian diet of child
No 1943 (96.0) 419 (94.4)
Yes 82 (4.0) 25 (5.6)
Regular intake of milk
No 490 (25.3) 107 (26.5)
Yes 1445 (75.3) 347 (73.5)
Regular intake of organic milk
No 641 (75.3) 152 (87.5)
Yes 210 (24.7) 59 (12.5)
Regular intake of yogurt
No 464 (24.4) 110 (28.4)
Yes 1438 (75.6) 338 (71.6)
Regular intake of organic yogurt
No 619 (71.5) 157 (87.5)
Yes 247 (28.5) 59 (12.5)
Regular intake of cheese
No 510 (27.1) 114 (30.1)
Yes 1370 (72.9) 330 (69.9)
Regular intake of organic cheese
No 740 (87.2) 186 (94.1)
Yes 109 (12.8) 28 (5.9)
Regular intake of organic fruit
No 1738 (85.5) 376 (84.5)
Yes 295 (14.5) 69 (15.5)
Regular intake of organic raw vegetables:
No 650 (74.8) 155 (71.4)
Yes 219 (25.2) 62 (28.6)
 
a Totals may not add up to the total group size due to missing values; b Data unavailable for the complete cohort; c 
Lower: primary school, preparatory vocational or lower general secondary school. Middle: vocational, higher general 
secondary or pre-university. High: higher vocational or academic education d Never: Child did not use a pacifier. 
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Supplementary Table 3. Multivariable logistic regression model showing associations between potential determinants 
and Methanobrevibacter smithii presence.
M. smithii presence
Main effects model (N=419)
Determinant OR (CI95%) FDR crit.a p-value
Regular intake of organic milkb, c
No Ref.
Yes 5.73 (1.92; 17.03) 0.010 0.002d
Regular intake of organic yogurtb, c
No Ref.




Organic (incl. biodynamic) (>25% organic) 0.37 (0.18; 0.78) 0.020 0.009d
Fiber intake (g)e 0.96 (0.90; 1.03) 0.040 0.256
Age at fecal sampling (years)e 0.83 (0.64; 1.09) 0.030 0.186
 
a Critical FDR cut-off level as determined by Benjamini-Hochberg procedure; b Missing value category omitted 
(included in FDR correction); c Due to multicollinearity both regular intake of organic milk and regular intake of 
organic yogurt are reported. Both were run in a separate model; d significant association after correction for FDR 
by Benjamini-Hochberg procedure; e Parameter estimates presented for the model containing organic milk intake. 
Parameter estimates did not change substantially when the variable ‘organic milk intake’ was replaced by the 
variable ‘organic yoghurt intake’ (data not shown).
 
Supplementary Table 4. Secondary multivariable logistic regression model showing associations between potential 
determinants and the presence of Methanobrevibacter smithii.
M. smithii presence
Main effects model (N=406)
Determinant OR (CI95%) FDR crit.a p-value
First exposure to antibiotics (during first 2 years of life)
Never Ref.
At 0-7 months 0.57 (0.31; 1.04) 0.030 0.065
At 8-12 months 1.20 (0.58; 2.48) 0.050 0.623
At 13-24 months 0.80 (0.40; 1.59) 0.040 0.519
Regular intake of organic products (cheese, milk and yogurt)




Organic (incl. biodynamic) (>25% organic) 0.32 (0.16; 0.67) 0.020 0.003b
 
a Critical FDR cut-off level as determined by Benjamini-Hochberg procedure; b Significant association after correction 
for FDR by Benjamini-Hochberg procedure.
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Supplementary Table 5. Multivariable linear regression model showing associations between potential determinants 
and the presence of Methanobrevibacter smithii abundance.
M. smithii abundance (log10 DNA copies per gram feces)
Main effects model (N=431)
Determinant β (CI95%) FDR crit.a p-value
Younger and older siblings (at 4-5 years of age)
None Ref.
One -0.88 (-1.91; 0.15) 0.029 0.094
Two or more -0.99 (-2.07; 0.09) 0.021 0.072
First exposure to antibiotics (during first 2 years of life)
Never Ref.
At 0-7 months -0.81 (-1.65; 0.02) 0.017 0.056
At 8-12 months 0.16 (-0.71; 1.03) 0.042 0.717
At 13-24 months 0.27 (-0.61; 1.14) 0.038 0.551
Monthly exposure to farm (animals) at 6-7 years of ageb
No Ref.
Yes -0.50 (-1.26; 0.25) 0.033 0.192
Presence of pets at 6 to 7 years of life
None Ref.
Dog 0.12 (-0.99; 1.23) 0.050 0.829
Cat 0.14 (-0.84; 1.12) 0.046 0.774
Other 1.03 (0.20; 1.86) 0.004 0.016
Combination 0.91 (-0.10; 1.91) 0.025 0.076
Breastfeeding (months) 0.07 (0.00; 0.15) 0.013 0.051
 
a Critical FDR cut-off level as determined by Benjamini-Hochberg procedure; b Missing value category omitted 
(included in FDR correction)
Supplementary Table 6. Final multivariable linear regression model showing associations between potential 
determinants and abundance of Methanobrevibacter smithii.
M. smithii abundance (log10 DNA copies per gram feces)
Adjusted main effects model (N=431)a
Determinant β (CI95%) FDR crit.b p-value
Younger and older siblings 
(at 4-5 years of age)
None Ref.
One -0.89 (-1.94; 0.16) 0.021 0.095
Two or more -1.04 (-2.14; 0.06) 0.011 0.065
First exposure to antibiotics (during first 2 years of life)
Never Ref.
At 0-7 months -0.81 (-1.65; 0.04) 0.009 0.062
At 8-12 months 0.17 (-0.70; 1.05) 0.035 0.697
At 13-24 months 0.26 (-0.63; 1.14) 0.029 0.568
Monthly exposure to farm (animals) at 6-7 years of agec
No Ref.
Yes -0.50 (-1.26; 0.27) 0.024 0.200
Presence of pets at 6 to 7 years of life
None Ref.
Dog 0.13 (-0.99; 1.25) 0.044 0.821
Cat 0.15 (-0.84; 1.14) 0.041 0.767
Other 1.04 (0.20; 1.88) 0.003 0.015
Combination 0.94 (-0.08; 1.96) 0.018 0.070
Breastfeeding (months) 0.08 (-0.01; 0.15) 0.015 0.065
 
a Model adjusted for: age at fecal sampling (years), gender (male/female), recruitment group (conventional/
alternative), total energy intake (kcal) and BMI (z-score); b Critical FDR cut-off level as determined by Benjamini-
Hochberg procedure; c Missing value category omitted (included in FDR correction)
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Supplementary Table 7. Main logistic regression model showing associations between potential determinants and 
presence of Methanosphaera stadtmanae.
M. stadtmanae presence
Main effects model (N=420)
Determinant OR (CI95%) FDR crit.a p-value
Birthweight (g)b 1.001 (1.000; 1.002) 0.027 0.061
Place and mode of deliveryb
Natural birth at home Ref.
Natural/artificial birth at hospital 1.49 (0.64; 3.46) 0.041 0.350
Caesarean section 5.14 (1.64; 16.07) 0.005 0.005
First exposure to antibiotics (during first 2 years of life)b
Never Ref.
At 0-7 months 0.60 (0.19; 1.95) 0.046 0.395
At 8-12 months 0.70 (0.22; 2.28) 0.050 0.552
At 13-24 months 2.72 (1.13; 6.57) 0.023 0.026
Regular intake of organic milkc, d
No Ref.
Yes 2.06 (0.66; 0.96) 0.029 0.214
Regular intake of organic yogurtc, d
No Ref.
Yes 1.69 (0.49; 5.86) - 0.680
Breastfeeding (months)b 1.06 (0.96; 1.16) 0.036 0.237
Regular intake of organic fruitb
No Ref.
Yes 3.06 (1.17; 8.03) 0.018 0.023
Animal protein intake (en%)b 0.81 (0.69; 0.96) 0.009 0.014
 
a Critical FDR cut-off level as determined by Benjamini-Hochberg procedure; b Parameter estimates presented for the 
model containing organic milk intake. Parameter estimates did not change substantially when the variable ‘organic 
milk intake’ was replaced by the variable ‘organic yoghurt intake’ (data not shown); c Missing value category omitted 
(included in FDR correction); d Due to multicollinearity both regular intake of organic milk and regular intake of organic 
yogurt were included in separate models, which included all other variables as listed in this table.
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Establishment of the gastrointestinal microbiota during infancy affects immune system 
development and oral tolerance induction. Perturbations in the microbiome during this period 
can contribute to development of immune-mediated diseases. We monitored microbiota 
maturation and associations with subsequent development of allergies in infants and children. 
 We collected 1453 stool samples, at 5, 13, 21 and 31 weeks post-partum (infants), and 
once at school-age (6–11 years), from 440 children (49.3% girls, 24.8% born by caesarean 
section; all children except for 6 were breastfed for varying durations; median 40 weeks; 
interquartile range, 30–53 weeks). Microbiota were analyzed by amplicon sequencing. 
Children were followed through 3 years of age for development of atopic dermatitis; 
data on allergic sensitization and asthma were collected when children were school age. 
 Diversity of fecal microbiota, assessed by Shannon index, did not differ significantly 
among children from 5 through 13 weeks after birth, but thereafter gradually increased to 
21 and 31 weeks. Most bacteria within the Bacteroidetes and Proteobacteria phyla were 
already present at 5 weeks after birth, whereas many bacteria of the Firmicutes phylum were 
acquired at later times in infancy. At school age, many new Actinobacteria, Firmicutes, and 
Bacteroidetes bacterial taxa emerged. The largest increase in microbial diversity occurred after 
31 weeks. Vaginal, compared with cesarean section delivery, was most strongly associated 
with an enrichment of Bacteroides species at 5 weeks through 31 weeks. From 13 weeks 
onwards, diet became most important determinant of microbiota composition—cessation of 
breastfeeding, rather than solid food introduction, was associated with changes. For example, 
Bifidobacteria, staphylococci, and streptococci significantly decreased upon cessation of 
breastfeeding, whereas bacteria within the Lachnospiraceae family (Pseudobutyrivibrio, 
Lachnobacterium, Roseburia, and Blautia) increased. When we adjusted for confounding 
factors, we found fecal microbiota composition to be associated with development of atopic 
dermatitis, allergic sensitization, and asthma. Members of the Lachnospiraceae family, as well 
as the genera Faecalibacterium and Dialister, were associated with a reduced risk of atopy. 
 In a longitudinal study of fecal microbiota of children from 5 weeks through 6–11 years, 
we tracked changes in diversity and composition associated with the development of allergies 
and asthma. 




Colonization of the intestinal tract during the neonatal period is of crucial importance for 
the maturation of the mucosal immune system and the induction of oral tolerance [1-3]. 
Animal studies have provided compelling evidence to support a causal role of the intestinal 
microbiota and its metabolites, especially in early life, in the etiology of allergic diseases [3-6]. 
 Numerous epidemiological studies [7-12] also suggest that the infant intestinal microbiota 
plays an important role in the manifestation of allergic diseases and asthma, although actual 
results vary considerably between studies. About half of the studies that examined intestinal 
microbial diversity in infancy and childhood reported a lower diversity among children 
with (subsequent) allergies, whereas the remaining studies found no evidence for such an 
association [13].   Moreover, despite many specific microbial taxa have been linked to allergies 
and asthma, it remains unclear which bacterial taxa prevent or promote disease onset [14]. 
 Lack of early stool sampling and different ages of stool sample collection, different 
microbiological profiling methods, and an inadequate control for potential confounders have 
been suggested to contribute to the heterogeneity between study results [9, 13]. Additionally, 
cross-sectional studies are prone to reverse causality, i.e. changes in the microbiota composition 
as a result of the disease manifestation, and only very few studies have sufficient clinical 
follow-up to link infant microbiota maturation to the subsequent development of asthma [11]. 
 Initial microbial colonization starts upon rupture of the amniotic membranes and 
subsequent passage through the birth canal when the infant is seeded by maternal 
microbial strains, a process which is impeded in case of a cesarean section delivery [15, 
16]. Subsequently, microbial populations evolve as the diet changes and the host develops. 
Given the highly dynamic and complex process of microbial assembly, succession and 
maturation, repeated sampling is important to allow analysis of the overall development 
of the indigenous infant microbial ecology [17]. Moreover, many of the antenatal and 
postnatal factors that influence microbial community assembly during infancy, such as 
birth mode and the presence of older siblings and furry pets in the household, have 
also been associated with the development of allergic diseases and asthma [9, 13, 
18, 19], highlighting the importance to account for potential confounding factors. 
 In the present study, we aimed to monitor microbial assembly, succession and 
maturation during the first year of life and identify hereditary, perinatal, environmental, 
lifestyle and dietary factors that drive microbiota development. Through the application 
Chapter 5
116
of various multivariable longitudinal models, including joint modelling, we next examined 
the dynamics in microbial diversity, composition and community structure in association 
with the subsequent risk of developing atopic dermatitis and asthma until to school-age. 
 Our findings indicate that alterations in microbial diversity and composition precede the 
onset of allergic manifestations, while emphasizing the importance of possible confounders.
Results
Design and clinical outcome measurements
Originally this study was designed as a randomized placebo-controlled clinical trial to examine 
the impact of a bacterial lysate, containing heat-killed Escherichia coli and Enterococcus 
faecalis, on the primary prevention of atopic dermatitis (AD) (registration no. ISRCTN60475069, 
ISRCTN registry) [20]. However, we did not find any evidence that the intervention affected 
the microbiota composition and therefore pooled both treatment arms in the downstream 
statistical analyses. Infants were clinically examined by a pediatrician on signs of AD at the 
ages of 1, 21 and 31 weeks and again at 1, 2 and 3 years of age as described previously 
[20]. The school-age follow-up of the study population (at 6-11 years) took place in 2013 
including clinical examination, lung function testing, skin prick tests, and serum analyses of 
specific IgE to the most common aero-allergens (house dust mite, dog, cat, mold (Alternaria, 
Cladosporium), birch and grass pollen. Children were classified as having current asthma in 
case of a doctor’s diagnosis in combination of any indicative symptoms in the last 12 months 
(wheezing, shortness of breath, nocturnal awakening die to shortness of breath and/or 
wheezing). Allergic sensitization was assessed by Skin Prick Test and serum sensitization for 
the above-mentioned allergens. The study and follow-up were approved by the hospitals 
local review board Charité Ethics Committee in 2002 and 2012. Parents and participants gave 
written informed consent.
Microbial profiling of fecal samples
Fecal DNA was isolated by a combination of bead beating and column-based purification as 
described in detail previously [21]. Barcoded universal primers adapted from Bartram and 
collegues [22] were used to amplify the variable 3 region of the 16S rRNA gene. Amplicons 
were sequenced using the Illumina MiSeq platform using 2x250 paired-end reads. The resulting 
sequencing data were processed using the short-read library 16S rRNA gene sequencing 
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pipeline (sl1p) [23] (for description see supplementary methods).  
 This resulted in a total of 93,475,612 reads from 1,468 samples that were clustered 
into 7,961 OTUs. Removal of OTUs that were observed in only a single sample and discarding 
OTUs with a fraction of the total number of sequences below 0.001, retained the majority 
of sequences (92,997,277) while significantly reducing the number of OTUs to 873. Finally, 
we eliminated 15 samples with a low coverage (<15,000 reads) and normalized the data 
using Rhea [24].  In order not to discard informative information, normalization in Rhea is 
performed by dividing OTU counts per sample for their total count (sample depth) and then 
multiplying the obtained relative abundance for the lowest sample depth (15,540 reads). 
Statistical Analysis
All the statistical analyses were performed two-sided using R, version 3.4.3. 
GI microbiota richness and maturation
The Chao1 index, as measure for the estimated microbial richness, and the Shannon index, 
as microbial diversity metric, were computed using the R package vegan 2.5.3 [25]. In 
order to compare the microbial community structure of samples, we used the unweighted 
UniFrac which incorporates phylogenetic distances between observed organisms. The R 
package GUniFrac 1.1 [26] was used to compute the unweighted UniFrac metric. Ordination 
of samples based upon the unweighted Unifrac dissimilarity was visualized using Principal 
Coordinate Analysis (PCoA) using the capscale function of the vegan package. The Friedman 
test was used to test for significant differences in Chao1, Shannon and loadings scores on the 
principal coordinates between all time-points, followed by Dunn’s test for post hoc pairwise 
comparisons between individual time-points. The p-values were finally FDR adjusted for 
multiple comparisons. In order to track the dynamics of individual OTUs within the four main 
bacterial phyla, we created Sankey plots using Sankeymatic. For readability of the Sankey 
plots, the OTU table was further filtered to OTUs that were present in > 10% of the samples 
during one or more time-points. We next investigated the maturity of the GI microbiota 
by computing the microbial-by-age z-score (MAZ) of the sample as described previously 
[27]. Shortly, we started feeding a random forest with a training set made of the microbial 
community composition of healthy children after filtering out all OTUs with a prevalence 
below 5%. Once the model was trained, we used it to predict the age of all the samples. 




All the statistical analyses were performed two-sided using R, version 3.4.3.  
GI microbiota richness and maturation 
 
The Chao1 index, as measure for the estimated microbial richness, and the Shannon index, 
as microbial diversity metric, were computed using the R package vegan 2.5.3 [25]. In 
order to compare the microbial community structure of samples, we used the unweighted 
UniFrac which incorporates phylogenetic distances between observed organisms. The R 
package GUniFrac 1.1 [26] was used to compute the unweighted UniFrac metric. 
Ordination of samples based upon the unweighted Unifrac dissimilarity was visualized 
using Principal Coordinate Analysis (PCoA) using the capscale function of the vegan 
package. The Friedman test was used to test for significant differences in Chao1, Shannon 
and loadings scores on the principal coordinates between all time-points, followed by 
Dunn’s test for post hoc pairwise comparisons between individual time-points. The p-
values were finally FDR adjusted for multiple comparisons. In order to track the dynamics 
of individual OTUs within the four main bacterial phyla, we created Sankey plots using 
Sankeymatic. For readability of the Sankey plots, the OTU table was further filtered to 
OTUs that were present in > 10% of the samples during one or more time-points. We next 
investigated the maturity of the GI microbiota by computing the microbial-by-age z-score 
(MAZ) of the sample as described previously [27]. Shortly, we started feeding a random 
forest with a training set made of the microbial community composition of healthy 
children after filtering out all OTUs with a prevalence below 5%. Once the model was 
trained, we used it to predict the age of all the samples. Finally, the z-score was computed 
using the following formula: 
 
𝑀𝑀𝑀𝑀𝑀𝑀 = 𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀 𝑀𝑀𝑎𝑎𝑎𝑎 − 𝑚𝑚𝑎𝑎𝑚𝑚𝑀𝑀𝑀𝑀𝑚𝑚 𝑀𝑀𝑜𝑜 𝑚𝑚𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀 𝑀𝑀𝑎𝑎𝑎𝑎 𝑀𝑀𝑜𝑜 ℎ𝑎𝑎𝑀𝑀𝑀𝑀𝑒𝑒ℎ𝑦𝑦 𝑀𝑀ℎ𝑀𝑀𝑀𝑀𝑚𝑚𝑀𝑀𝑎𝑎𝑚𝑚 𝑀𝑀𝑜𝑜 𝑠𝑠𝑀𝑀𝑚𝑚𝑎𝑎 𝑀𝑀ℎ𝑀𝑀𝑀𝑀𝑚𝑚𝑀𝑀𝑀𝑀𝑀𝑀𝑎𝑎𝑀𝑀𝑀𝑀 𝑀𝑀𝑎𝑎𝑎𝑎(𝑠𝑠𝑒𝑒𝑀𝑀𝑚𝑚𝑚𝑚𝑀𝑀𝑀𝑀𝑚𝑚 𝑚𝑚𝑎𝑎𝑑𝑑𝑀𝑀𝑀𝑀𝑒𝑒𝑀𝑀𝑀𝑀𝑚𝑚 𝑀𝑀𝑜𝑜𝑚𝑚𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀 𝑀𝑀𝑎𝑎𝑎𝑎 𝑀𝑀𝑜𝑜 ℎ𝑎𝑎𝑀𝑀𝑀𝑀𝑒𝑒ℎ𝑦𝑦 𝑀𝑀ℎ𝑀𝑀𝑀𝑀𝑚𝑚𝑀𝑀𝑎𝑎𝑚𝑚 𝑀𝑀𝑜𝑜 𝑒𝑒ℎ𝑎𝑎 𝑠𝑠𝑀𝑀𝑚𝑚𝑎𝑎 𝑀𝑀ℎ𝑀𝑀𝑀𝑀𝑚𝑚𝑀𝑀𝑀𝑀𝑀𝑀𝑎𝑎𝑀𝑀𝑀𝑀 𝑀𝑀𝑎𝑎𝑎𝑎) 
 
Dirichlet Multinomial Mixture (DMM) clustering, an unsupervised clustering method that 
uses Laplace approximation to identify groups of communities (enterotypes) with similar 
composition, was performed as previously described [28]. We then analysed the transition 
of infants through these DMM-clusters with age [29]. 
  
Dirichlet Multinomial Mixture (DMM) clustering, an unsupervised clustering method that 
uses Laplace approximation to identify groups of communities (enterotypes) with similar 
composition, was performed as previously described [28]. We then analysed the transition 
of infants through these DMM-clusters with age [29].
Analysis of factors shaping the GI microbiota
We examined which hereditary, perinatal, environmental, lifestyle and dietary factors were 
associated with the establishment of the microbiome during infancy (see supplementary 
methods for detailed description). In order to examine which of these factors were associated 
with the DMM clusters at baseline and/or with the transition of DMM clusters between the age 
of 5 and 31 weeks, multinomial logistic regression analysis were used. Only factors that were 
significantly associated with the (transition of) DMM clusters in the univariable analyses, were 
included in the final multivariable model. We next used multivariate association with linear 
models (MaAsLin) [30] to examine the association between these factors with and individual 
microbial taxa and multivariable linear regression models to examine the association with the 
microbial diversity and maturity.  The effect size and significance of each of the covariates on 
the microbial community structure was determined using the envfit function in vegan [25]. 
Ordination was performed using the PCoA based on unweighted UniFrac metric obtained 
as described above. The significance value was determined based on 999 permutations. All 
P values derived from envfit were adjusted for multiple comparisons using FDR adjustment 
(Benjamini–Hochberg procedure). In order to understand which of the covariates had the 
strongest impact on the overall microbial community structure, we performed a Permutational 
Analysis of the Variance (PERMANOVA) based on unweighted UniFrac. Only covariates that 
were statistically significant in the envfit analyses were included in the PERMANOVA.
Analysis on association between microbiota and allergic manifestations 
To examine how the longitudinal variation of the microbial diversity (Shannon index) and 
maturity (MAZ) of the GI microbiota affects the time to development of AD, we. applied a 
joint model [31] using the JM function of the JMpackage [32] (for details see supplementary 
methods). To examine the impact of microbial diversity and maturity on asthma and allergic 
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sensitization at school-age, a Generalized Linear Model (GLM) was built using lme41.1.19. 
The same covariates as included in the JM were incorporated as potential confounding 
factors. Since both asthma and sensitization were binary outcomes, a binomial distribution 
was chosen for the GLM. To identify if specific bacterial genera were differentially abundant 
in children with and without allergic manifestations, we used the MetaLonDa package [33]. 
To ensure meaningful p-values we performed 999 permutations. To select only the significant 
associations, we choose a threshold of 0.05 for the p-values after FDR adjustment.
Results
Study population characteristics
The study, initially designed as a randomized, placebo-controlled trial on the primary 
prevention of AD by an orally applied lysate of heat-killed Escherichia coli and Enterococcus 
faecalis, consisted of healthy newborns (n = 606) with a single or double heredity for atopy 
[20]. During the first 3 years of life, children were deeply phenotyped by physical examination 
and the collection of detailed questionnaires at 7 clinical visits. At school-age, children 
were contacted again to determine the establishment of asthma and allergic sensitization. 
 For the present study, only children with at least three fecal samples collected during 
the first year and/or feces collected at school-age were included (n = 440). Of these children, 
217 (49.3%) were girls, 187 (42.5%) had older siblings, 109 (24.8%) were born by caesarean 
section and 29 (6.6%) were reportedly treated with antibiotics in the first 31 weeks of life. 
All except 6 children received breastfeeding, although the duration of breastfeeding varied 
considerably with a median duration of 40 weeks [IQR: 30-53]. Solid food was introduced at 
a median age of 25 weeks [IQR: 22 – 27] (Supplementary Table S1). 
Development of the microbiota between early infancy and school-age
We first examined the compositional changes in the microbiota during infancy and compared 
this to the school-age microbiota composition. Samples collected at the age of 5 (n = 306), 13 
(n = 287), 21 (n = 268) and 31 (n = 307) weeks post-partum and again at school-age (n = 300) 
were profiled by amplicon sequencing of the 16S rRNA hypervariable V3 gene region. Upon 
quality filtering and removal of samples with low sequencing depth (n = 15), 1,453 samples 
with a median sequencing depth of 62,420 reads/sample (range 15,540 – 168,848) were 
retained for downstream analysis and clustered into 873 operational taxonomic units (OTUs). 
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 Microbial diversity, assessed by the Shannon index, was not significantly different between 
ages 5 and 13 weeks but thereafter gradually increased from 13 to 21 and 31 weeks after birth 
(Fig. 1A). The largest increase in microbial diversity occurred after the age of 31 weeks as indicated 
by the steep increase in the Shannon index at school-age (p = 7.99*10-28). Similar findings 
were observed for the microbial richness as assessed by the Chao1 (Supplementary Table S2). 
 Principle coordinate analyses indicated that the microbial community structure as 
assessed by the unweighted Unifrac metric also gradually shifted during infancy with the most 
prominent shift between the age of 21 and 31 weeks (Fig 1B, p = 1.58*10-27, Supplementary 
Table S3). The school-age samples, however, clustered separately and showed less inter-
individual variation as compared to the infant samples. 
Tracking individual OTUs based on their presence or absence revealed different dynamics 
within the dominant phyla (Supplementary Fig 1). The majority of OTUs within the phyla of 
Actinobacteria, Bacteroidetes and Proteobacteria found during infancy were already present 
at 5 weeks after birth, whereas almost half of the OTUs within the phylum of Firmicutes were 
only acquired at later infant time-points. At school-age, many new Actinobacteria, Firmicutes, 
and Bacteroidetes OTUs emerged on top of the OTUs already present during infancy. In 
contrast, only few new OTUs emerged within the phylum Proteobacteria at school-age, while 
a significant portion of the infant OTUs were lost thereafter.
 We next examined the bacterial genera that contribute most to the temporal dynamics in 
microbial diversity and community structure. Towards school-age the prevalence in many of the 
genera within the phylum of Proteobacteria dramatically decreased, whereas the prevalence 
of genera within the phylum of Firmicutes, and in particular within the Lachnospiraceae 
and Ruminococcaceae families strongly increased (Fig 1C). Moreover, with the exception 
of Bifidobacterium, the relative abundance of all of the major bacterial genera changed 
significantly (Friedman test, all P-values<0.001, Supplementary Table 4) throughout infancy 
and childhood (Supplementary Fig. 2A-B). Escherichia was the most abundant genus at 5 weeks 
of age followed by Bifidobacterium and Streptococcus. Escherichia still remained the most 
abundant genus at 31 weeks of age but was now followed by Bacteroides and Veillonella. At 
school-age the most abundant genera were Blautia, Faecalibacterium and Ruminococcus.











































































































































Figure 1. Microbiota maturation throughout infancy and childhood (N= 1,453 stool samples from 440 children). A, Microbial diversity 
(Shannon index) gradually increased throughout infancy and has markedly risen at school-age (p = 7.72*10-53, Friedman, p-values 
for post-hoc analyses using Dunn’s test are depicted in the table). B, Principal Coordinate Analysis (PCoA) based on unweighted 
Unifrac dissimilarity indicates a gradual shift in microbial community structure along PC1 during infancy and a completely distinct 
structure at school-age (p = 6.0*10-51, Friedman, p-values for post-hoc analyses using Dunn’s test are depicted in Supplementary 
Table 3). C, Cladogram depicting the bacterial genera detected in the children’s fecal microbiota. Background and branch colors 
reflect the different phyla. The height of the outer ring reflects the average relative abundance of a genus across all infant time 
points, whereas the color density of the five inner rings reflects the prevalence of the genus at the individual time points (with 
opaque color indicating a prevalence of 100 percent and fully transparent indicating a prevalence of 0 percent).
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The length of breastfeeding represents the main driver of the infant’s microbiota composition
To identify covariates associated with the microbiota dynamics during infancy, we continued 
our analyses focusing on the infant samples. Dirichlet multinomial mixtures (DMM) modelling 
on OTU-level data formed six clusters (based on lowest Laplace approximation) (Fig. 2A-B). 
 To illustrate the progression of samples through each DMM cluster with age, we applied a 
transition model as described previously [29].  Clusters 1 and 3 were the most dominant at the 
age of 5 weeks and thereafter transitions were chaotic, consistent with the previously identified 
developmental phase of the microbiome during the first 14 months of life [29].  Although 
cluster 1 remained dominant until the age of 31 weeks, cluster 3 gradually disappeared in 
favor of clusters 4 and 5 (Fig 2C). Multinomial logistic regression analyses indicated that the 
initial microbiota cluster at 5 weeks of age was mainly determined by birth mode. The chance 
that a newborn’s microbiota belonged to cluster 3 was strongly increased among infants 
born by cesarean section [Supplementary Table 5]. This cluster was remarkably different 
with respect to the abundance of several of the driving OTUs. In particular a Klebsiella OTU 
exhibited a high abundance at the expense of an Escherichia OTU that dominated many of 
the other clusters. Additionally, Citrobacter, Leclercia and Raoultella OTUs were characteristic 
for cluster 3 (Fig 2B).














































































































































































































Figure 2. Community typing by Dirichlet Multinomial Mixtures of infant samples revealed six clusters (N= 1,154 
stool samples from 312 children). A, Heat map showing the relative abundance of the 30 most important/dominant 
OTUs per DMM cluster. B, Principal Component Analysis (PCA) on OTU-level data with samples colored according 
to DMM cluster. Ellipses indicate the 95% confidence interval. Vertical and horizontal bar charts depict OTUs with 
the highest loadings on PC1 and PC2 respectively. The OTUs with the highest positive and negative loadings on 
PC1 and PC2 are plotted in the PCA. C, Transition model showing the progression of samples through the six DMM 
clusters from one sampling time-point to the next time-point.
Analysis of the most common transition trajectories, revealed that for both children starting 
in cluster 1 as well as for children starting in cluster 3, transition towards clusters 4 and 5 
significantly increased when breastfeeding was ceased [Supplementary Table 5]. These results 
were further supported by the overall bacterial profiles throughout infancy. At the age of 5 weeks, 
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the largest amount of variance was explained by birth mode (Fig. 3A). At the genus level, vaginal 
as compared to cesarean section delivery was most strongly associated with an enrichment 
of Bacteroides spp., at 5 weeks and until the age of 31 weeks (Supplementary Table 6). 
 At the age of 13, 21 and 31 weeks, breastfeeding explained by far the greatest variance 
in bacterial community profiles (Fig 3B-D). Permutational multivariate analyses of variance 
confirmed that the duration of breastfeeding had a stronger impact than the introduction of 
solid foods (Fig 3E, Supplementary Table 7). Bifidobacteria, staphylococci and streptococci 
amongst others significantly decreased upon cessation of breastfeeding, whereas many 
bacteria within the Lachnospiraceae family (e.g. Pseudobutyrivibrio, Lachnobacterium, 
Roseburia, Blautia) increased (Supplementary Table 6).
 A longer duration of breastfeeding was also associated with a lower microbial diversity 
(Supplementary Table 8) as well as with a lower microbial-by-age z-score (MAZ) (Supplementary 
Table 9). The MAZ is calculated by training a machine-learning algorithm on the microbiota 
composition of a dataset with known biological age, thereafter the age of samples is predicted 
based on its microbiota composition. A lower MAZ is thus indicative for a delayed microbial 
maturation.
 Furthermore, the exposure to older siblings was associated with an increase in several 
genera within the phylum of Actinobacteria (Bifidobacterium and Corynebacterium at 5 
weeks and Egghertella at 21 weeks, Supplementary Table 6) and a higher microbial diversity 
at 31 weeks of age (Supplementary Table 9). Finally, besides dietary factors, the microbial 
community structure was most strongly associated with the presence of AD at time of sample 
collection.
Alterations in microbial composition, diversity and maturity precede manifestations of atopy
To further investigate whether differences in microbiota development precede the onset 
of atopic disease, we applied several longitudinal analyses while controlling for potential 
confounding factors by adjusting for other covariates.
 We first applied multivariate joint models on the microbial diversity and maturity in 
association to AD. Joint models have become increasingly popular as a statistical framework 
to concurrently analyze longitudinal data (e.g. biomarker evolution) and survival data (e.g. 
time-to-disease onset). [31] They have, to our knowledge, not been applied in the microbiome 
research field so far. While accounting for known risk factors for AD, we found that the 
temporal pattern of microbial diversity was independently and inversely associated with 
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AD (Hazard rate (HR)= 0.21; p=1.15*10-4, Figure 4A-B, Supplementary Table 10), indicating 
that a lower microbial diversity  throughout infancy is associated with an increased risk of 
AD. For the temporal pattern of microbial maturity, expressed as microbial age z-scores, we 
found a statistically significant positive association with AD (HR=1.14, p=1.94*10-5, Figure 
4C-D, Supplementary Table 11). Next, we used the recently introduced metagenomics 
longitudinal differential abundance (MetaLonDa) method [33] to identify time intervals of 
differentially abundant bacterial genera between infants that did or did not develop AD. 
 Among children who did not develop AD during follow-up, the relative abundance of 
Atopobium (days 25.6 - 79.4, FDRadjusted p = 7.65*10
-3), Corynebacterium  (days 126.1 - 151.2, 
FDRadjusted p = 9.68*10
-3),  both members of the phylum Actinobacteria, and Prevotella (days 
104.6 - 133.3, FDRadjusted p <0.001) were temporarily enriched when compared to children 
who developed AD. Most pronounced were, however, the associations of Lachnobacterium 
and Faecalibacterium, which were significantly enriched during the entire period of fecal 
sampling among children who remained free from AD (Figure 4E-G, Supplementary Table 
12).
 We next, examined whether the infant microbiota composition was also associated 
with allergic manifestations at school-age, including allergic sensitization and asthma. Blood 
samples for the determination of allergic sensitization at school age were available for 292 
out of the 440 children included in the present study. Like for AD, we found a higher diversity 
of the infant microbiota to be associated with decreased risk of allergic sensitization at 
school-age (Shannon index at 31 weeks ORadjusted = 0.19, p = 7.33*10
-3, Supplementary Figure 
3A, Supplementary Table 13). A higher microbial maturity very early in life was associated 
with an increased risk of allergic sensitization (MAZ at 5 weeks ORadjusted = 1.46, p = 5.01*10
-3, 
Supplementary Figure 3B, Supplementary Table 14), again in line with findings for AD. We 
could, however, not identify individual bacterial genera with differential abundance over a 
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Figure 3. Microbiota community structure is most strongly influenced by breastfeeding (N= 961 stool samples 
from 312 children). A-D, Polar plots visualizing the amount of variance of microbial communities at 5 weeks (A), 13 
weeks (B), 21 weeks (C) and 31 weeks (D) of age that could be explained by 18 covariates as analyzed using EnvFit. 
The height of the bars reflects the amount of variance (r2) explained by each covariate. Covariates are colored to 
highlight parental health status and ethnicity (purple), perinatal covariates (orange), diet and medication (red) and 
environmental exposures (green). Asterisks indicate significant covariates (false discovery rate (FDR) P< 0.05) at 
each time point. E, Permutational Multivariate Analysis of Variance (PERMANOVA) combining all covariates that 
were significantly associated with microbial community variation at any given time point in the EnvFit analyses. 
The size of the dots reflects the R2. Only samples without missing data on the included covariates were included 
in PERMANOVA (5 weeks: N= 238, 13 weeks: N = 233, 21 weeks: N = 231, 31 weeks: N= 259). Asterisks indicate 
statistical significance with *p<0.05, **p<0.01, ***p<0.001. 
 A clear association between microbial diversity and asthma could not be detected. Yet, 
in line with allergic sensitization and AD, a higher microbial maturity at the ag of 5 weeks 
was also associated with an increased risk for asthma (MAZ at 5 weeks ORadjusted = 1.43, p = 
7.78*10-3, Supplementary Figure 3C-D, Supplementary Tables 15 and 16). Multiple bacterial 
genera were differentially abundant over time in children who did or did not develop asthma. 
The genera that were differentially abundant across the entire time-period during which 
the microbiota composition was monitored included Lachnobacterium,  Lachnospira (both 
members of the Lachnospiraceae family) and Dialister (Veillonellaceae), which were all 
significantly enriched in healthy as compared to asthmatic children (Supplementary Figure 
3E-G, Supplementary Table 17).
Chapter 5
128
Figure 4. Microbiota composition, diversity and maturity is linked to the subsequent development of atopic 
dermatitis (N= 961 stool samples from 312 children). A, Volcano plot depicting the regression coefficients from the 
joint model on the association between the Shannon index and atopic dermatitis (AD). The dashed line depicts the 
threshold for statistical significance at p<0.05. Variables depicted below the dashed line were statistically significantly 
associated with AD in the final model. Positive coefficients (variables to the right of the vertical line) were associated 
with an increased AD risk. Negative coefficients (variables to the left of the vertical line) were associated with a 
decreased AD risk. The Hazard Ratio is given by the exponent of the coefficient (e.g. for Shannon index: e^-1.57 
results in a HR of 0.21). B, Development of microbial diversity (Shannon index) throughout infancy among children 
that did (red line) or did not (green line) develop AD as modelled by Loess regression. Grey areas represent the 95% 
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confidence intervals. C, Volcano plot depicting the regression coefficients from the joint model on the association 
between the microbial age z-score (MAZ) and the development of atopic dermatitis (AD). The dashed line depicts 
the threshold for statistical significance at p<0.05. D, Development of microbial maturity (MAZ-score) throughout 
infancy among children that did (red line) or did not (green line) develop AD as modelled by Loess regression. Grey 
areas represent the 95% confidence intervals. E-G, Time intervals of differential abundance in Faecalibacterium 
(E), Lachnobacteriumn (F), and Prevotella (G) between infants that did or did not develop AD as identified from 
MetaLonda analyses. Significantly different time-intervals (FDR-adjusted p<0.05) are depicted by gray shading.
Discussion
This study aimed to longitudinally analyze the process of gastrointestinal microbial community 
assembly, succession and maturation throughout the most critical time-window of immune 
development and linked microbiota maturation during this time to the development of 
clinical signs of allergic disease, while carefully controlling for potential confounding factors.
 Our results indicate a dynamic microbiota during infancy which is far from completely 
matured at 31 weeks of age.  In early infancy the microbial composition was most strongly 
affected by birth mode, while from 13 weeks onwards diet became the most important factor. 
Our data support previous reports, showing that Bacteroides are most strongly affected by 
birth mode [29, 34-36]. The difference in microbial community structure and lower abundance 
of Bacteroides in cesarean section as compared to vaginal delivered infants persisted up 
to the age of 31 weeks of age and withstood mutual adjustment for other determinants, 
including breastfeeding. This suggests that the impact of cesarean section delivery could 
not be compensated by breastfeeding. Given the increased risk of future diseases, including 
allergies and asthma [37, 38], among children born by cesarean section, more research is 
warranted to elucidate the need for and efficacy of restoring the natural microbial colonization 
process upon cesarean delivery.
 We furthermore showed that cessation of breastfeeding was more strongly associated 
with microbial composition and maturity than solid food introduction. In line with previous 
[11, 35, 39], these results suggest that the introduction of solid food does not appear to result 
in a profound shift in microbial community structure as long as breastfeeding is continued. 
Only when breastfeeding is ceased, maturation of the microbiota is accelerated with a 
decrease in degraders of human milk oligosaccharides and an increase in microbial diversity 
and compositional changes towards bacterial genera specialized in degrading complex dietary 
carbohydrates. The generally observed lower microbial diversity in infants during breastfeeding 
[40] seems at first contradictory with the concept that a “healthy” and resilient microbiome is 
highly diverse [41]. However, in line with most prospective studies [42], we did not find a direct 
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association between breastfeeding duration and the risk of AD. The fact that breastfeeding 
reduces the risk of several other diseases, including metabolic diseases, which on the other 
hand are also associated with a lower microbial diversity, suggests that the context is of crucial 
importance when considering microbial diversity. For example, loss of microbiota diversity 
generally opens up niches for opportunistic invaders [41], while the plethora of bioactive 
components transferred by breastfeeding protect against colonization by such opportunistic 
pathogens [43]. This further underscores the need for meticulous adjustment for diet as a 
confounding factor in the association between microbiota and disease outcomes.
 Using various multivariable longitudinal analysis, we furthermore demonstrated that 
the microbial community structure, diversity and maturity as well as the relative abundance 
of several individual genera were associated with the subsequent development of allergic 
manifestation. We know from previous animal studies and large longitudinal human cohorts 
that intestinal microbial dysbiosis in allergic diseases is mainly observed within a critical 
window in early life [44]. The comparability between studies is, however, hampered by the 
highly dynamic microbial communities within this early time window, which likely results in 
different associations at different sampling time points. The main strengths of the present 
study are its prospective design, repeated sample collection and the deep clinical phenotyping. 
 The regular physical examinations of the children throughout the first 3 years of life in 
combination with the collection of detailed questionnaire data allowed not only deep clinical 
phenotyping, but also an accurate assessment of the time of disease onset. The follow-up 
into school-age further facilitated a reliable classification of children who developed allergic 
asthma as it is well-known that wheezing symptoms at an earlier age are often transient and 
caused by episodic viral infections [45].
 We observed a lower microbial diversity to be associated with AD development 
and allergic sensitization, but not with asthma. This is consistent with previous studies 
that also reported a reduced microbial diversity in association to AD [46-49] and 
sensitization[7, 50]. In contrast, a link between microbial diversity and wheeze or asthma 
could often not be observed [51-53]. Although atopic manifestations are common 
comorbidities, these results support previous conclusions from COPSAC that extrapolation 
of risk factors between different atopic disorders may not always be justified [54]. 
 The increased risk of AD, sensitization and asthma among children with a higher microbial 
maturity might at first seem in contrast with the above-mentioned results for microbial 
diversity and with findings of previous studies. Indeed recent results from COPSAC2010 linked a 
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low microbial maturity with later onset of asthma in children born to asthmatic mothers [11]. 
In our study, the microbial maturity was however only significantly increased at 5 weeks of 
age in children who developed sensitization (as determined by Skin Prick Tests and serum IgE 
levels to the most common aero-allergens) and asthma. Also, for children with AD, we observed 
a microbial maturity (MAZ) that was significantly higher at the earliest recorded time-point 
but gradually decreased and became even lower at the age of 31 weeks when compared 
to the MAZ of children that did not develop AD. This temporally higher MAZ in very young 
infants might therefore suggest a dysregulated colonization process, e.g. with some bacterial 
taxa arriving (too) early, rather than a more mature overall microbial community structure. 
 Next to differences in microbial diversity and maturity, we were able to identify microbial 
taxa that were differentially abundant among infants who did or did not develop allergic 
disease manifestations. Lachnobacterium and Faecalibacterium were significantly decreased 
throughout infancy among children who developed AD. Also, Lachnospira and Dialister, next 
to Lachnobacterium, were significantly decreased among children who developed asthma. 
 The fact that these bacterial taxa were not only differentially abundant at a single time-
point but throughout infancy strengthens the likelihood of a causal role in the protection 
against allergic disease. Altogether our results indicate that microbial perturbations in early life 
are also associated with asthma at school age, although perturbations are not identical to those 
observed in children that developed AD.  In line with our findings, analysis on the microbiota 
composition at 3 months of age within the Canadian Healthy Infant Longitudinal Development 
(CHILD) Study revealed Lachnospira and Faecalibacterium to be significantly decreased 
among children at risk for allergic wheeze at the age of 1 year [52]. Moreover, a lower relative 
abundance of amongst others Lachnospiraraeceae incertae sedis, Faecalibacterium and 
Dialister at the age of 1 year in children from COPSAC2010 was associated with an increased risk 
of asthma at 5 years [11]. Fermentation products of these bacteria are a possible explanation 
for the protective effect of these bacteria.  Acetate is one of the fermentation products of 
Lachnospira and to a lesser account Lachnobacterium. Animal studies have previously shown 
that acetate-feeding leads to a marked suppression of allergic airway disease in a mouse-
model for human asthma. The underlying cellular mechanism was related to the effect of 
acetate on Treg cells, particularly through epigenetic modification of the Foxp3 protomotor 
[5].
 Faecalibacterium (prausnitzii) is well-known for its anti-inflammatory effects, amongst 
others through the production of butyrate [55] and a microbial anti-inflammatory molecule 
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(MAM) that inhibits the NF-κB pathway [56]. Two recent studies have identified another 
lactate-consuming butyrate-producing genus, Anaerostipes, associated with a decreased risk 
of food allergy [57] and eczema [58]. The very low abundance of this genus in our population 
could potentially explain the lack of association in our study.
 The application of several types of longitudinal data-analysis, including the joint modelling 
of longitudinal and survival data which had previously not been used for microbiota data 
analyses, enabled us to demonstrate that alterations in microbial diversity, maturity and 
composition preceded the clinical manifestations of atopic diseases.  Although this statistical 
framework reveals the temporality of associations thereby suggesting causal relationships, 
causality can never be proven in an observational study. For example, microbial perturbations 
could be an epiphenomenon of exposure to yet another unknown risk factor for allergy. Also, 
it cannot be ruled out that early preclinical manifestation of allergies or genetic predisposition 
for allergy might impact the microbiota composition. Moreover, our findings on fecal collections 
might not fully reflect alterations in the microbiome on allergy development at the level of 
(small) intestinal mucosa.
 It is therefore of importance not only to replicate findings in similar cohorts, but also 
to conduct future experimental studies building upon these findings in order to reveal the 
underlying biological mechanisms and prove causality.
 In conclusion, our results demonstrate the importance of birth mode and diet on the 
early maturation of the infant microbiota and demonstrate that, upon careful adjustment 
of important confounding factors, alterations in the microbial colonization process of the 
infant intestinal tract precede the development of AD, sensitization and asthma. In particular 
members of the Lachnospiraceae family, as well as the genera Faecalibacterium and Dialister 
appear to protect against allergies. These findings further support the future development of 
evidence-based intervention strategies targeting the microbiota to prevent or treat allergic 
diseases in early life.  
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Supplementary Figure 1. Tracking the flow of OTUs within the four main phyla throughout infancy and childhood 
(N= 1,453 stool samples from 440 children).  OTUs that were shared by at least 10 percent of the population during 
one or more time points were tracked using Sankey plots in the four major phyla. The rectangle height indicates 
the relative number of OTUs and the rectangle color reflects the children’s age. The lines represent the transfer of 
OTUs between time points. At school-age many new OTUs within the Actinobacteria, Firmicutes and Bacteroidetes 
were gained, whereas a major loss of OTUs in Proteobacteria was observed.
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Supplementary Figure 2. Relative abundance of the main bacterial genera at different time-points during infancy 
and at school-age (N= 1,453 stool samples from 440 children). Comparison were made among the 20 most abundant 
genera and stratified according to age. The black dots represent the median values and the violins are colored 
according to age.  A, relative abundance of the main genera within the phyla of Proteobacteria, Actinobacteria, 
Bacteroidetes and Verrucomicrobia. B, relative abundances of the main genera within the Firmicutes phylum. To 
test for significant changes in relative abundances with age, the Friedman test was used followed by the Dunn’s 
test for post-hoc analyses. FDR-adjusted p-values are presented in Supplementary Table 4.  
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Birth mode  
Natural vaginal delivery 304 (69.1)
Assisted vaginal delivery 26 (5.9)
Cesarean section 109 (24.8)
Number of older siblings  
No older siblings 253 (57.5)
1 older sibling 150 (34.1)
> 2 older siblings 37 (8.4)
Eczema mother  
Yes 161 (36.2)
No 279 (63.4)
Eczema father  
Yes 92 (20.9)
No 346 (78.6)
Asthma mother  
Yes 142 (32.3)
No 298 (67.6)
Asthma father  
Yes 102 (23.2)
No 337 (76.6)
Maternal smoking in pregnancy  
No 348 (79.1)
Yes 92 (20.9)
Maternal smoking after pregnancy  
No 341 (77.5)
Yes 99 (22.5)






Antibiotics before age 31 weeks  
No 411 (93.4)
Yes 29 (6.6%)
*Numbers may not add up to 440 (100%) due to missing data
Variable Median (IQR)
Maternal age at delivery (in years) 33 (29-36)
Birth Weight (in grams) 3497 (3202-3800)
Breast feeding in weeks 40 (30-53)
Age at introduction of solids (in weeks) 25 (22-27)
Gestational age (in weeks) 40 (38-40)
Start at daycare (in months) 13 (11-22)
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Supplementary Table S2 - Microbial richness as assessed by Chao1 index across time-points
Age Median Chao1 Interquartile range 
5 weeks 147.23 41.6 - 188.64
13 weeks 170.8 65.13 - 214.3
21 weeks 182.71 66.11 - 220.88
31 weeks 189.83 74.13 - 239.52
School-age 379.83 216.52 - 432.17
Test P-value
Friedman test 7.724E-53
Variable 1 Variable 2 Test P-value
Chao1 at 5 weeks Chao1 at 13 weeks Dunn’s test 1.37E-02
Chao1 at 5 weeks Chao1 at 21 weeks Dunn’s test 1.52E-05
Chao1 at 5 weeks Chao1 at 31 weeks Dunn’s test 1.65E-07
Chao1 at 5 weeks Chao1 at school-age Dunn’s test 7.55E-21
Chao1 at 13 weeks Chao1 at 21 weeks Dunn’s test 4.09E-03
Chao1 at 13 weeks Chao1 at 31 weeks Dunn’s test 4.09E-03
Chao1 at 13 weeks Chao1 at school-age Dunn’s test 7.68E-21
Chao1 at 21 weeks Chao1 at 31 weeks Dunn’s test 9.09E-01
Chao1 at 21 weeks Chao1 at school-age Dunn’s test 7.55E-21
Chao1 at 31 weeks Chao1 at school-age Dunn’s test 8.56E-21
Related samples statistics based only on children with samples collected at every single time-point (N = 606 
samples of 121 children)
Supplementary Table S3 - Testing for statistically significant associations between age of sample collection and 
principal coordinates of PCo1 as depicted in Figure 1
Test P-value
Friedman 6.002E-51
Variable 1 Variable 2 Test P-value
PCo1 at 5 weeks PCo1 at 13 weeks Dunn’s test 2.32E-04
PCo1 at 5 weeks PCo1 at 21 weeks Dunn’s test 2.12E-03
PCo1 at 5 weeks PCo1 at 31 weeks Dunn’s test 5.65E-34
PCo1 at 5 weeks PCo1 at school-age Dunn’s test 1.21E-27
PCo1 at 13 weeks PCo1 at 21 weeks Dunn’s test 3.27E-01
PCo1 at 13 weeks PCo1 at 31 weeks Dunn’s test 1.21E-27
PCo1 at 13 weeks PCo1 at school-age Dunn’s test 8.53E-27
PCo1 at 21 weeks PCo1 at 31 weeks Dunn’s test 1.58E-27
PCo1 at 21 weeks PCo1 at school-age Dunn’s test 1.03E-25
PCo1 at 31 weeks PCo1 at school-age Dunn’s test 3.99E-28
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Supplementary Table S5 - Multinomial logistic regression analyses on the association between demographic, 
lifestyle and medical factors in association with DMM clusters and trajectories
 FINAL MULTIVARIABLE MULTINOMIAL LOGISTIC REGRESSION MODEL ON COVARIATES IN ASSOCIATION TO DMM CLUSTERS AT 5 WEEKS OF AGE.
 Variable Exp(B) 95% Confidence Interval for Exp (B) P-value
DMM Cluster 1 (n = 75) - 
Reference category - - - - 
DMM Cluster 2 (n = 29) Breastfed (in weeks) 0.998 0.983-1.014 8.27E-01
 C-section delivery 1.610 0.520 - 4.974 4.10E-01
 Eczema mother 1.574 0.476 - 5.204 4.57E-01
 Asthma father 0.685 0.188 - 2.497 5.67E-01
 1 older sibling 2.097 0.815 - 5.398 1.25E-01
 > 2 older siblings 2.931 0.645 - 13.315 1.64E-01
DMM Cluster 3  (n = 76) Breastfed (in weeks) 0.997 0.985 - 1.010 6.81E-01
 C-section delivery 3.346 1.488 - 7.528 3.00E-03
 Eczema mother 2.238 0.895 - 5.596 8.50E-02
 Asthma father 0.700 0.274 - 1.787 4.56E-01
 1 older sibling 1.019 0.487 - 2.133 9.60E-01
 > 2 older siblings 0.765 0.180 - 3.254 7.17E-01
DMM Cluster 4 (n = 20) Breastfed (in weeks) 0.965 0.938 - 0.992 1.20E-02
 C-section delivery 0.242 0.028 - 2.109 1.99E-01
 Eczema mother 2.564 0.713 - 9,220 1.49E-01
 Asthma father 3.338 1.006 - 11.075 4.90E-02
 1 older sibling 2.527 0.802 - 7.956 1.13E-01
 > 2 older siblings 2.815 0.443 - 17.903 2.73E-01
DMM Cluster 5 (n = 11) Breastfed (in weeks) 0.990 0.964 - 1.017 4.57E-01
 C-section delivery 6.347 1.467 - 27.456 1.30E-02
 Eczema mother 0,.808 0.105 - 6.212 8.37E-01
 Asthma father 0.931 0.140 - 6.175 9.41E-01
 1 older sibling 1.635 0.323 - 8.277 5.52E-01
 > 2 older siblings 16.669 2.535 - 109.587 3.00E-03
DMM Cluster 6 (n = 14) Breastfed (in weeks) 1.013 0.993 - 1.034 1.98E-01
 C-section delivery 1.371 0.310 - 6.065 6.78E-01
 Eczema mother 2.233 0.514 - 9.703 2.84E-01
 Asthma father 3.455 0.937 - 12.748 6.30E-02
 1 older sibling 0.343 0.066 - 1.783 2.03E-01
 > 2 older siblings 0.502 0.045 - 5.555 5.74E-01




FINAL MULTIVARIABLE MULTINOMIAL LOGISTIC REGRESSION MODEL 
ON COVARIATES IN ASSOCIATION TO MOST COMMON DMM CLUSTER 
TRAJECTORIES
 Variable Exp(B) 95% Confidence Interval for Exp (B) P-value
DMM Cluster trajectory 1 
-> 1 (n =26) -  Reference 
category
- - - - 
DMM Cluster trajectory 1 
-> 4 (n = 22)
 
 
Breastfed (in weeks) 0.959 0.928 - 0.992 1.40E-02
Age introduction solids 
(weeks) 0.943 0.774-1.148 5.57E-01
Age at start day care 
(months) 0.958 0.876 - 1.048 3.53E-01
DMM Cluster trajectory 1 
-> 5 (n = 14)
 
 
Breastfed (in weeks) 0.948 0.909 - 0.989 1.20E-02
Age introduction solids 
(weeks) 0.818 0.660 - 1.014 6.70E-02
Age at start day care 
(months) 1.004 0.909 - 1.108 0./944
DMM Cluster trajectory 3 
-> 1 (n = 16) Breastfed (in weeks) 0.980 0.950 - 1.010 1.92E-01
 Age introduction solids (weeks) 1.074 0.876 - 1.315 4.93E-01
 Age at start day care (months) 0.981 0.890 - 1.081 6.95E-01
DMM Cluster trajectory 3 
-> 3 (n = 11)
 
 
Breastfed (in weeks) 0.997 0.958 - 1.037 8.69E-01
Age introduction solids 
(weeks) 0.836 0.636 - 1.100 2.01E-01
Age at start day care 
(months) 1.130 1.016 - 1.257 2.50E-02
DMM Cluster trajectory 3 
-> 4 (n = 13)
 
 
Breastfed (in weeks) 0.939 0.896 - 0.985 1.00E-02
Age introduction solids 
(weeks) 0.776 0.618 - 0.974 2.80E-02
Age at start day care 
(months) 0.970 0.865 - 1.087 5.97E-01
DMM Cluster trajectory 3 
-> 5 (n = 25)
 
 
Breastfed (in weeks) 0.949 0.916 - 0.983 4.00E-03
Age introduction solids 
(weeks) 0.905 0.744 - 1.102 3.21E-01
Age at start day care 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Supplementary Table S7 - Permutational analyses of variance on demographic, dietary, lifestyle and medical 
factors associated with microbial community structure
Permutational analysis of the variance at age 5 weeks (N = 238)
Variable Df SumOfSqs R2 F P-value
Asthma Mother 1 0.049 0.002 0.556 9.59E-01
Ethnicity 1 0.063 0.003 0.716 8.13E-01
Birth Mode 2 0.291 0.014 1.654 1.70E-02
Day care 1 0.095 0.005 1.079 3.22E-01
Smoke DP 1 0.112 0.005 1.276 1.69E-01
Smoke AP 1 0.102 0.005 1.157 2.56E-01
Breastfed 1 0.094 0.004 1.066 3.90E-01
Residual 229 20.169 0.962   
Total 237 20.976 1.000   
Permutational analysis of the variance at age 13 weeks (N = 233)
Variable Df SumOfSqs R2 F P-value
Asthma Mother 1 0.082 0.004 0.997 4.47E-01
Ethnicity 1 0.074 0.004 0.903 5.69E-01
Birth Mode 2 0.169 0.009 1.025 4.07E-01
Day care 1 0.099 0.005 1.202 2.25E-01
Smoke DP 1 0.107 0.005 1.299 1.74E-01
Smoke AP 1 0.122 0.006 1.486 7.39E-02
Breastfed 1 0.305 0.016 3.717 9.99E-04
Solids 1 0.119 0.006 1.448 9.19E-02
AD 1 0.085 0.004 1.038 3.81E-01
Residual 222 18.241 0.940   
Total 232 19.403 1.000   
Permutational analysis of the variance at age 21 weeks (N = 231)
Variable Df SumOfSqs R2 F P-value
Asthma Mother 1 0.103 0.006 1.360 1.25E-01
Ethnicity 1 0.113 0.006 1.498 8.19E-02
Birth Mode 2 0.171 0.009 1.132 2.36E-01
Day care 1 0.099 0.006 1.319 1.33E-01
Smoke DP 1 0.111 0.006 1.466 7.79E-02
Smoke AP 1 0.099 0.005 1.312 1.27E-01
Breastfed 1 0.468 0.026 6.212 9.99E-04
Solids 1 0.103 0.006 1.370 1.15E-01
AD 1 0.135 0.007 1.785 2.00E-02
Residual 220 16.589 0.922   
Total 230 17.991 1.000   
Permutational analysis of the variance at age 31 weeks (N = 259)
Variable Df SumOfSqs R2 F P-value
Asthma Mother 1 0.046 0.002 0.516 9.84E-01
Ethnicity 1 0.148 0.006 1.647 4.80E-02
Birth Mode 2 0.244 0.010 1.359 4.90E-02
Day care 1 0.098 0.004 1.093 2.93E-01
Smoke DP 1 0.152 0.006 1.694 3.70E-02
Smoke AP 1 0.078 0.003 0.871 6.28E-01
Breastfed 1 0.663 0.027 7.377 9.99E-04
Solids 1 0.180 0.007 1.999 2.00E-03
AD 1 0.241 0.010 2.679 9.99E-04
Residual 248 22.287 0.923   
Total 258 24.137 1.000   
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Supplementary Table S8 - Multivariable linear regression analyses on demographic, dietary, lifestyle and medical 
factors associated with microbial maturatity (Microbial Age z-scores)
MAZ index at age 5 weeks (N = 235)







Beta   Lower Bound Upper Bound
(Constant) -2.378 5.265  -0.452 6.520E-01 -12.757 8.000
Birhmode assisted vaginal -0.476 0.680 -0.040 -0.701 4.840E-01 -1.816 0.863
Birhmode cesarean section 0.711 0.367 0.111 1.937 5.400E-02 -0.013 1.434
1 older sibling -0.362 0.371 -0.060 -0.976 3.300E-01 -1.092 0.369
> 2 older siblings 0.763 0.620 0.078 1.230 2.200E-01 -0.459 1.984
Sex -0.287 0.320 -0.051 -0.897 3.710E-01 -0.918 0.344
Birth Weight -0.001 0.000 -0.077 -1.220 2.240E-01 -0.001 0.000
Gestational age 0.175 0.136 0.082 1.284 2.010E-01 -0.094 0.444
Breastfeeding duration -0.010 0.007 -0.097 -1.507 1.330E-01 -0.024 0.003
Ethnicity 0.104 1.022 0.006 0.102 9.190E-01 -1.910 2.119
Maternal age delivery -0.035 0.035 -0.060 -1.003 3.170E-01 -0.104 0.034
AD father 0.279 0.405 0.043 0.689 4.920E-01 -0.519 1.077
AD mother -0.694 0.436 -0.103 -1.592 1.130E-01 -1.553 0.165
Asthma father 0.417 0.407 0.060 1.023 3.080E-01 -0.386 1.220
Asthma mother 0.894 0.366 0.152 2.444 1.500E-02 0.173 1.615
Smoking in pregnancy 0.364 0.393 0.056 0.928 3.540E-01 -0.410 1.138
Smoking after pregnancy -0.168 0.401 -0.026 -0.418 6.760E-01 -0.959 0.623
AD 3.203 0.356 0.536 8.986 0.000E+00 2.500 3.905
Household with furry pets 0.179 0.339 0.030 0.528 5.980E-01 -0.490 0.848
Start of daycare in months -0.014 0.021 -0.039 -0.647 5.180E-01 -0.055 0.028
Age of introduction solids (months) -0.020 0.043 -0.030 -0.477 6.340E-01 -0.105 0.064
antibiotic use prior to sample 
collection -0.116 1.717 -0.004 -0.068 9.460E-01 -3.500 3.268
MAZ index at age 13 weeks (N = 231)







Beta   Lower Bound Upper Bound
(Constant) 5.589 5.543  1.008 3.140E-01 -5.338 16.516
Birhmode assisted vaginal 0.262 0.734 0.025 0.357 7.220E-01 -1.185 1.709
Birhmode cesarean section 0.337 0.384 0.060 0.878 3.810E-01 -0.420 1.094
1 older sibling 0.172 0.382 0.033 0.449 6.540E-01 -0.581 0.925
> 2 older siblings 0.598 0.674 0.071 0.887 3.760E-01 -0.731 1.927
Sex -0.138 0.336 -0.028 -0.410 6.820E-01 -0.799 0.524
Birth Weight -0.001 0.000 -0.147 -1.937 5.400E-02 -0.002 0.000
Gestational age -0.059 0.143 -0.031 -0.409 6.830E-01 -0.341 0.224
Breastfeeding duration -0.008 0.007 -0.087 -1.111 2.680E-01 -0.022 0.006
Ethnicity -0.764 1.009 -0.054 -0.757 4.500E-01 -2.753 1.225
Maternal age delivery 0.019 0.037 0.038 0.523 6.010E-01 -0.054 0.092
AD father -0.043 0.410 -0.008 -0.105 9.160E-01 -0.852 0.766
AD mother 0.211 0.469 0.036 0.451 6.530E-01 -0.714 1.137
Asthma father 0.724 0.450 0.115 1.610 1.090E-01 -0.162 1.610
Asthma mother 0.293 0.379 0.057 0.774 4.400E-01 -0.453 1.039
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Supplementary Table S8 - Continued
MAZ index at age 13 weeks (N = 231)








Beta   Lower Bound
Upper 
Bound
Smoking in pregnancy 0.296 0.400 0.054 0.740 4.600E-01 -0.492 1.084
Smoking after pregnancy -0.349 0.403 -0.064 -0.867 3.870E-01 -1.144 0.445
AD 0.052 0.366 0.010 0.142 8.870E-01 -0.669 0.773
Household with furry pets -0.136 0.347 -0.027 -0.391 6.960E-01 -0.820 0.549
Start of daycare in months 0.023 0.018 0.085 1.229 2.210E-01 -0.014 0.059
Age of introduction solids (months) -0.005 0.045 -0.009 -0.113 9.100E-01 -0.093 0.083
antibiotic use prior to sample 
collection -0.021 0.054 -0.026 -0.388 6.990E-01 -0.128 0.086
MAZ index at age 21 weeks (N - 228)








Beta   Lower Bound
Upper 
Bound
(Constant) 8.762 5.692  1.539 1.250E-01 -2.463 19.986
Birhmode assisted vaginal -0.628 0.734 -0.056 -0.856 3.930E-01 -2.076 0.820
Birhmode cesarean section -0.652 0.395 -0.110 -1.651 1.000E-01 -1.430 0.126
1 older sibling -0.134 0.384 -0.025 -0.349 7.270E-01 -0.891 0.623
> 2 older siblings 0.985 0.632 0.113 1.558 1.210E-01 -0.262 2.232
Sex 0.727 0.335 0.143 2.171 3.100E-02 0.067 1.386
Birth Weight 0.000 0.000 0.004 0.055 9.560E-01 -0.001 0.001
Gestational age -0.105 0.150 -0.052 -0.700 4.850E-01 -0.400 0.190
Breastfeeding duration -0.004 0.007 -0.040 -0.542 5.880E-01 -0.018 0.010
Ethnicity -4.363 1.117 -0.255 -3.907 0.000E+00 -6.565 -2.161
Maternal age delivery -0.047 0.036 -0.091 -1.289 1.990E-01 -0.118 0.025
AD father -0.437 0.417 -0.076 -1.049 2.960E-01 -1.260 0.385
AD mother -0.243 0.465 -0.039 -0.522 6.020E-01 -1.160 0.674
Asthma father 0.072 0.429 0.012 0.167 8.680E-01 -0.775 0.918
Asthma mother 0.838 0.382 0.156 2.191 3.000E-02 0.084 1.592
Smoking in pregnancy -0.504 0.421 -0.083 -1.198 2.320E-01 -1.333 0.325
Smoking after pregnancy 1.106 0.419 0.189 2.637 9.000E-03 0.279 1.933
AD** 0.917 0.358 0.172 2.559 1.100E-02 0.210 1.623
Household with furry pets 0.215 0.362 0.039 0.593 5.540E-01 -0.499 0.929
Start of daycare in months 0.002 0.019 0.008 0.114 9.090E-01 -0.035 0.039
Age of introduction solids (months) -0.018 0.044 -0.029 -0.411 6.820E-01 -0.104 0.068
antibiotic use prior to sample 
collection -1.055 0.676 -0.107 -1.561 1.200E-01 -2.388 0.278
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MAZ index at age 31 weeks (N = 253)








Beta   Lower Bound
Upper 
Bound
(Constant) -2.944 4.998  -0.589 5.560E-01 -12.792 6.904
Birhmode assisted vaginal 1.245 0.686 0.113 1.814 7.100E-02 -0.107 2.597
Birhmode cesarean section 0.254 0.354 0.045 0.719 4.730E-01 -0.443 0.952
1 older sibling -0.361 0.353 -0.069 -1.024 3.070E-01 -1.056 0.334
> 2 older siblings -0.273 0.581 -0.033 -0.470 6.390E-01 -1.418 0.871
Sex -0.072 0.306 -0.015 -0.236 8.130E-01 -0.676 0.531
Birth Weight -0.001 0.000 -0.097 -1.408 1.600E-01 -0.001 0.000
Gestational age 0.077 0.130 0.041 0.592 5.540E-01 -0.179 0.332
Breastfeeding duration** -0.018 0.007 -0.192 -2.724 7.000E-03 -0.031 -0.005
Ethnicity 1.271 0.947 0.086 1.342 1.810E-01 -0.594 3.136
Maternal age delivery* 0.072 0.034 0.141 2.130 3.400E-02 0.005 0.139
AD father -0.551 0.384 -0.099 -1.434 1.530E-01 -1.309 0.206
AD mother -0.384 0.421 -0.064 -0.912 3.630E-01 -1.214 0.446
Asthma father -0.329 0.398 -0.054 -0.827 4.090E-01 -1.114 0.455
Asthma mother -0.526 0.348 -0.101 -1.511 1.320E-01 -1.211 0.160
Smoking in pregnancy -0.195 0.373 -0.034 -0.523 6.020E-01 -0.930 0.540
Smoking after pregnancy 0.131 0.373 0.023 0.351 7.260E-01 -0.605 0.866
AD** -0.977 0.332 -0.188 -2.945 4.000E-03 -1.630 -0.323
Household with furry pets 0.287 0.322 0.055 0.890 3.740E-01 -0.348 0.921
Start of daycare in months -0.030 0.017 -0.113 -1.798 7.400E-02 -0.063 0.003
Age of introduction solids (months) -0.012 0.040 -0.021 -0.308 7.590E-01 -0.092 0.067
antibiotic use prior to sample 
collection 0.431 0.502 0.055 0.860 3.910E-01 -0.557 1.420
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Supplementary Table S9 - Multivariable linear regression analyses on demographic, dietary, lifestyle and medical 
factors associated with microbial diversity  (Shannon)
Shannon index at age 5 weeks (N = 235)







Beta   Lower Bound Upper Bound
(Constant) 0.984 1.142  0.861 3.900E-01 -1.267 3.234
Birhmode assisted vaginal 0.075 0.153 0.032 0.487 6.270E-01 -0.227 0.376
Birhmode cesarean section -0.025 0.081 -0.020 -0.314 7.540E-01 -0.184 0.134
1 older sibling 0.057 0.080 0.050 0.722 4.710E-01 -0.099 0.214
> 2 older siblings 0.006 0.134 0.003 0.047 9.620E-01 -0.257 0.270
Sex 0.045 0.070 0.042 0.636 5.250E-01 -0.093 0.183
Birth Weight 0.000 0.000 0.080 1.110 2.680E-01 0.000 0.000
Gestational age 0.023 0.030 0.056 0.765 4.450E-01 -0.036 0.082
Breastfeeding duration -0.001 0.002 -0.065 -0.875 3.820E-01 -0.004 0.002
Ethnicity 0.017 0.220 0.005 0.078 9.380E-01 -0.417 0.451
Maternal age delivery 0.003 0.008 0.030 0.441 6.590E-01 -0.012 0.018
AD father 0.019 0.088 0.015 0.212 8.320E-01 -0.154 0.191
AD mother -0.183 0.097 -0.140 -1.888 6.000E-02 -0.374 0.008
Asthma father 0.083 0.091 0.062 0.917 3.600E-01 -0.095 0.261
Asthma mother -0.068 0.079 -0.060 -0.860 3.900E-01 -0.224 0.088
Smoking in pregnancy -0.029 0.087 -0.023 -0.331 7.410E-01 -0.199 0.142
Smoking after pregnancy 0.014 0.084 0.012 0.166 8.680E-01 -0.152 0.180
AD -0.004 0.076 -0.004 -0.055 9.560E-01 -0.154 0.145
Household with furry pets -0.146 0.075 -0.127 -1.953 5.200E-02 -0.293 0.001
Start of daycare in months 0.002 0.004 0.027 0.413 6.800E-01 -0.006 0.010
Age of introduction solids 
(months) -0.010 0.009 -0.078 -1.084 2.800E-01 -0.028 0.008
antibiotic use prior to 
sample collection -0.025 0.281 -0.006 -0.090 9.280E-01 -0.580 0.529
Shannon index at age 13 weeks (N = 231)







Beta   Lower Bound Upper Bound
(Constant) 4.139 1.268  3.264 1.000E-03 1.639 6.639
Birhmode assisted vaginal 0.184 0.168 0.076 1.098 2.730E-01 -0.147 0.515
Birhmode cesarean section 0.031 0.088 0.025 0.358 7.210E-01 -0.142 0.205
1 older sibling 0.005 0.087 0.004 0.054 9.570E-01 -0.168 0.177
> 2 older siblings 0.157 0.154 0.081 1.019 3.090E-01 -0.147 0.461
Sex 0.018 0.077 0.016 0.236 8.140E-01 -0.133 0.170
Birth Weight 0.000 0.000 -0.119 -1.573 1.170E-01 0.000 0.000
Gestational age -0.034 0.033 -0.079 -1.035 3.020E-01 -0.099 0.031
Breastfeeding duration -0.001 0.002 -0.046 -0.587 5.580E-01 -0.004 0.002
Ethnicity 0.100 0.231 0.031 0.431 6.670E-01 -0.356 0.555
Maternal age delivery -0.004 0.008 -0.036 -0.493 6.230E-01 -0.021 0.013
AD father 0.020 0.094 0.016 0.208 8.350E-01 -0.166 0.205
AD mother 0.124 0.107 0.092 1.154 2.500E-01 -0.088 0.336
Asthma father -0.012 0.103 -0.008 -0.113 9.100E-01 -0.214 0.191
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Shannon index at age 13 weeks (N = 231)







Beta   Lower Bound Upper Bound
Asthma mother -0.006 0.087 -0.005 -0.064 9.490E-01 -0.176 0.165
Smoking in pregnancy -0.053 0.091 -0.042 -0.583 5.610E-01 -0.234 0.127
Smoking after pregnancy -0.035 0.092 -0.028 -0.380 7.040E-01 -0.217 0.147
AD -0.074 0.084 -0.062 -0.888 3.760E-01 -0.239 0.091
Household with furry pets -0.034 0.079 -0.029 -0.429 6.680E-01 -0.191 0.123
Start of daycare in months -0.006 0.004 -0.101 -1.452 1.480E-01 -0.014 0.002
Age of introduction solids 
(months) -0.006 0.010 -0.047 -0.605 5.460E-01 -0.026 0.014
antibiotic use prior to 
sample collection 0.001 0.012 0.006 0.094 9.250E-01 -0.023 0.026
Shannon index at age 21 weeks (N = 228)







Beta   Lower Bound Upper Bound
(Constant) 3.346 1.192  2.807 5.000E-03 0.996 5.696
Birhmode assisted vaginal -0.156 0.154 -0.067 -1.009 3.140E-01 -0.460 0.148
Birhmode cesarean section -0.074 0.082 -0.061 -0.902 3.680E-01 -0.236 0.088
1 older sibling 0.042 0.081 0.038 0.526 6.000E-01 -0.117 0.201
> 2 older siblings 0.005 0.133 0.003 0.037 9.710E-01 -0.257 0.267
Sex 0.083 0.070 0.079 1.183 2.380E-01 -0.055 0.222
Birth Weight 0.000 0.000 -0.056 -0.757 4.500E-01 0.000 0.000
Gestational age 0.004 0.031 0.009 0.122 9.030E-01 -0.058 0.065
Breastfeeding duration** -0.004 0.001 -0.199 -2.685 8.000E-03 -0.007 -0.001
Ethnicity -0.207 0.235 -0.058 -0.882 3.790E-01 -0.669 0.255
Maternal age delivery 0.000 0.008 -0.002 -0.024 9.810E-01 -0.015 0.015
AD father -0.111 0.088 -0.094 -1.265 2.070E-01 -0.284 0.062
AD mother -0.069 0.097 -0.054 -0.712 4.780E-01 -0.260 0.122
Asthma father -0.012 0.089 -0.010 -0.137 8.910E-01 -0.188 0.164
Asthma mother 0.059 0.080 0.053 0.729 4.670E-01 -0.100 0.217
Smoking in pregnancy -0.058 0.087 -0.046 -0.661 5.090E-01 -0.230 0.115
Smoking after pregnancy -0.060 0.088 -0.050 -0.686 4.930E-01 -0.233 0.113
AD -0.100 0.075 -0.091 -1.334 1.840E-01 -0.248 0.048
Household with furry pets 0.036 0.076 0.032 0.477 6.340E-01 -0.113 0.186
Start of daycare in months 0.003 0.004 0.060 0.882 3.790E-01 -0.004 0.011
Age of introduction solids 
(months)** -0.028 0.009 -0.224 -3.086 2.000E-03 -0.046 -0.010
antibiotic use prior to 
sample collection 0.109 0.138 0.055 0.793 4.290E-01 -0.162 0.380
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Supplementary Table S9 - Continued 
Shannon index at age 31 weeks (N = 253)







Beta   Lower Bound
Upper 
Bound
(Constant) 2.551 1.064  2.399 1.700E-02 0.456 4.647
Birhmode assisted vaginal -0.012 0.142 -0.005 -0.082 9.340E-01 -0.292 0.269
Birhmode cesarean section 0.009 0.076 0.008 0.122 9.030E-01 -0.140 0.158
1 older sibling 0.104 0.075 0.091 1.386 1.670E-01 -0.044 0.251
> 2 older siblings* 0.246 0.124 0.136 1.978 4.900E-02 0.001 0.491
Sex -0.029 0.065 -0.028 -0.448 6.550E-01 -0.157 0.099
Birth Weight 0.000 0.000 0.017 0.248 8.040E-01 0.000 0.000
Gestational age 0.021 0.028 0.051 0.757 4.500E-01 -0.033 0.075
Breastfeeding duration** -0.005 0.001 -0.238 -3.449 1.000E-03 -0.008 -0.002
Ethnicity -0.202 0.203 -0.063 -0.996 3.200E-01 -0.602 0.198
Maternal age delivery -0.007 0.007 -0.060 -0.915 3.610E-01 -0.021 0.008
AD father -0.073 0.082 -0.060 -0.885 3.770E-01 -0.235 0.089
AD mother 0.072 0.089 0.056 0.810 4.190E-01 -0.104 0.249
Asthma father 0.092 0.084 0.071 1.106 2.700E-01 -0.072 0.257
Asthma mother 0.068 0.074 0.061 0.918 3.600E-01 -0.078 0.215
Smoking in pregnancy 0.031 0.079 0.025 0.391 6.960E-01 -0.125 0.187
Smoking after pregnancy 0.002 0.079 0.002 0.025 9.800E-01 -0.155 0.158
AD -0.178 0.070 -0.158 -2.525 1.200E-02 -0.317 -0.039
Household with furry pets -0.010 0.069 -0.009 -0.148 8.820E-01 -0.145 0.125
Start of daycare in months 0.000 0.004 0.002 0.028 9.780E-01 -0.007 0.007
Age of introduction solids 
(months)** -0.029 0.008 -0.232 -3.459 1.000E-03 -0.046 -0.013
antibiotic use prior to 
sample collection -0.001 0.106 -0.001 -0.010 9.920E-01 -0.209 0.207
Supplementary Table S10 - Joint modelling on the association between longitudinal microbial diversity (Shannon 
index) and the time to development of atopic dermatitis (AD)
Joint modelling on MAZ scores and atopic dermatitis (N = 312)
Effect Value Std. Err. z-value p-value
Treatment (reference = placebo) -0.06407407 0.211695794 -0.30267049 7.62E-01
Gender (reference = boy) 0.034598927 0.211291403 0.16374981 8.70E-01
AD father (reference = no) 0.906944883 0.290099079 3.126328035 1.77E-03
Breastfeeding duration (weeks) 0.007557587 0.00364736 2.072070356 3.83E-02
1 older sibling (reference = no sibs) 0.154546605 0.238565208 0.647817031 5.17E-01
> 2 olders siblings -0.034512157 0.375489343 -0.091912482 9.27E-01
Furry pets in household (reference = no) -0.078684706 0.23136654 -0.340086798 7.34E-01
Cesarean section birth mode (reference = 
natural vaginal delivery) -0.12821753 0.474555339 -0.27018457 7.87E-01
Assisted vaginal delivery -0.343478873 0.267486101 -1.284099886 1.99E-01
Birth weight (in grams) 0.510627325 0.264140586 1.933164954 5.32E-02
AD mother (reference = no) 0.766246518 0.305654581 2.506903427 1.22E-02
ASSOCIATION (MAZ scores) 0.127799617 0.029913897 4.272249057 1.94E-05
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log(xi.1) -4.595666187 1.097884853 -4.185927309 2.84E-05
log(xi.2) -4.671636806 1.098344847 -4.253342489 2.11E-05
log(xi.3) -2.512362383 1.302212452 -1.929302995 5.37E-02
log(xi.4) -7.065394817 8240.266544 -0.000857423 9.99E-01
Supplementary Table S11 - Joint modelling on the association between longitudinal microbial maturity (MAZ 
score) and the time to  development of atopic dermatitis (AD)
Joint modelling on MAZ scores and atopic dermatitis (N = 312)
Effect Value Std. Err. z-value p-value
Treatment (reference = placebo) -0.06407407 0.211695794 -0.30267049 7.62E-01
Gender (reference = boy) 0.034598927 0.211291403 0.16374981 8.70E-01
AD father (reference = no) 0.906944883 0.290099079 3.126328035 1.77E-03
Breastfeeding duration (weeks) 0.007557587 0.00364736 2.072070356 3.83E-02
1 older sibling (reference = no sibs) 0.154546605 0.238565208 0.647817031 5.17E-01
> 2 olders siblings -0.034512157 0.375489343 -0.091912482 9.27E-01
Furry pets in household (reference = no) -0.078684706 0.23136654 -0.340086798 7.34E-01
Cesarean section birth mode 
(reference = natural vaginal delivery)
-0.12821753 0.474555339 -0.27018457 7.87E-01
Assisted vaginal delivery -0.343478873 0.267486101 -1.284099886 1.99E-01
Birth weight (in grams) 0.510627325 0.264140586 1.933164954 5.32E-02
AD mother (reference = no) 0.766246518 0.305654581 2.506903427 1.22E-02
ASSOCIATION (MAZ scores) 0.127799617 0.029913897 4.272249057 1.94E-05
log(xi.1) -4.595666187 1.097884853 -4.185927309 2.84E-05
log(xi.2) -4.671636806 1.098344847 -4.253342489 2.11E-05
log(xi.3) -2.512362383 1.302212452 -1.929302995 5.37E-02
log(xi.4) -7.065394817 8240.266544 -0.000857423 9.99E-01
Supplementary Table S12 - METALONDA analyses on microbial genera in association to atopic dermatitis
MetaLonDa Analysis Output in association to Atopic Dermatitis
Bacterial Genera start (days) end (days) dominant FDR adjusted p-value
Corynebacterium 126.110 151.240 HC 9.68E-03
Atopobium 25.590 79.440 HC 7.65E-03
Prevotella 104.570 133.290 HC 0.00E+00
Lachnobacterium 25.590 61.490 HC 1.18E-02
Lachnobacterium 108.160 129.700 HC 6.49E-03
Lachnobacterium 208.680 269.710 HC 5.00E-03
Faecalibacterium 47.130 201.500 HC 5.08E-03
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Supplementary Table S13 - Logistic regression model of microbial diversity (Shannon index) in association to 
allergic sensitization at school-age
Logistic regression model of microbial diversity (Shannon index) in association to allergic sensitization at 
school-age
Coefficents Estimate Std. Error z value P-value
(Intercept) 5.627791598 3.674612075 1.531533529 1.26E-01
Shannon at 5 weeks -0.410285084 0.454296315 -0.903122193 3.66E-01
Shannon at 13 weeks -0.208920785 0.527504064 -0.396055309 6.92E-01
Shannon at 21 weeks 0.279310503 0.601239738 0.464557623 6.42E-01
Shannon at 31 weeks -1.620866258 0.604467106 -2.681479675 7.33E-03
Breastfeeding duration (weeks) -3.030233351 0.873149718 -3.470462497 5.20E-04
Solid food introduction (week) 6.294484319 3.381347875 1.861531126 6.27E-02
Cesarean section -0.238619825 1.081714761 -0.220594036 8.25E-01
Assisted vaginal delivery -0.94531093 0.626875226 -1.507973023 1.32E-01
Birth Weight (g) -0.000366139 0.00065891 -0.555673949 5.78E-01
Sex Female (reference = male) -0.527185935 0.500811149 -1.052664135 2.92E-01
Treatment Control (reference = yes) 0.742100392 0.503761986 1.473117091 1.41E-01
No AD Father (reference=Yes) -1.635728509 0.645015214 -2.535953375 1.12E-02
No AD Mother (reference=Yes) -0.655147341 0.663647229 -0.987192159 3.24E-01
1 older sibling (reference = no sibs) 0.45591163 0.568647631 0.801747172 4.23E-01
> 2 olders siblings -6.44E-05 0.999108354 -6.44E-05 1.00E+00
Furry pets in household (reference = no) -0.72774705 0.548034524 -1.327921908 1.84E-01
Supplementary Table S14 - Logistic regression model of microbial maturity (MAZ score) in association to allergic 
sensitization at school-age
Logistic regression model of microbial maturity (MAZ-score) in association to allergic sensitization at school-
age
Coefficents Estimate Std. Error z value P-value
(Intercept) -0.087464637 2.640818493 -0.033120276 9.74E-01
MAZ at 5 weeks 0.382210056 0.136202238 2.806195127 5.01E-03
MAZ at 13 weeks -0.164301672 0.140623631 -1.16837882 2.43E-01
MAZ at 21 weeks 0.050549523 0.182113301 0.277571833 7.81E-01
MAZ at 31 weeks -0.016145267 0.133545263 -0.120897342 9.04E-01
Breastfeeding duration (weeks) -3.026775739 0.884920175 -3.420394091 6.25E-04
Solid food introduction (week) 8.847895913 3.301639509 2.679849175 7.37E-03
Birth Weight (g) -0.00039128 0.000649369 -0.602553926 5.47E-01
Treatment Control (reference = yes) 0.957059287 0.534603349 1.790223143 7.34E-02
Sex Female (reference = male) -0.402875364 0.508750997 -0.791891054 4.28E-01
Cesarean section -0.236701605 1.019008403 -0.232286215 8.16E-01
Assisted vaginal delivery -0.842345125 0.656241797 -1.283589569 1.99E-01
No AD Father (reference=Yes) -1.43835435 0.64026914 -2.246483953 2.47E-02
No AD Mother (reference=Yes) -0.52709629 0.640499938 -0.822945108 4.11E-01
1 older sibling (reference = no sibs) 0.119864913 0.552340617 0.217012672 8.28E-01
> 2 olders siblings -0.745760306 1.048383644 -0.711342942 4.77E-01
Furry pets in household (reference = no) -0.840188796 0.565073526 -1.486866323 1.37E-01
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Supplementary Table S15 - Logistic regression model of microbial diversity (Shannon index) in association to 
asthma at school-age
Logistic regression model of microbial diversity (Shannon index) in association to asthma at school-age
Coefficents Estimate Std. Error z value P-value
(Intercept) -9.519296394 5.319877537 -1.789382618 7.36E-02
Shannon at 5 weeks -0.431558541 0.692669049 -0.623037137 5.33E-01
Shannon at 13 weeks 0.065089728 0.751687765 0.086591443 9.31E-01
Shannon at 21 weeks -0.02811964 0.661640302 -0.04249989 9.66E-01
Shannon at 31 weeks 0.164692463 0.801999013 0.205352451 8.37E-01
Breastfeeding duration (weeks) -0.254586729 0.764690582 -0.332927768 7.39E-01
Solid food introduction (week) 6.194863693 5.019759796 1.234095643 2.17E-01
Cesarean section 0.344889489 1.456595944 0.236777735 8.13E-01
Birth Weight (g) 0.001270255 0.00090951 1.396637011 1.63E-01
Assisted vaginal delivery -0.825554535 0.948850266 -0.870057758 3.84E-01
Treatment Control (reference = yes) -0.166071147 0.657007741 -0.252768936 8.00E-01
Sex Female (reference = male) -2.051878298 0.859550668 -2.387152234 1.70E-02
No AD Father (reference=Yes) 0.085116272 0.823378904 0.103374365 9.18E-01
No AD Mother (reference=Yes) -0.313860614 1.003653848 -0.31271799 7.54E-01
1 older sibling (reference = no sibs) 0.643148333 0.754705643 0.852184343 3.94E-01
> 2 olders siblings -15.68707851 1926.712049 -0.00814189 9.94E-01
Furry pets in household (reference = no) 1.483880523 0.934270057 1.588277941 1.12E-01
Supplementary Table S16 - Logistic regression model of microbial maturity (MAZ score) in association to asthma 
at school-age
Logistic regression model of microbial maturity (MAZ-score) in association to asthma at school-age
Coefficents Estimate Std. Error z value P-value
(Intercept) -12.40821269 5.470392851 -2.268248923 2.33E-02
MAZ at 5 weeks 0.363442479 0.136558324 2.661445086 7.78E-03
MAZ at 13 weeks -0.415956399 0.187305674 -2.220735705 2.64E-02
MAZ at 21 weeks 0.254280302 0.228921442 1.110775385 2.67E-01
MAZ at 31 weeks -0.104036691 0.157184716 -0.661875362 5.08E-01
Breastfeeding duration (weeks) -0.486254724 0.839838341 -0.578986099 5.63E-01
Solid food introduction (week) 10.08291775 5.955334706 1.69309002 9.04E-02
Cesarean section 1.480313854 1.561995355 0.94770695 3.43E-01
Assisted vaginal delivery -1.1528046 1.0910663 -1.056585287 2.91E-01
Birth Weight (g) 0.001070665 0.000970668 1.103018401 2.70E-01
Treatment Control (reference = yes) 0.126012384 0.750777261 0.167842569 8.67E-01
Sex Female (reference = male) -3.129532598 1.16397764 -2.688653536 7.17E-03
No AD Father (reference=Yes) 0.731989105 0.882583537 0.829370903 4.07E-01
No AD Mother (reference=Yes) -1.282273155 1.392172865 -0.921058862 3.57E-01
1 older sibling (reference = no sibs) 0.961383693 0.768278099 1.25134856 2.11E-01
> 2 olders siblings -14.55804809 1838.156717 -0.007919917 9.94E-01
Furry pets in household (reference = no) 1.829645625 1.082872207 1.68962285 9.11E-02
Chapter 5
156
Supplementary Table S17 - METALONDA analyses on microbial genera in association to asthma
MetaLonDa Analysis Output in association to Asthma
Bacterial Genera start (days) end (days) dominant FDR adjusted p-value
Actinomyces 183.040 192.000 HC 1.809E-02
Enterococcus 167.360 194.240 HC 3.307E-02
Streptococcus 44.160 129.280 Asthma 1.741E-02
Streptococcus 183.040 236.800 HC 3.156E-03
Sarcina 28.480 57.600 HC 8.062E-03
Sarcina 84.480 86.720 HC 4.844E-02
Sarcina 88.960 93.440 HC 4.521E-02
Lachnobacterium 28.480 100.160 HC 1.365E-02
Lachnobacterium 138.240 176.320 HC 4.618E-03
Lachnobacterium 221.120 236.800 HC 2.783E-02
Lachnospira 48.640 80.000 HC 1.717E-02
Lachnospira 91.200 200.960 HC 2.878E-03
Lachnospira 218.880 236.800 HC 1.040E-03
Dialister 28.480 122.560 HC 6.209E-04
Dialister 131.520 144.960 Asthma 1.378E-02
Dialister 151.680 176.320 HC 1.200E-02
Dialister 203.200 207.680 HC 4.823E-02
Dialister 216.640 236.800 HC 1.935E-02
Klebsiella 28.480 102.400 HC 6.922E-03
Leclercia 28.480 187.520 HC 2.746E-03
Haemophilus 115.840 236.800 HC 1.038E-02
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Reliable biomarkers to predict asthma in wheezing preschool children are lacking. We examined 
whether gut microbial composition in preschool wheezers was associated with asthma, and 
investigated associations between gut microbiota and atopic sensitisation, regulatory T-cells 
(Tregs), and Foxp3 gene expression.
 In the Asthma Detection and Monitoring study, 202 wheezing children aged 2-4 years 
and 50 healthy controls were followed until the age of 6 years, when a diagnosis of asthma 
was made. At age 2-4 years, faecal microbial composition was analysed by sequencing 
of the 16S rRNA V3-V4 gene region. In blood, atopic sensitisation (Phadiatop Infant test), 
proportion of Tregs (CD4+CD25highCD127-), and Foxp3 gene expression were assessed. 
 We found no difference in gut microbial diversity, richness, or overall microbial community 
structure between transient wheezers and true asthmatics, or between preschool wheezers and 
healthy controls. However, the relative abundance of the genera Collinsella (p=0.01) and Dorea 
(p=0.02) was significantly lower in wheezing compared to healthy children, whereas Gemmiger 
(p=0.03) and Escherichia (p=0.02) were significantly higher in preschool wheezers who developed 
asthma. In particular, a high relative abundance of Escherichia was associated with a 4.6-fold 
increased odds of asthma (p=0.02). No significant correlations between abundance of specific 
bacterial genera and atopic sensitisation, Tregs, and Foxp3 gene expression were detected. 
 In conclusion, gut microbial diversity and overall gut microbial community structure at 
preschool age were not associated with wheezing or future asthma. However, some bacterial 
genera were associated with wheezing or subsequent asthma, suggesting some microbial 
dysbiosis in children prone for developing asthma.




Wheezing in preschool children is common, but only one third of wheezing preschool 
children will eventually develop asthma [1]. Currently, a reliable biomarker to predict which 
wheezing children will develop asthma is lacking [2]. Consequently, both underdiagnosis 
of asthma and overtreatment of children with episodic viral wheeze still frequently occur. 
 In the development of childhood asthma, genetic susceptibility and early life 
environmental exposures play a major role, leading to an immunological dysbalance 
favouring a T-helper type 2 (Th2) response [3]. In the past years, the impact of gut microbiota 
perturbations on this immunological dysbalance has gained widespread attention. Data from 
birth cohort studies showed that gut microbial dysbiosis in the first year of life was associated 
with asthma development [4-8]. Recent studies have shown the influence of short-chain 
fatty acids (SCFAs), originating from bacterial fermentation of dietary fibres in the gut, on 
regulatory T-cells (Tregs) which are crucial in maintaining an adequate immune balance [9-11]. 
Moreover, a high-fibre diet increased the levels of SCFAs in mice, which markedly suppressed 
allergic airways disease by enhancing Treg numbers and function [12]. This protective 
effect was partly explained by increasing acetylation at the Foxp3 promoter region [12]. 
 These studies show our increased understanding regarding the role of the gut 
microbiota in asthma development. However, the majority of studies have been performed 
in animals, whereas most human studies have focused on the association between infant 
gut microbiota and asthma-like symptoms at an age when a reliable diagnosis of asthma 
cannot yet be made. Finally, no studies have been performed that investigated gut microbial 
composition in wheezing children, and its association with subsequent development of asthma. 
 In the current study, we profiled the gut microbiota in a cohort of wheezing and healthy 
preschool children, which were prospectively followed until the age of 6 years when a definitive 
diagnosis of asthma was made. Our aims were to: (1) investigate differences in gut microbial 
composition between wheezing preschool children and healthy controls, (2) assess whether 
the gut microbiota in wheezing preschool children were associated with the development of 
childhood asthma, (3) investigate associations between the gut microbial profiles and atopic 





In the Asthma Detection and Monitoring (ADEM) study (clinicaltrial.gov: NCT 00422747), 
202 wheezing children and 50 healthy controls aged 2 to 4 years were prospectively 
followed until 6 years of age [13, 14]. The primary goal of the ADEM study was to assess 
the diagnostic accuracy of various tests. Moreover, important pathogenic pathways for 
the early development of asthma were studied. A detailed study protocol with in- and 
exclusion criteria was previously published [15]. The study was approved by the Dutch 
national medical ethical committee, and written informed consent was given by all parents. 
 At inclusion, clinical characteristics, and faecal and blood samples were collected. 
Clinical characteristics were collected using validated questionnaires [16, 17]. 
 At the age of 6 years, a clinical diagnosis (healthy, transient wheeze or true asthma) 
was made by two experienced paediatric pulmonologists and a computer based algorithm 
[18]. 
DNA isolation and amplicon sequencing of the 16S rRNA V3-V4 gene region
By using a standardised protocol, faeces of all participating children was collected at inclusion 
[19]. After reception, samples were immediately frozen at -80 °C until further analysis. DNA 
isolation was performed using a combination of mechanical (repeated bead beating) and 
chemical lysis followed by column-based purification as described previously [20]. For each 
DNA isolation batch, additional isolation was performed on PCR-grade water as a negative 
control. Amplicon libraries of the 16S rRNA V3-V4 gene region and subsequent sequencing 
(Illumina, MiSeq) was performed by Baseclear [Leiden, the Netherlands], see supplementary 
material for more details. Data demultiplexing, length and quality filtering, pairing of reads 
and clustering of reads into Operational Taxonomic Units (OTUs) at 97% sequence identity was 
done using the online Integrated Microbial Next Generation Sequencing (IMNGS) platform 
[21], using default settings except for minimum and maximum length for amplicons which 
were set at 300 and 600 bp respectively. IMNGS is based upon the UPARSE algorithm [22]. 
 Data normalisation, diversity, taxonomical binning and group comparisons were 
performed using Rhea package [23]. In order not to discard informative data, normalisation 
in Rhea is performed by dividing OTU counts per sample for their total count (sample depth) 
followed by multiplying all of the obtained relative abundance for the lowest sample depth 
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(8,278 reads/sample). Alpha- (observed species, Chao1 and Shannon index) and beta-diversity 
(generalised Unifrac, Bray-Curtis dissimilarity) estimates were computed in R [24]. 
Atopy
Atopy was defined positive when a specific IgE concentration against a mixture of inhalant and 
food allergens was ≥ 0.35 kU/L (Phadiatop Infant test; Phadia, Uppsala, Sweden). IgE-mediated 
asthma was defined as children with a diagnosis of asthma at age 6 years, and specific IgE levels 
≥ 0.35 kU/l against one or more aeroallergens as determined by the Phadiatop Infant test. 
Regulatory T cells
Tregs (CD4+CD25highCD127-) were determined by flow cytometry. As published before, the 
CD4+CD25highCD127- phenotype was shown to be a valid surrogate for Foxp3 positive Tregs 
in our study population [25].
Foxp3 gene expression
Total RNA was extracted from peripheral blood mononuclear cells (PBMC), and expression 
of Foxp3 gene was assessed. A detailed study procedure was previously published [14].   
Data analysis
IBM SPSS Statistics 20, SAS 7.30 and R statistical software were used for data analysis. To test 
for statistical significant differences in the overall microbial community structure between 
study groups, permutational multivariate analysis of variance (PERMANOVA) using distance 
matrices (vegan::adonis) were performed. Enterotyping, using Dirichlet Multinomial Mixture 
(DMM) clustering, was performed as described previously [26], in order to cluster faecal 
samples based upon specific microbial community structures. To examine whether the study 
group associated with specific enterotypes, multivariable logistic regression analyses were 
performed while adjusting for potential confounders (sex, breastfeeding, birth season, parental 
atopy, siblings, parental smoking status, day care).  To test whether specific microbial taxa 
and/or microbial diversity differed between study groups (e.g. healthy controls vs. wheeze 
or transient wheeze vs. asthma), Kruskal-Wallis tests and Mann-Whitney U tests were used. 
For those bacteria that appeared to be statistically significantly different between the study 
groups in univariable analyses, multivariable logistic regression analyses were performed to 
examine whether these associations remained upon adjustment for potential confounders 
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(see above). To identify possible relations between microbial richness, diversity and genus 
abundance and continuous outcomes (i.e. Foxp3 gene-expression and Tregs) spearman 
correlations were used.   
Results
Faecal and blood samples were collected. Faecal microbial composition was analysed by 
sequencing of the 16S rRNA V3-V4 gene region (see flow chart, Figure S1). A total of 12,230,374 
V3-V4 reads were generated. After trimming, quality filtering, removal of potential chimeric 
reads, de-multiplexing, and removal of low abundant operational taxonomic units (OTUs), 
6,885,888 paired-end sequences belonging to 336 OTUs were retained for downstream 
analysis. Samples of three participants failed during sequencing and were excluded from 
subsequent analysis. For the remaining samples of 230 children (70 asthmatics, 114 transient 
wheezers, and 46 healthy controls), the number of sequences per sample ranged from 2,362 
to 44,357 (median 30,471). In blood, atopic sensitisation (Phadiatop Infant test), proportion of 
Tregs by flow cytometry (CD4+CD25highCD127-), and Foxp3 gene expression were assessed. 
The baseline characteristics are displayed in Table S1.
Microbiota richness and diversity
First, we examined whether microbial richness and diversity at preschool age were predictive 
for future asthma development. Neither the microbial richness (OR 0.99 [95%CI 0.98-1.01]; 
P = .46), nor the microbial diversity as assessed by the Shannon index (OR 1.01 [0.98-1.04]; 
P = .53) were significantly different between transient wheezing children and true asthmatics 
while adjusting for potential confounders (sex, breastfeeding, birth season, atopy parents, 
siblings, parental smoking status, day care attendance; Figure 1A-B). At preschool age, these 
indices were also not different between wheezers and healthy controls, while adjusting for 
potential confounders (Figure S2).
Enterotypes
Next, we examined the overall microbial community structure (as assessed by the Bray-Curtis 
dissimilarity), which was neither significantly different between transient wheezers and true 
asthmatics (PERMANOVA P = .07, Figure 1C), nor between preschool wheezers and healthy 
controls (PERMANOVA P = .22, Figure S2). Microbial profiles of all children were clustered using 
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Dirichlet Multinomial Mixture (DMM) modelling. Three distinct clusters (enterotypes) were 
identified, that is those that were driven by a relatively high abundance of Bifidobacterium, 
Bifidobacterium combined with Blautia, and Prevotella combined with Bifidobacterium, 
respectively. Neither the number of wheezing children who developed asthma, nor the 
proportion of children with preschool wheeze were significantly different among the three 
enterotypes, while adjusting for multiple confounders in multivariable logistic regression 
analyses (Table S2 and S3). Altogether these results indicate that microbial diversity and 
overall microbial community structure are not predictive for subsequent asthma development 
among preschool wheezing children.
Figure 1 - Microbial richness, diversity and community structure among preschool wheezing children who did 
(true asthmatics) or did not (transient wheezers) subsequently develop asthma. Microbial richness (observed 
species) (A) and diversity (Shannon effector index) (B) are not significantly different between transient wheezers 
and true asthmatics (ns: nonsignificant; Kruskal-Wallis). C, Multidimensional scaling (MDS) based on Bray-Curtis 
dissimilarity indicates three different enterotypes driven by Bifidobacterium, Bifidobacterium/Blautia and Prevotella/
Bifidobacterium. Overall, microbial community structure is not statistically significantly different between transient 




Furthermore, we examined whether the relative abundance of specific bacterial genera 
was predictive for future asthma development. Using multivariable logistic regression, we 
found that the relative abundance of the genera Gemmiger (P = .03) and Escherichia (P = 
.02) was significantly higher in wheezing children who developed asthma at age 6 years 
(Figure 2A-B). The risk of developing asthma was highest in those children who harboured 
the highest relative abundance of these two bacterial genera (Figure 2C-D). In particular, a 
high relative abundance of Escherichia was associated with 4.6-fold increased odds of asthma 
(P = .02, Figure 2D). When comparing preschool wheezers with healthy controls, the relative 
abundance of Collinsella (P = .01) and Dorea (P = .02) was significantly lower in wheezing 
children (Figure S3).
Figure 2 - The relative abundance of specific microbial taxa increases the risk of subsequent asthma. The relative 
abundance of bacterial genera Gemmiger (P = .03) and Escherichia (P = .02) is higher in true asthmatic children 
compared with transient wheezers (A, B). Multiple logistic regression analyses show that the higher risk to develop 
asthma among children with a high abundance of Gemmiger and Escherichia remained statistically significant 
upon adjustment for sex, breastfeeding, birth season, atopy parents, siblings, parental smoking status and day 
care attendance (C, D)
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Gut microbiota and sensitization, Tregs and Foxp3 gene expression
Finally, we examined whether gut microbial profiles were related to atopic sensitisation, Tregs 
and Foxp3 gene expression. Besides a weak, yet statistically significant, positive correlation 
between Foxp3 gene expression and bacterial diversity (Shannon index) within the entire 
study population (Spearman’s rho = 0.16; P = .02), atopic sensitisation, Tregs and Foxp3 
gene expression were neither associated with the overall microbial community structure 
(Bray-Curtis dissimilarity) nor with the abundance of specific bacterial genera.
Discussion 
In this study, we investigated the gut microbiota in wheezing preschool children and healthy 
controls at 2-4 years of age and assessed its association with asthma at age 6 years. To the best 
of our knowledge, no previous studies have examined the microbiota in wheezing preschool 
children and its association with asthma progression. We did not observe a difference in gut 
microbial diversity, richness, or overall microbial community structure between transient 
wheezers and true asthmatics, or between preschool wheezers and healthy controls. However, 
on a genus level, some bacterial genera were associated with wheezing (Collinsella and Dorea) 
or with the subsequent development of asthma (Gemmiger and Escherichia). No significant 
correlations between the abundance of specific bacterial genera and atopic sensitisation, 
Tregs, and Foxp3 gene expression were detected.
  The ADEM study was designed to assess the diagnostic accuracy of various tests in 
the early prediction of asthma in wheezing preschool children and to investigate basic 
pathogenetic mechanisms underlying an early asthma development. Previously, we reported 
on a high diagnostic accuracy for an early asthma diagnosis (95% area under the receiver 
operating characteristic curve) by combining exhaled volatile organic compounds in exhaled 
breath with expression of inflammation genes, and the Asthma Predictive Index [14]. 
 The present study revealed that gut microbial richness, diversity and overall 
community structure at the age of 2-4 years were, however, not suitable to predict asthma. 
These findings suggest that at an age beyond infancy, when the gut microbiome is largely 
stabilised, microbiota perturbations might only be modest. This is in line with the proposed 
window-of-opportunity, the first months of life, during which the microbiome is thought 
to have its strongest impact on immune maturation and tolerance development [27, 28], 
and underscores the importance of timing of faecal sampling. However, this early time-
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window might not be a suitable age to identify biomarkers for asthma prediction as 
manifestation of wheezing symptoms may not have yet occurred. Moreover, the bacterial 
genera Gemmiger and Escherichia were significantly associated with asthma, suggesting that 
some microbial dysbiosis might still exist at preschool age among wheezing children prone 
for developing asthma. In particular, a high relative abundance of Escherichia in wheezing 
children was associated with a 4.6-fold increased odds of asthma at the age of six years. 
 Given the lack of similar studies in this age group, we can only compare our findings 
with those of birth cohort studies assessing the relationship between the infant microbiota 
and subsequent asthma development. The design of these birth cohort studies differ, 
however, with respect to timing of faecal sampling, geographical influences, differences 
in environmental exposures (e.g. mode of delivery, diet, exposure to antibiotics), and 
heterogeneity in the definitions of asthma. Only in two Scandinavian birth cohorts, 
asthma diagnosis was robust and in accordance with international guidelines [6, 29]. 
In other studies, asthma was diagnosed at a younger age than a reliable diagnosis is 
normally made, or diagnosis was based on parentally reported symptoms [4, 5, 7, 8]. 
 Regarding gut microbial diversity, a lower diversity at age 1 week and 1 month was 
associated with asthma in a small Swedish birth cohort [29]. However, this could not be 
replicated in two other studies [4, 6]. In the COPSAC2010 study, beta-diversity (but not alpha-
diversity) at age 12 months was significantly related to asthma development [6]. With respect 
to gut microbial composition, alterations in early life were associated with asthma development 
[4-8]. Microbial alterations at age 1 and 3 months were associated with asthma at age 4 in two 
North-American birth cohorts [4, 7, 8]. Gut microbial alterations at 12 months were associated 
with asthma at age 5 in the COPSAC2010 study, predominantly in children born to asthmatic 
mothers [6]. In contrast, no significant association between gut microbial changes in the first 
month of life and asthma were found [6]. Beside these differences in timing, some bacterial 
genera were repeatedly and significantly associated with asthma in these birth cohort studies. 
In particular, decreased relative abundances of Faecalibacterium [4, 6, 7], Bifidobacterium 
[6, 7], and the family Lachnospiraceae [4, 6, 8], showed a relationship with asthma. 
 Although the genus Escherichia was not associated with asthma in the COPSAC2010 
study, children who were still in a relatively immature microbiome cluster at the age of 1 
year did show a higher asthma risk [6]. This cluster was amongst others driven by a higher 
abundance of Enterobacteriaceae. Moreover, in a recent paediatric study, Escherichia was 
one of three significantly predominant genera in children with asthma (mean age 5.6 years) 
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compared to healthy controls [30]. Furthermore, in a recent adult study, Escherichia was one 
of two genera that discriminated asthmatics with fixed airway obstruction from those with 
no airway obstruction [31]. These results are in line with our findings, potentially indicating 
that the abundance of Escherichia may play a role in the early development of asthma. 
 The increased Escherichia abundance might be indicative for delayed microbiota 
maturation as it has been previously shown that Escherichia dominate the microbiota 
composition in early infancy after which their abundance gradually decreases [6, 32]. On 
the other hand, an increased number of aerotolerant bacteria, in particular the family of 
Enterobacteriaceae, has also been associated with other types of inflammatory diseases, such 
as Inflammatory Bowel Disease [33], and it has been suggested that an increased abundance of 
aerotolerant bacteria might be a nonspecific response to inflammatory conditions [34]. Finally, 
in a recent study an increase in Escherichia appeared to reduce butyrate production, which 
was associated with asthma [30]. Potentially, Escherichia abundance has a wider influence on 
SCFAs production, thereby causing an immunological dysbalance leading to a Th2-response. 
 In this study, we tried to unravel pathophysiological mechanisms by combining gut 
microbiota assessment with atopic sensitisation, Tregs, and Foxp3 gene expression. However, 
no significant associations between either of these parameters and genera abundance were 
observed. The association between atopic sensitisation and gut microbiota was recently 
reviewed to be inconsistent [35]. In our study, the number of sensitised preschool children 
might have been too low for a significant result. Regarding Tregs, a possible explanation might 
be that we assessed the number of Tregs, but not their function. Another potential explaining 
mechanism comes from two recent murine studies where SCFAs, microbial metabolites of dietary 
fibre fermentation, influenced lung inflammation by direct or indirect effects on T cells and 
dendritic cells [36, 37]. These data suggest that gut microbial influences on the development of 
asthma are not purely restricted to the number and function of Tregs. This might also explain the 
lack of a positive association with Foxp3 gene expression, which is a key regulator gene of Tregs. 
 The strength of our study is that we assessed the gut microbial profiles of a large 
group of wheezing preschool children, using modern sequencing techniques. To our 
knowledge no similar study in wheezing preschool children, at an age that the gut 
microbiome is more mature, has been performed. Another strength is a reliable asthma 
diagnosis at age 6 based on symptoms, medication use, and lung function measurements. 
 In conclusion, gut microbial diversity and overall gut microbial community structure at 
age 2-4 years was not associated with preschool wheezing or future asthma development at 
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age 6. When compared to microbial perturbations during infancy, microbial perturbations 
at preschool age appear to be only modestly associated with asthma. On a genus level 
some bacterial genera were associated with wheezing (Collinsella and Dorea) or subsequent 
development of asthma (Gemmiger and Escherichia), suggesting some microbial dysbiosis 
in children prone for developing asthma. The role of these genera in the development of 
asthma warrants further investigation.
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Table S1 - Baseline characteristics of the study population.







Age (years), mean (SEM)                                                                                                                                 3.5 (0.12) 3.3 (0.07) 3.3 (0.08)
Sex: male / female (n/n) 22/24 60/54 42/28
Atopy* 22 18 33
Allergic rhinitis 2 2 7
Eczema** 24 34 44
Use of inhaled corticosteroids*** 0 12 30
Use of short acting β2-agonists*** 0 28 51
Use of long acting β2-agonists** 0 2 6
Day-care attendance 65 75 73
Exposure to furry pets 57 46 46
Passive smoking 35 28 30
Breast feeding 65 61 73
First degree relative with atopic constitution† 63 72 74
 
Results are displayed as %, unless stated otherwise. Abbreviation SEM: standard error of the mean. *Significantly 
different between children with transient wheeze and children with asthma (p < 0.05); **Significantly different 
between healthy controls and children with asthma (p < 0.05); ***Significantly different between all groups (p < 
0.05); †First-degree relative with eczema, asthma or allergic rhinitis.
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Table S2. Association between enterotype status and childhood asthma.
Enterotypes n/N (%)§ ORadj* 95% CI p-value
Bifidobacterium‡  38/105 (36.2) 1.0 - -
Bifidobacterium-Blautia 22/51 (43.1) 1.454 0.707-2.994 0.31
Prevotella 10/28 (35.7) 0.707 0.276-1.809 0.47
 
§Number of children with asthma/total number of children in the given enterotype (proportion of children with 
asthma in enterotype). ‡ Reference category. *Adjusted for sex, breastfeeding, birth season, atopy parents, siblings, 
parental smoking status, day care attendance.
Table S3. Association between enterotype status and childhood wheeze.
Enterotypes  n/N (%)§ ORadj* 95% CI p-value
Bifidobacterium‡  105/137 (76.6) 1.0 - -
Bifidobacterium-Blautia 51/63 (80.1) 1.167 0.537-2.540 0.70
Prevotella 28/30 (93.3) 4.282 0.940-19.51 0.06
 
§Number of children with wheeze/total number of children in the given enterotype (proportion of children with 
wheeze in enterotype). ‡ Reference category. *Logistic regression model Adjusted for sex, breastfeeding, birth 
season, atopy parents, siblings, parental smoking status, day care attendance.
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Figure S2. Microbial richness (observed species), microbial diversity (Shannon effector index), and microbial 
profiles of all children clustered into different enterotypes. Microbial richness (A) and diversity (B) are not 
significantly different between healthy and wheezing children (ns: non-significant; Kruskall-Wallis). C: 
Multidimensial scaling (MDS) based on Bray-Curtis dissimilarity indicates three different enterotypes of 
Bifidobacterium, Bifidobacterium/Blautia and Prevotella/Bifidobacterium in the general microbial community 
structure. Microbial community structure is not statistically significantly different between healthy and wheezing 
children (permutational analysis of variance (PERMANOVA)). 
Figure S2. Microbial richness (observed species), microbial diversity (Shannon effector index), and microbial profiles 
of all children clustered into different enterotypes. Microbial richness (A) and diversity (B) are not significantly 
different between healthy and wheezing children (ns: non-significant; Kruskall-Wallis). C: Multidimensial scaling 
(MDS) based on Bray-Curtis dissimilarity indicates three different enterotypes of Bifidobacterium, Bifidobacterium/
lautia nd Prevotella/Bifidobacterium in the general microbial c mmunity structure. Microbial c mmunity structure 




Figure S3. The relative abundance of specific microbial taxa decreases the risk of wheeze. The relative 
abundance of bacterial genera Collinsella (p=0.01) and Dorea (p=0.02) is lower in wheezing children compared to 
healthy controls (A, B). The adjusted odds ratio for wheeze according to the relative abundance of the genera as 
derived from multiple logistic regression analysis show a higher risk to develop wheeze with a low abundance of 
Collinsella and Dorea (C, D). Adjusted for sex, breastfeeding, birth season, atopy parents, siblings, parental 
smoking status, day care attendance. 
Figure S3. The relative abundance of specific microbial taxa decreases the risk of wheeze. The relative abundance 
of bacterial genera Collinsella (p=0.01) and Dorea (p=0.02) is lower in wheezing children compared to healthy 
controls (A, B). The adjusted odds ratio for wheeze according to the relative abundance of the genera as derived 
from multiple logistic regression analysis show a higher risk to develop wheeze with a low abundance of Collinsella 
and Dore  (C, D). Adjusted for sex, breastf eding, birth season, atopy paren s, siblings, parental moking status, 
day care attendance.
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Oral administration of probiotic bacteria to preterm neonates to prevent the development 
of necrotizing enterocolitis (NEC) has been recommended. The influence of probiotics on 
the endogenous microbiome has however remained incompletely understood. We therefore 
aimed to characterize the persistence of probiotic bacteria and their influence on the microbial 
ecosystem during and after the intervention and their association with the development of NEC. 
 We conducted an observational study including 80 preterm neonates, and collected 
fecal material of preterm infants hospitalized at the NICU of RWTH Aachen University 
Hospital weekly between January 1, 2016, and December 31, 2017. Neonates born at a 
gestational age <32-weeks received daily probiotic supplementation with Bifidobacterium 
(B.) longum and Lactobacillus (L.) acidophilus as a standard procedure (probiotic1 group). 
Supplementation had to be ceased due to a supply limitations (control group). Another 
probiotic formula consisting of B. longum, L. acidophilus, B. lactis, and L. casei was subsequently 
introduced (probiotic2 group). We subsequently profiled the fecal samples by 16S rRNA 
sequencing and monitored the presence of the probiotic bacteria by quantitative PCR. 
 80 neonates with a median gestational age of 26-30 weeks were included. Microbiota 
profiles differed between the control group and both probiotic groups. Probiotic 
supplementation was associated with lower temporal variation as well as higher relative 
abundance of Bifidobacterium and Enterobacter combined with reduced abundance of 
Escherichia, Enterococcus and Klebsiella. Colonization by probiotic bifidobacteria was observed 
in approximately 50% of infants although it remained transient in the majority of cases. 
Few children exhibited a more persistent colonization of up to 13 weeks. A significantly 
reduced monthly incidence of NEC was observed in neonates supplemented with probiotics. 
 Our results demonstrate successful transient colonization of preterm neonates by 
probiotic bacteria influencing the endogenous microbiota. The abundance of individual 
bacterial taxa associated with the development of NEC was reduced by the treatment. These 
results emphasizes that early infancy represents a critical period during which probiotic 
supplementation may allow targeted manipulation of the enteric microbiota and confer a 
clinical benefit.




Following birth, establishment of the early intestinal microbiota is characterized by major 
fluctuations in the relative abundance of the prominent bacterial taxa associated with an 
increase in the bacterial diversity over time [1, 2].
 Preterm birth increases the inter-individual variation in the early fecal microbial 
ecosystem and enhances the colonization by opportunistic pathogens due to delivery by 
cesarean section, delayed onset and a reduced rate of enteral feeding by breast milk, the 
need for antibiotic therapy and prolonged exposure to the hospital environment [3, 4]. 
Together with the immature immune system and mucosal tissue, these microbiota alterations 
may enhance the susceptibility for necrotizing enterocolitis (NEC), an inflammatory disease 
of the preterm neonate’s mucosal tissue associated with high morbidity and mortality [5]. 
 Oral administration of probiotic bacteria to preterm neonates was reported to decrease 
the incidence of NEC in a number of studies[6]. Despite these promising results and the 
subsequent routine probiotic administration to preterm neonates in some institutions [7, 8], 
the precise influence of the administered probiotic bacteria on the existing microbial ecosystem 
during and following the intervention has remained incompletely understood. In particular, 
this relates to the selection and comparative analysis of probiotic strains and formulations, 
the persistence of the administered probiotic bacteria as well as their influence on the 
preexisting colonizing bacteria [9-11]. To gain more insight into the underlying mechanisms, 
we compared the microbiota in 174 fecal samples of 80 preterm neonates in the absence of 
as well as prior to, during and after oral administration of two different probiotic consortia 





Preterm infants of gestational age <32 weeks were included in this natural experiment at 
the NICU of RWTH Aachen University Hospital between January 2016 and 2018. Initially, 
from birth until 36 weeks of gestational age, infants received daily a supplemented milk 
regimen (Infloran) as a standard procedure (P1 group). The probiotic contained the bacteria 
Bifidobacterium longum subsp. infantis and Lactobacillus acidophilus at a 1:1 ratio at 109 
CFU/g. This standard supplementation with probiotic bacteria had to be temporarily suspended 
due to the unavailability of this probiotic on the market. During this time between May 
and December 2016, preterm neonates only received milk without probiotic supplement 
(control group). After December 2016, probiotic administration to all preterm (<36 weeks) 
neonates was reinstalled with another probiotic supplement (DarmfloraPlus) containing 
Bifidobacterium longum, Bifidobacterium animalis subsp. lactis, Lactobacillus acidophilus, 
Lactobacillus casei at a 1:1 ratio at 109 CFU/g. There were no exclusion criteria for the probiotic 
supplementation and the initial antibiotic standard regimen for neonates consisted of ampicillin 
(100mg/kg) and tobramycin (3 mg/kg) in 3-4 daily doses. Infants were sampled weekly during 
their hospitalization on the neonatal intensive care unit (NICU). The final samples were 
selected based on the first available sample within the timepoints described in Figure 1a. In 
an additional group of 16 neonates we longitudinally sampled weekly from supplementation 
up to 20 weeks after cessation of the probiotic to assess the persistence. Moreover, we also 
included longitudinal samples of three patients that developed NEC closely to the diagnosed 
onset of the disease. The study was recorded in the German Register Clinical Studies under 
accession number DRKS/GCTR 00021034 and was approved by the ethics committee of the 
medical faculty of the RWTH University of Aachen (approval number EK307/15).
Microbial profiling of fecal samples
Metagenomic DNA was isolated from fecal samples thawed on ice and resuspended in 600 μL 
DNA stabilization buffer (Stratec Biomedical) following a previously described protocol [12]. 
Briefly, 500 µl 5% (w/v) N-laurolylsarcosine and 250 µl 4 M guanidinethiocyanat were added 
to the samples and cells were mechanically lysed by repeated bead beating (3 x 40 s) with 500 
mg 0.1 mm glass beads (Roth). Next, samples were vortexed and centrifuged (15.000 × g for 
3 min at 4° C) after adding 15 mg poly-vinylpolypyrrolidone. Subsequently, the supernatant 
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was incubated with 1% ribonuclease (10 mg/mL) for 40 min at 37 °C. Finally, column-based 
purification was performed using the NucleoSpin gDNA Clean-up Kit (Macherey-Nagel). 
The bacteria-specific primers 341F and 785R were used to amplify the variable 3-4 region 
of the 16S rRNA gene from 12 ng metagenomic DNA by a two-step PCR (2x 15 cycles) [13, 
14]. PCR amplicons were purified using the AMPure XP system (Beckmann), and sequenced 
using 2x275 paired-end reads spiked with 25% PhiX on a Miseq platform (Illumina Inc.). All 
generated sequences from this study have been deposited to the Qiita and ENA databases 
and can be accessed under No. 13071. 
Microbiome data processing and statistics
A total of 8,335,421 generated sequences were processed using the DADA2 package in R to 
create single amplicon sequence variants (ASV’s) [15]. Quality filtering, removing of sequence 
errors and chimeras was performed using default settings and taxonomy was assigned with 
SILVA on a species level. For the removal of potential contamination, we used the Decontam 
package in R with the ‘combined’ setting [16]. Here, all samples with a DNA concentration 
below the detection limit (<0.10 ng/ul) were set at half the lowest detected concentration 
of 0.05 ng/ul and extraction controls were used as negative controls. Subsequently, we 
omitted samples with a low sequencing depth (<8000 sequences) and removed ASVs that 
were low abundant (<0.25% in all samples). This resulted in a total of 7,708,120 sequences 
ranging from 7,727 to 72,816 reads per sample (median 21,113) that belonged to 4,981 
ASVs for downstream analyses. Lastly, we normalized the retained ASV counts by dividing 
each value to the total sum per sample and multiplied by the lowest sample depth [17]. 
 We computed the alpha-diversity (Shannon index and observed species) and the 
Bray-Curtis metrics in order to determine the microbial community structure using the R 
package Phyloseq 1.30.0 [18]. The ordination of samples based on the Hellinger transformed 
genus composition or Bray-Curtis dissimilarity was visualized using Principal Component 
Analysis (PCA) or Principal Coordinate Analysis (PCoA), respectively. The Mann-Whitney U 
or Kruskal-Wallis tests were used to test for differences in relative abundances, Bray-Curtis 
distances, microbial richness and diversity between two or multiple groups respectively. 
Following the Kruskal-Wallis test, the Dunn’s test was performed for pairwise post hoc 
comparisons. Subsequently, the alpha-diversity was used as a continuous variable in a 
linear regression model to test for a significant trend across timepoints. In order to evaluate 
significant separations between groups of samples, we performed a permutational multivariate 
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analysis of variance (PERMANOVA) based on Bray-Curtis distances. We examined factors 
that were significantly associated with the microbial community variation at the different 
timepoints by PERMANOVA to determine potential confounders: timepoint, feeding-type, 
sepsis, antibiotics, mode of delivery, birthweight, gestational age, sex, and PROM. We 
next combined the identified potential confounding factors with the variable probiotic 
group in a multivariate analyses and re-evaluated the significance. Moreover, we also 
tested the dispersion of the samples, a required assumption for the PERMANOVA test. 
All these statistical analyses were performed two-sided with R 3.6.1 or GraphPad Prism 8. 
 SparCC correlation analyses were performed to identify specific associations taking the 
compositional nature of the data into account by MicrobiomeAnalyst with default settings [19]. 
Only correlations of >0.3 that were statistically significant were included in the network analyses. 
 Differentially abundant bacterial genera were identified using Linear discriminant 
analysis Effect Size (LEfSe) with default settings [20]. 
Detection of probiotic bacteria & antimicrobial resistance genes (qPCR)
For the quantification of Lactobacillus acidophilus (5’ AAACTGCAATTTAAGATTATGAGT TTC / 
GGTACCGTCTTGATTATTAGTGTA 3’), Bifidobacterium lactis (5’ CATCGCAACTTCACCCACATTG 3’ / 
5’ ATGCCGTACCCCTGAATGAAG 3’), Bifidobacterium longum (5’ CGGCGTYGTGACCGTTGAAGAC 
3’ / 5’ TGYTTCGCCRTCGACGTCCTCA 3’), Lactobacillus casei (5’ TGCCCATTAGCATACTGGACC 
3’ / 5’ ACCCGAGCCTTTGCCAA 3’) all fecal samples were subjected to real-time PCRs [21, 
22]. We validated the existing assays by using amplifying the DNA of the cultured probiotic 
strains. Upon confirmation of the PCR amplicons by Sanger sequencing, products were 
cloned into a pGEM-T easy vector (Promega Corporation, Madison, WI, USA) for construction 
of standard curves. Thereafter, the amount of plasmid copies normalized to the amount 
of DNA were calculated for each fecal sample from the cycle threshold values using the 
standard curves. For this assay 2 µl DNA and 0.4 μM primer was used as input, employing 
SYBR Green chemistry (Supermix™ SYBR®, Bio-Rad) and a CFX96 System (Bio-Rad). All 
targets were amplified at an annealing temperature of 65 °C except for the Lactobacillus 
acidophilus (60 °C). CFX Manager 3.1 (Bio-Rad) was used for analysis of the real-time qPCR 
data. Samples that were below the detection limit were included with zero plasmid copies. 
 The qPCR of antimicrobial resistance genes vanA, vanB, CTXM-1, CTXM-2 was performed 
in a multiplex reaction and CTXM-9 in a simplex reaction as described earlier [23, 24]. Primer-
probe concentrations for vanA (GCCGGAAAAAGGCTCTGAA / TCCTCGCTCCTCTGCTGAA) and 
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vanB (CGCAGCTTGCATGGACAA / GGCGATGCCCGCATT) were 800 nM of each primer and 
200 nM probe (vanA_probe: FAM-ACGCAGTTATAACCGTTCCCGCAGACC-BHQ1 / vanB_probe: 
VIC-TCACTGGCCTACATTC-MGB-NFQ). The qPCR of CTX-M (ATGTGCAGYACCAGTAARGTKATGGC 
/ ATCACKCGGRTCGCCNGGRAT) contained 500 nM of each primer and 100 nM 
probe (CTX-M-1: JOE-CCCGACAGCTGGGAGACGAAACGT-BHQ1 / CTX-M-2: FAM-
CAGGTGCTTATCGCTCTCGCTCTGTT-BHQ1 / CTX-M-9: JOE-CTGGATCGCACTGAACCTACGCTGA-
BHQ1). Each PCR was performed in a total volume of 25 μL consisting of 12.5 μL ABsolute QPCR 
ROX Mix (Thermo Scientific, Waltham, MA, USA), the primer-probe mixture and template DNA. 
The amplification was achieved on a 7900HT Fast Real-Time PCR System (Applied Biosystems, 





As part of a longitudinal observational study, we collected fecal material of preterm infants 
hospitalized at the NICU of RWTH Aachen University Hospital weekly between January 2016 
and 2018. Between January 2016 and May 2016, neonates born at <32-weeks gestational 
age received daily probiotic supplementation consisting of Bifidobacterium longum and 
Lactobacillus acidophilus as a standard clinical procedure (probiotic 1 [P1] group). In May 
2016, this probiotic was no longer commercially available and supplementation had to be 
ceased (control group). From January 2017 onwards, another probiotic mixture consisting 
of B. longum, L. acidophilus, Bifidobacterium lactis, and Lactobacillus casei (probiotic 2 [P2] 
group) was introduced and administered to preterm neonates. Supplementation of both 
probiotic products continued until 36 weeks postmenstrual age. In total, we selected 174 fecal 
samples from 80 preterm neonates. The population characteristics, including gestational age, 
birthweight, sex and feeding-mode, were comparable between all three groups (Table S1). 
The median gestational age ranged from 26 to 30 weeks and most neonates were born by 
caesarian section. For the comparative analysis between groups (P1, P2 and control group), 
samples were clustered in four age-windows as follows: week 1 after birth, week 3-4 after birth, 
week 7-9 after birth and week 10-12 after birth corresponding to “before” (T0), “during” (T1), 
“shortly after” (T2) and “long after” (T3) probiotic supplementation, respectively (Figure 1a).
Supplementation of probiotic bacteria affects the microbiota composition in early life
To assess global compositional differences in the gut microbiome of neonates, we profiled 
fecal samples by V3-V4 16S rRNA gene amplicon sequencing. A total of 7,708,120 sequences 
with a median of 21,113 [range 7,727 - 72,816] reads per sample were retained after quality 
filtering and assigned to 4,981 amplicon sequence variants (ASVs) for subsequent analyses. 
  The fecal microbial richness gradually increased significantly with age (linear regression 
p<0.0001, p=0.01, and p=0.0021 for control, P1, and P2 groups, respectively), but was not 
significantly different between the control and probiotic groups (Figure 1b, Figure S1a-d). Similar 
results were obtained for the microbial diversity as examined by the Shannon index (Figure S1e-h). 
  As expected, no significant difference in the general microbial community composition 
was observed between the three groups prior to the start of probiotic supplementation (T0) 
(Figure S2a). In contrast, significant differences in the microbial composition between the 
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control group and both probiotic groups at the time of probiotic supplementation was observed 
(Figure 1c). The changes in the microbial community structure remained after identification and 
correction for potential confounders such as feeding-type, sepsis, administration of antibiotics 
and gestational age (Table S2, Table S3). Notably, significant differences between the control 
group and both probiotic groups were also detected after removal of all probiotic-specific ASV’s 
from the analysis (Figure S3). This suggests that the observed changes are not solely a direct 
consequence of the bacteria added to the enteric community by oral probiotic supplementation. 
 Additionally, neonates receiving probiotic supplementation at T1 showed less inter-
individual variation and thus a more homogenous microbiota composition compared to infants 
in the control group (Figure 1d). Although the latter effect was not detected at subsequent 
time-points (Figure S2b-f), the significant difference in the global microbial community 
structure remained also shortly (T2) and long (T3) after cessation of probiotic supplementation 
(Figure 1e & f). The Bray-Curtis dissimilarity between samples collected during probiotic 
supplementation (T1) and both follow-up time-points (T2 and T3) was significantly lower 
for both probiotic groups as compared to the control group (Figure 1g & h). This suggests 
that probiotic supplementation reduces the temporal compositional variation and results in 
a more stable microbial community structure. 
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Figure 1 - Microbiota composition and stability in neonates with or without probiotic supplementation. (A) 
Infographic of study outline (n=51-66 per group for all subsequent cohort-analyses) (B) Microbial richness (number 
of ASVs) shows a gradual increase with age for all groups (linear regression: pfor trend<0.0001, pfor trend = 0.01, 
pfor trend =0.0021 for controls, probiotic1, probiotic2, respectively). (C) Principal Coordinate Analysis (PCoA) based 
on ASV-derived Bray-Curtis dissimilarity exhibiting differences in microbial community structure between control 
and probiotic groups at T1 (p<0.001, Permanova). (D) Bray-Curtis distance compared to T1 at T1 (within group 
distance). (E,F) PCoA between control and probiotic groups at T2 (p<0.001, Permanova) (E), and at T3 (p<0.001, 
Permanova) (F). (G,H) Bray-Curtis distance compared to T1 at T2 (G), and at T3 (H). (Kruskal-Wallis test with Dun’s 
test for post-hoc comparisons (control-group is reference), mean and SD; ****, p<0.0001).
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Probiotic administration influences specific taxa of the endogenous microbiota
We subsequently assessed how probiotic administration influenced specific endogenous 
bacterial taxa over time (T1-T3). First, we determined how the genera that explained 
most of the variation in the overall microbiota community structure were associated 
with probiotic administration. Klebsiella, Escherichia, Bifidobacterium, Enterococcus 
and Enterobacter represented the main genera driving the separation in microbial 
community structure between the three groups. Enhanced abundance of Klebsiella was 
typically found in neonates without probiotic supplementation. In contrast, neonates 
receiving P2 were characterized by higher abundance of Enterobacter and reduced 
abundance of Escherichia (Figure 2a). Increased relative numbers of Bifidobacterium 
and Enterococcus were most commonly observed among neonates that received P1. 
 Secondly, the taxonomic changes of these five genera over time indicated that 
probiotic supplementation reduced the temporal fluctuations in microbiota composition. 
Whereas the abundance of Enterococcus, Escherichia and Klebsiella were highly dynamic 
in the control group, a more stable pattern could be observed in probiotic supplemented 
neonates (Figure 2b). This more stable pattern was accompanied by an expansion of the genus 
Bifidobacterium in P1 group and an expansion of the genus Enterobacter in the P2 group. 
 Lastly, linear discriminant analysis revealed that Bifidobacterium was the most strongly 
enriched genus among neonates receiving P1 at all time-points, while lactobacilli were only 
significantly enriched at T1 (Figure 2c-e). In addition, after probiotic supplementation neonates 
harbored less Klebsiella and two members of the Clostridiales order when compared to control 
neonates. Moreover, although the second probiotic similarly to P1 was associated with a 
higher abundance of bifidobacteria and decreased levels of Klebsiella at T3, these neonates 
could most profoundly be differentiated from the control group by a higher abundance of 
Enterobacter at all time points (Figure 2f-h). Remarkably, the neonates receiving P2 showed a 
strong decrease in Enterococcus and Escherichia at T1 and T2-T3, respectively. Furthermore, 
in both probiotic groups the abundance of bifidobacterial species other than those included 




Figure 2 - Association of probiotic administration with specific taxa. (A) Principal Component Analysis (PCA) 
illustrating the separation between the control and probiotic groups at T1-T3. Vectors depict the five genera that 
explained most of the variation in microbial community structure (B) Relative abundances of the five genera over 
time for the three different groups. (C) Linear discriminant analyses with Effect Size (LEfSe) were employed to 
identify differentially abundant bacterial genera between probiotic 1 supplemented and control neonates at T1, 
(D) at T2, (E) and at T3. (F) LefSe between probiotic 2 supplemented and control neonates at T1, (G) at T2, (H) and 
at T3 (LDA-score>0.2 and p<0.05, Wilcoxon signed-rank test).
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Intestinal colonization by probiotic bacteria after cessation of supplementation
Next, we established qPCRs specific for the administered probiotic bacteria in order to 
quantitatively monitor their ability to colonize and persist after cessation of supplementation. 
None of the probiotic bacteria were detected prior to supplementation (T0) (Figure 
S4g-j). In contrast, qPCR detection confirmed the markedly higher abundance of B. 
longum and L. acidophilus in neonates receiving P1 and B. longum, B. lactis, L. acidophilus 
and L. casei in neonates receiving P2 as compared to controls (Figure 3a-l). Notably, B. 
longum was still enriched at T2 i.e. after cessation of supplementation with P1, whereas 
B. lactis and L. acidophilus remained increased after cessation (T2) of supplementation 
with P2. Importantly, probiotic bacteria did not permanently colonize since no significant 
differences between probiotic and control groups were observed at T3. However, B. 
lactis was still detectable in some (4/11) infants that received P2 at T3 (Figure 3f). 
  To further investigate the nature and duration of probiotic persistence we analyzed fecal 
samples of 16 neonates collected weekly during and until 20 weeks after cessation of probiotic 
supplementation. We tracked probiotic-specific Bifidobacterium ASVs (i.e. ASVs present in the 
probiotic formulas and absent in any of the control neonates) (Figure S5a-b) and performed 
the strain-specific qPCRs. Since the prevalence pattern of the different probiotic bacteria 
varied considerably (Figure S5c-f), we categorized the neonates into ‘persistently’ colonized 
(first two samples after cessation positive for probiotic strains), ‘transiently’ colonized (at 
least one sample collected in the first two weeks after cessation positive for probiotic strains, 
but subsequent samples negative) and not colonized (1st and 2nd sample upon probiotic 
cessation negative for probiotic strains). Thereby, the probiotic bifidobacteria were shown to 
persistently but mostly transiently colonize the neonatal gut after cessation (Figure 4 a-b). On 
the other hand, L. acidophilus was absent in almost all neonates that had received P1 whereas 
it remained present (persistently or transiently) in the majority of neonates supplemented 
with P2 (Figure 4c-d). Neonates supplemented with P2 also showed persistence of B. lactis 
and L. casei in some neonates, but most neonates had become negative for these probiotic 
strains (Figure 4e-f). In some children, the colonization of Bifidobacterium persisted up to 




Abundance of pathobionts and prevention of necrotizing enterocolitis 
Probiotic supplementation both increased the stability in the overall community structure 
of the neonatal gut microbiota  as well as reduced the abundance of pathobionts known to 
induce strong proinflammatory responses. Since these changes might protect against the 
adverse effects of an altered microbiota, we next investigated the influence of probiotic 
supplementation on the incidence of necrotizing enterocolitis (NEC) and the presence of 
clinically relevant antimicrobial resistance (AMR) genes. Despite the low overall occurrence 
of NEC during our study period (n=10), a significantly reduced incidence was observed in 
neonates supplemented with P1 or 2 as compared to control neonates (Figure 5a). We 
therefore analyzed the composition of the fecal microbiota of three NEC-patients prior 
to the clinical onset of the disease. Interestingly, a dramatic bloom of enterococci was 
observed, representing the most abundant taxa before the onset of the disease (Figure 
S6a). Notably, Enterococcus is only low abundant in neonates without NEC as depicted from 
the control group at T2 accompanied with Klebsiella as the most dominant taxa (Figure 
2b). To further elucidate the role of the probiotic bacteria herein, we performed SparCC 
correlation network analyses taking the compositional nature of the data into account [25]. 
Interestingly, probiotic supplementation with bifidobacteria and lactobacilli both correlated 
with the abundance of the NEC-pathobiont Enterococcus [26, 27]. In neonates receiving 
P1, bifidobacteria and lactobacilli were positively correlated. Lactobacilli in turn exhibited 
a direct negative network correlation with enterococci (Figure 5b, Figure S7a ). In neonates 
receiving P2, bifidobacteria and lactobacilli positively correlated with Enterobacter that in turn 
exhibited a negative correlation with the NEC-pathobiont Enterococcus (Figure 5c, Figure S7b). 
 As probiotic administration was associated with a decreased abundance of Enterococcus, 
Escherichia and Klebsiella in preterm infants (Figure 2c-h), probiotics might also reduce 
the prevalence of antibiotic resistant strains. The presence of resistant strains significantly 
hampers an effective antimicrobial therapy in the event of infection. Enterococci can harbor 
the resistance genes vanA and vanB conferring resistance to glycopeptide antibiotics such 
as vancomycin and teicoplanin. Enterobacteriaceae, such as Escherichia and Klebsiella, can 
encode for extended-spectrum beta-lactamases (ESBLs) conferring resistance to most beta-
lactam antibiotics. We therefore investigated the presence of vanA and vanB as well as the 
most prevalent ESBL (CTX-M group 1, 2, and 9) genes. However, the prevalence of these 
antibiotic resistance genes was not significantly altered by probiotic supplementation, possibly 
due to the low overall presence of antibiotic resistance genes in the enteric microbiota of 
the population analyzed (Figure S6b-c).




































































































































































































































































Figure 4 - Colonization by probiotic bacteria after cessation of supplementation. (A) Colonization pattern from 
longitudinally sampled neonates (n=8 / group) after cessation of probiotic supplementation for ASV-tracked 
Bifidobacterium in probiotic 1 supplemented neonates,  (B) Bifidobacterium in probiotic 2 supplemented neonates, 
(C) qPCR-tracked Lactobacillus acidophilus in probiotic 1 supplemented neonates, (D) Lactobacillus acidophilus, 
(E) Bifidobacterium Lactis, (F) and Lactobacillus casei in probiotic 2 supplemented neonates. Categorized into 
‘persistent’ colonizers (first two weekly timepoints after cessation were positive for probiotic strains),  ‘transient’ 
(sample collected in the first two weeks after cessation was positive, but subsequent sample was negative) and 
‘absent’ (first timepoint upon probiotic cessation was negative for probiotic bacteria).













































































































































































































































































































































With weekly fecal sampling and clinical monitoring, our study represents a longitudinal 
observational study with three groups, a group of children that was left untreated (control 
group) and two groups of children that received two different probiotic supplements (P1, 
and P2). Although the different groups were sampled during consecutive time periods, the 
standard medical care regimen (except probiotic supplementation), the medical and nursing 
staff as well as the neonatal intensive care unit (NICU) environment and medical equipment 
were identical for all patients included in the study and no cross colonization between patients 
could occur [28, 29].
 In contrast to many previous studies among adults and infants [10, 30, 31], we showed 
persistence of several probiotic strains upon cessation of supplementation. Administered 
bifidobacteria persisted for 2-12 weeks following cessation in approximately a quarter of 
the neonates, whereas persistence of lactobacillus strains was observed less frequently. 
This superior persistence of bifidobacterial strains when compared to lactobacilli has 
also been observed in several other studies [9, 11, 29]. The mechanisms underlying the 
differential persistence are largely unclear, but the gut luminal milieu, the characteristics 
of the administered bacterial strains as well as their competitive fitness may all contribute. 
Interestingly, we detected differences in colonization of the probiotic bacteria between our 
two supplemented probiotic formulas which suggests strain differences or competition. 
For example, B. lactis but not B. longum remained significantly enriched after cessation of 
supplementation in neonates that received P2 when compared to neonates in the control 
group. In addition, L. acidophilus persisted in neonates that received P2 in contrast to P1 
supplemented neonates.
  Probiotic administration significantly altered the enteric microbiota composition even 
after removing probiotic ASVs from the sequencing data. Thus, the administered probiotic 
bacteria directly or indirectly influence the endogenous microbiota consistent with the 
results of other studies [9-11, 29]. Most notably, although bacterial richness and diversity 
remained unaffected, probiotic administration significantly reduced the inter-individual 
variation and temporal microbiota changes. Neonates, in particular preterm neonates, have 
been shown to exhibit high inter-individual variation and major fluctuations in the enteric 
microbiota composition during the early postnatal period [1, 4, 32, 33]. High individual 
variation and compositional fluctuations may contribute to a decreased resilience and 
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colonization resistance, and thus a more stable microbiota composition might protect from 
disease-promoting compositional changes. Moreover, the preterm microbiota is typically 
dominated by pathobionts such as Escherichia, Enterobacter and Klebsiella that produce 
potent immunomodulatory molecules such as endotoxin and fimbriae and frequently carry 
genes conferring antibiotic resistance [3, 26, 34]. Reducing such bacteria might lower the 
risk of inappropriate inflammation or systemic infection. In this respect, Klebsiella, one of 
the major bacteria driving the global community structure in the preterm neonates without 
probiotic supplementations did not contribute to the overall community structure in children 
supplemented with probiotics administration. An observation which is in line with the results 
of the study by Alcon-Giner and colleagues [29].
 As expected probiotic supplementation led to enrichment of Bifidobacterium spp. 
and Lactobacillus spp. However, this was not limited to an enrichment of the probiotic 
bifidobacterial and lactobacillus species. In accordance with another recent report, the 
administration of probiotic bifidobacterial species fostered the growth of endogenous 
bifidobacterial species such as B. breve, B. bifidum and B. animalis [29]. Cross-feeding between 
species within a genus or induced adaptation of the local gut environmental might contribute 
to this. In contrast, pathobionts such as Klebsiella or Escherichia as well as Clostridioides and 
enterococci were reduced in probiotic treated infants. These results are largely consistent 
albeit not identical with observations described in other studies [9, 29]. Despite the reduced 
abundance of enterococci and Enterobacteriaceae (Klebsiella and Escherichia), the prevalence 
of genes encoding vancomycin resistance and ESBLs was not reduced among neonates 
supplemented with probiotics. These findings contrast a previous study, which observed 
ESBL-genes in stools of non-probiotic very preterm infants but not in probiotic-treated 
extremely preterm infants [35]. Previous clinical and animal studies suggested that the enteric 
microbiota together with the immature mucosal tissue contribute to the etiology of NEC [34]. 
Changes in the microbiota composition would therefore be expected prior to disease onset. 
A number of human cohort studies with regular postnatal sampling of preterm neonates 
reported on the enteric microbiota composition in healthy infants and infants with NEC 
[26, 36]. However, no specific pathogen, pathobiont or microbiota signature was detected 
that unequivocally predicted disease onset. Notably, almost all cases of NEC documented 
during the study period occurred in neonates of the control group confirming a significant 
protective effect of probiotic supplementation. For three patients with NEC, consecutive 
samples were available prior to disease onset. All three exhibited a significantly enhanced 
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abundance of enterococci prior to disease onset. An increase in enterococci or enterococcus-
associated secondary metabolite gene clusters was also noted in other studies [26, 37]. 
Additionally, certain strains of the Enterococcus faecalis have been shown to increase the 
tissue pathology in a rodent NEC model [27]. Two of the patients in the present study also 
exhibited an enhanced abundance of Klebsiella, an organism associated with an increased risk 
of NEC in several studies [26, 36]. Moreover, an increased abundance of Enterobacteriaceae 
prior to NEC onset have been found [36, 38, 39]. As expected, the abundance of members 
of the Enterobacteriaceae family (Escherichia and Klebsiella) also increased in abundance 
during the NEC-induced intestinal inflammation [36]. Although the mechanism by which 
probiotics protect against NEC is unclear, our results are consistent with the idea that it may 
include enhanced resilience of the enteric microbiota to exogenous stimuli, the reduction of 
pathobionts or indirect immunomodulatory effects on the host’s developing intestinal tissue 
and mucosal immune system [40, 41].
  The daily dose of 109 supplemented bacteria is substantial given that the total bacterial 
number within the newborn gut is estimated at 106-1012 [42, 43]. Given the immature intestinal 
tissue and mucosal immune system and high susceptibility to systemic bacterial infection of 
preterm neonates a careful consideration of potential risks of oral administration of viable 
bacteria is warranted. Cases of sporadic systemic infections with orally applied probiotic 
bacteria in extremely preterm neonates have indeed been reported sporadically [44]. In the 
present study no adverse effects or infections by the administered probiotic were observed 
during the study period.
  Nevertheless, the observational character represents a limitation of our study precluding 
any blinded and randomized study design. The consecutive “enrollment” of the three patient 
groups also harbors the risk of unidentified changes in the standard patient care during the 
study period that may influence the clinical outcome. In addition, the relatively small sample 
size limits the statistical power of our analysis in particular with respect to the analysis of 
the enteric microbiota prior to the clinical onset of NEC. Altogether our study provides 
important insights that warrant confirmation, preferably in experimental studies. Sampling 
after discharge would ideally be included in such future studies in order to assess the long-
term consequences of probiotic supplementation.
 In conclusion, our results show a significant influence of oral probiotic administration 
on the global microbial community structure and the abundance of specific taxa. The data 
emphasize the unique period of early infancy for the establishment of the enteric microbiota 
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and suggest a beneficial effect of probiotic supplementation to preterm neonates. is a where 
probiotics seem to be successful to influence the gut microbiota.
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Figure S1 - Microbiota diversity in preterms with or without probiotic supplementation. (A-D) Richness (number 
of ASVs) of the three different groups at T0 (A), T1 (B), T2 (C) and T3 (D). (E-H) Shannon index for the microbiota 
of the three different groups at T0 (E), T1 (F), T2 (G) and T3 (H). Kruskal-Wallis test to controls with Dun’s post-test 




Figure S2 - Microbial composition and stability in preterms with or without probiotic supplementation. (A) 
PCoA based on ASV-derived Bray-Curtis dissimilarity does not show significant differences in microbial community 
structure between control and probiotic groups at T0 (not significant, Permanova). (B-C) Bray-Curtis within group 
(control-group is reference)distance at T2 (B), and T3 (C). (D-F) PCoA based on ASV-derived Bray-Curtis dissimilarity in 
microbial community structure between T1-T3 for the control group (D), probiotic 1 group (E), and probiotic 2 group 
(F). (Kruskal-Wallis test with Dun’s test for post-hoc comparisons, mean and SD; ***, p<0.001; ns, not significant).
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Figure S3 - Microbial composition in preterms with or without probiotic supplementation upon removal of 
probiotic ASVs. (A-D) PCoA based on Bray-Curtis dissimilarity at T0 (ns: not significant, Permanova) (A), T1 (p<0.001, 
Permanova) (B), T2 (p<0.001, Permanova) (C) and T3 (p<0.001, Permanova) (D).
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Figure S4 - Association of probiotic administration with specific taxa. (A-C)  LefSe with bifidobacterial species between 
probiotic 1 supplemented and control neonates at T1, (A) at T2, (B) and at T3 (C). (D-F) LefSe with bifidobacterial 
species between probiotic 2 supplemented and control neonates at T1, (D) at T2, (E) and at T3 (F) (LDA-score>0.2 
and p<0.05, Wilcoxon signed-rank test). (G-J) Quantitative abundance before probiotic supplementation at T0 of the 
probiotic bacteria Bifidobacterium lactis (G), Bifidobacterium longum (H), Lactobacillus acidophilus (I), Lactobacillus 
casei (J) (Kruskal-Wallis test with Dun’s test for post-hoc comparisons (control-group is reference), mean and SD; 
ns, not significant).
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Figure S5 - Colonization by probiotic bacteria after cessation of supplementation. (A-B) Relative abundance 
of probiotic-specific Bifidobacterium-ASVs that are absent in control neonates after cessation of probiotic 
supplementation at T2 (A) and T3 (B) (Kruskal-Wallis test with Dun’s test for post-hoc comparisons (control-
group is reference), mean and SD; *, p<0.05;****, p<0.0001; ns, not significant). (C-F) Colonization prevalence 
from longitudinally sampled neonates (n=8 / group) after cessation of probiotic supplementation for ASV-tracked 
Bifidobacterium (C), qPCR-tracked Bifidobacterium lactis (D), Lactobacillus acidophilus (E), and Lactobacillus casei 
(F).  No necrotizing enterocolitis, sepsis or antibiotic-treatment at the time of sample collection occurred in the 
included neonates directly after probiotic cessation except for P41 and P188 (both antibiotics provided 1-2 weeks 
after probiotic cessation for sepsis treatment).
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Figure S6 - Microbial dynamics in preterm neonates developing necrotizing enterocolitis. (A) The relative abundances 
of the 10 most abundant genera over time around the diagnosed onset of necrotizing enterocolitis (blue line) 
for three patients. (B) Prevalence of vanA/vanB genes conferring resistance to vancomycin. (C) Prevalence of 
extended-spectrum beta-lactamase encoding genes  (CTX-M genogroups 1, 2 and/or 9) conferring resistance to 
most beta-lactam antibiotics.
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Figure S7 - : Correlations between genera upon probiotic administration. (A-B) Correlation heatmap based on the 
coefficients of the SparCC analyses between relative genus abundances of control and probiotic 1 administered 








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Supplementary Table 3 – PERMONAVA on P groups corrected by significant covariates
Adjusted for Timepoint P-value for probiotic group
Milktype T1 0.001
T3 0.002
Gestational Age T0 0.125
PROM T2 0.001
Noa Penders (12 years) 
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The role of the gut microbiome and how it unfolds in early life
Our body harbors numerous microorganisms, including bacteria, archaea, eukaryotic microbes 
and viruses, which together exert a wide variety of vital biological and physiological processes. 
The majority of these microbes consist of bacteria that help with dietary digestion (e.g. 
resistant carbohydrates), produce essential micronutrients and signaling molecules in the 
gut (i.e. vitamins and serotonin) [1] and defend against infections by providing colonization 
resistance [2]. The intestinal microbiome plays also a critical role in the maturation of our 
immune system, particularly in the early phases of life, during infant development and growth 
[3-5]. In contrast to the microbiota of adults, which is relatively stable, this early age-window 
is characterized by major changes in the gut microbiota composition. Given the instability 
of the microbiome during this early time-window and its strong and non-redundant priming 
effect on the host’s immune system, a comprehensive insight into the ecological factors that 
shape the microbiota during early life is of particular importance. Not in the least, because 
this co-development of the microbiome and the host immune system during infancy may have 
life-long consequences on the susceptibility to inflammatory and immune-mediated diseases 
[4-6]. To this end, my thesis aimed to unravel environmental and host-related factors that 
determine the ultimate composition and explain inter-individual variation in the microbiota 
during infancy, which is pivotal in order to better understand the role of the microbiota in 
health and disease.
The development of the gut microbiota during the postnatal period
In chapter 2, we provide an overview of the origin and importance of pioneer bacteria 
and the known evolutionary factors that influence the development of the infant gut 
microbiota. The microbiota establishes from the initial inoculum to a complex and diverse 
ecosystem during the first years of life and is influenced by a large number of perinatal 
environmental and maternal factors, e.g. mode of delivery, antibiotic treatment, breast 
milk versus formula and other dietary factors. Thus, microbial maturation relies on the 
transmission of microbes (dispersal) and is further influenced by factors that provide a 
selective advantage to certain bacteria (habitat filtering) or impact succession of initial 
bacteria (historical contingency) during infancy. However, the perinatal, environmental and 
maternal factors studied so far together can only partly explain the individual variation in 
the microbiota development. One explanation is the lack of detailed insight in the precise 
dynamics of the microbiome development in early life as the majority of birth cohort studies 
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only collected fecal samples at a few time-points during infancy or focused on a limited number 
of determinants. In addition, many other unidentified factors, such as internal host factors, 
might also explain why our understanding of inter-individual microbiota variation is still limited. 
 In chapter 3, we therefore closely monitored the development and succession of bacteria 
in both the small intestine as well as colon of mice and examined whether host metabolic 
factors are involved in this maturation process of the microbiota. Careful microbiota profiling 
throughout the postnatal period until adulthood revealed major age-dependent compositional 
changes. The bacterial richness and diversity initially decreased in both small intestine and 
colon within the first 24 hours after birth. This reduction immediately after birth most likely 
illustrates the inability of many of the ingested bacterial species to permanently colonize 
the neonatal intestine during or shortly after birth consistent with previous reports [7-9]. 
In addition, the general microbiota composition, dominated by facultative anaerobes such 
as Staphylococcus, Streptococcus and Escherichia, was highly similar between the colon and 
small intestine early after birth. The most profound changes could be observed upon weaning 
– the complete transition to solid food and cessation of breastfeeding. After weaning, the 
composition diverged into a site-specific intestinal microbiota. In the small intestine the 
relative increase of Lactobacillus continued, whereas a more complex composition developed 
in the colon, characterized by an expansion of obligate anaerobes such as Bacteroides among 
others. Altogether, this suggests a late emergence of an organ-specific microbiota that occurs 
around weaning.
 Next to these dietary changes, the development of digestive organs is accompanied 
by increased metabolic capacity during the postnatal period [10, 11]. These metabolic and 
dietary changes may together contribute to intestinal substrate availability and could thereby 
influence the observed bacterial succession and overall microbial ecosystem maturation 
[12]. We therefore screened hepatic bile acids, amino acids, biogenic amines, acylcarnitines, 
glycerophospholipids, sphingolipids and sugar at different ages. The switch in diet during 
weaning most likely induced the observed moderate but significant decrease of mainly 
amino acids and biogenic amines towards adulthood. These metabolites are present in 
breast milk and the majority of the amino acids in the gut is indeed suggested to derive 
from nitrogen sources such as dietary proteins while only a fraction is produced by intestinal 
bacteria [13, 14]. Moreover, we identified bile acids as potential drivers of the site-specific 
microbiota development with causality being confirmed by functional in vitro tests and oral 
bile acid administration. The selected bile acids (e.g. taurine-conjugated β-muricholic acid 
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and ursodeoxycholic acid) particularly fostered the succession of Lactobacillus within the 
small intestine. Lactobacilli are well-known for their health-beneficial properties [15, 16], 
and the rapid expansion of Lactobacillus along with the increase in bacterial richness upon 
bile acid supplementation could also promote colonization resistance. Hence, the capability 
of the microbiota community to protect our gut against pathogens might be accelerated by 
bile acids, preventing adverse effects on the infant’s health [chapter 7]. The concept that 
bile acids can mediate colonization resistance is further supported by data demonstrating 
that specific bile acids prevent infections by the opportunistic pathogen Clostridioides 
difficile [17-19]. Therefore, bile acids might contribute to the outcompetition of pathogens. 
Moreover, chapter 3 clearly demonstrated that host factors, often omitted in microbial 
ecology studies, are important in the maturation of the microbiota in general. The use of 
animal studies is crucial to decipher the complete puzzle of determinants that contribute 
to microbial homeostasis. The controlled environment and shared lifestyle of these animal 
models are suitable for subsequent studies discovering the local host aspects associated with 
the infant microbiota. All in all, future research should take the ontogeny of other organs 
into account in combination with the focus on the detailed host-microbe interactions herein. 
 In chapter 3, we provide further results that support the idea that the development and 
maturation of the intestinal microbiota continues towards adulthood as reported previously 
by other studies [20, 21], chapter 5]. The early colonization phase was characterized by a high 
interindividual variation and low diversity. Towards adult-age microbial diversity continuously 
increased and the interindividual variation decreased. Interestingly, during the postnatal 
period the abundance of the most dominant genera such as Escherichia gradually decreased 
in favor of a relative enrichment in Lactobacillus in both small intestine and colon [chapter 3]. 
This dramatic reduction of Proteobacteria is in line with findings of our human birth cohort 
towards school-age [chapter 5] where Escherichia was the most abundant genus until 31 
weeks after birth.
  In line with chapter 3 and a few other studies [12, 22, 23], our data from the birth 
cohort presented in chapter 5 show that the dietary transition with cessation of breastmilk 
was more strongly related with microbial compositional changes and maturity than the 
introduction of solid food. The latter suggests that the change in diet to solid food does not 
result in major shifts in microbial community structure as long as breastfeeding is continued. 
The microbial transformation upon cessation of breastfeeding induces powerful responses 
of the mucosal immune system for later in life, the so-called ‘weaning reaction’ [24]. This 
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reaction is characterized by enhanced expression of intestinal interferon (IFN)-y and tumor 
necrosis factor (TNF)-a, which is caused by the omission of epidermal growth factor (EGF) 
present in breast milk. Interestingly, this response led to protection to inflammatory diseases 
in adults associated with induction of specific regulatory T cells. However, this ‘weaning 
reaction’ seems to be highly time-dependent as it does not occur in an effort to introduce this 
change a week later. An intriguing phenomenon that emphasizes the combined effect of the 
microbiota, diet, and ontogeny in priming of the immune system and lifelong gut homeostasis. 
 The dietary changes continue during infancy, impacting the aforementioned 
substrate availability and associated microbial successions. In particular, a wide range 
of bacteria consume dietary fibers and generate hydrogen and beneficial short-chain 
fatty acids (SCFA’s). The methanogenic archaea, often neglected as members of the gut 
microbiota, stimulate the constant fermentation of these dietary fibers by metabolizing 
excessive hydrogen generated during carbohydrate fermentation into methane. In 
chapter 4, we showed that among environmental factors such as hygiene, medication, 
lifestyle and diet the occurrence of methanogenic archaea (Methanobrevibacter smithii) 
in children positively correlated with the consumption of organic yogurt and milk. 
We subsequently confirmed that these archaea are indeed present in milk products, 
suggesting that dairy consumption may facilitate archaeal gut colonization in children. 
 Colonization of methanogens is of importance in facilitating the fermentation capacity 
of the microbiome and thereby the production of the immune-modulatory SCFAs which in 
turn might protect against the development of inflammatory or immune-mediated diseases 
such as allergies. The methanogenic archaea directly stimulate the induction of adaptive 
and innate immune responses and expansion of specific B and T cells. Moreover, they are 
able to regulate the secretion of antimicrobial peptides, activate the inflammasome, and 
drive the production of certain cytokines such as TNF (Th1) [25]. The beneficial events are 
supported by a first study on the association of intestinal colonization by methanogenic 
archaea and asthma in the same pediatric cohort [[26], chapter 4]. A lower risk of asthma 
was associated with higher abundance of archaea in these children. Moreover, a trend 
for a decreased risk for atopic dermatitis and sensitization to allergens was also observed 
in the presence of archaea. In addition, there is evidence that organic dairy consumption 
as such is protective against eczema [27]. Thus, these data again shed light on the 
complex functional interactions between dietary, microbial and developmental facets of 
the immune system, which need to be elucidated together to unravel the link between 
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the presence of methanogenic archaea and the onset of allergic diseases in early life. 
 Mode of delivery is perhaps one of the factors most commonly linked to changes in the 
microbiota establishment in early life [21, 28]. C-section numbers are rising worldwide [29]. 
Nowadays one out of five babies is delivered by c-section with numbers having almost doubled 
since 2000. Notably, the Netherlands has one of the lowest c-section rates (17%) among 
developed countries, especially when compared to neighboring countries such as Germany 
(30%) [29]. The latter might be because pregnant women at low risk of birth complications 
get unique midwife-led care in the Netherlands which is associated with lower intervention 
rates [30, 31]. Although in some cases it might be a life-saving procedure, the high number 
of c-section without medical reason (called elective c-section) are worrisome. The microbiota 
of c-section delivered infants is characterized by delayed colonization of important members 
like Bacteroides species compared to vaginally delivered infants [12, 21, 28, 32-36]. In chapter 
5, we studied the establishment of the human infant’s gut microbiota longitudinally and 
further support that Bacteroides are indeed most strongly affected by the birth mode. The 
decreased levels of Bacteroides in infants born by c-section remained significant in our 
study after careful adjustment for other confounders such as feeding type and persisted 
for up to 31 weeks. Although recent findings further demonstrated that the compositional 
effect of these pioneer bacteria could last until 4-years postpartum in the infant gut [33, 
37], we could no longer identify differences at school-age (6-11 years) between children 
born by c-section as compared to those born vaginally. In chapter 7, we investigated the 
microbiota of preterm infants during the initial months of life. These preterms were most 
often delivered by c-section, and Bacteroides were indeed absent among the abundant taxa. 
Although c-section is accompanied by prophylactic antibiotic administration to the mother, 
the effect of delivery mode on the infant’s gut microbiota has recently been demonstrated to 
be independent of this antibiotic exposure [32]. In this study, the intrapartum antibiotic dose 
was administered only after clamping of the umbilical cord in mothers undergoing c-section, 
enabling the researchers to examine the impact of the birth mode on the neonatal microbiota 
in the absence of antibiotic exposure to the baby. This study confirmed the lower levels of 
Bacteroides spp. and Bifidobacterium spp.in c-section delivered infants, suggesting that 
maternal transfer during vaginal delivery is crucial to acquire certain microbial species in early 
life. Moreover, new evidence suggests that the microbiota seeding from mother to infant not 
only occurs by vaginal transmission but rather via fecal microbial transmission during delivery 
[32, 36]. The latter has been investigated by comparing both maternal rectal and vaginal 
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samples to the newborn’s fecal microbiota demonstrating more identical bacterial strains in 
infant samples and the maternal samples obtained rectally. Altogether, our (Chapter 5) and 
previous work show that Bacteroides represent the main maternal strains being transferred 
to the intestine of neonates born by vaginal delivery [28, 36, 38]. The lack of transmission of 
these strains during c-section delivery is related to lower levels of TNF-α and IL-18 in both 
the neonatal blood as well as the culture medium of primary immune cells stimulated with 
endotoxin isolated from their fecal material [38, 39]. This decrease in endotoxin-induced 
immune system priming has the potential for profound effects in later life. 
The gut microbiota in the pathogenesis of (allergic) diseases
The alterations in the gut microbiota have been implicated in the pathogenesis of several 
inflammatory and immune-mediated disorders in adults, including Crohn’s disease [40, 
41], ulcerative colitis [42] and non-alcoholic fatty liver disease [43] as well as other chronic 
disorders such as obesity [44], autism [45] and allergies [46]. There is increased concern that 
disruption of the early life microbiota might play a causal role in the onset of these conditions, 
especially in allergic diseases like asthma and atopic dermatitis. For instance, as compared 
to babies born vaginally, infants born by c-section more frequently experience infections, 
adverse effects on immune development and inflammatory disorders, including allergies 
[47, 48]. In the context of two birth cohort studies, mode of delivery was indeed shown to 
strongly affect both the risk of allergies and asthma and the infant microbiota [49]. Nowadays, 
these atopic diseases are the most common chronic pediatric disorders affecting more than 
300 million children in the (western) world [50]. Although numerous epidemiological studies 
suggest that the infant intestinal microbiota plays an important role in the manifestation of 
allergic diseases and asthma, these are mostly based on cross-sectional studies and thus 
lack early and additional samples prior to disease onset. Therefore, the timing and nature 
of the influence of intestinal microbes in the etiology of allergies remains largely unknown 
and has been incompletely elucidated.
  In chapter 5, we therefore studied the development of the gut microbiota during infancy 
at several time points during the first year of life and once at school-age, and related microbiota 
dynamics to the onset of allergies and asthma. We showed that the microbiota in general, its 
developmental state as well as the abundance of specific bacterial taxa were associated with 
the subsequent development of allergic disorders. For instance, using longitudinal analyses 
and careful correction of potential confounders, we found the abundance of Lachnobacterium 
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to be significantly lower throughout infancy both in children who developed atopic dermatitis 
and asthma as compared to children that remained free from allergic symptoms whereas a 
lower abundance of Faecalibacterium was indicative for atopic dermatitis.
 The protective property of Faecalibacterium (prausznitzii) against allergies could be 
due to its immunomodulatory activities [51]. The bacterial metabolite butyrate and a specific 
microbial anti-inflammatory molecule (MAM) of Faecalibacterium might contribute to these 
effects [52, 53]. MAM inhibits nuclear factor kB (NF-kB) activity in immune cells of the lamina 
propria and thereby reduces the interferon (IFN)-y and interleukin (IL)-17 production. Together 
with the epigenetic regulatory effect of butyrate this may induce differentiation and expansion 
of regulatory T cells. Moreover, butyrate also suppresses allergen-induced histamine release by 
mast cells via histone deacetylases [54]. Our reported association between Faecalibacterium 
abundance and the risk of subsequent allergy development confirmed previous findings. The 
CHILD study, for instance, revealed Faecalibacterium to be decreased in children at 3 months 
of age who were at risk for allergic wheeze at one year of age [55]. Furthermore, a lower 
relative Faecalibacterium abundance at one year of age was associated with an increased 
risk of asthma at five years in the COPSAC study [22].
 To date, we seem to be the first that link substantial perturbations of Lachnobacterium 
to the development of allergic manifestations. The latter might be due to the late discovery 
of this microbe [56] and so far its depletion has only been associated with primary biliary 
cirrhosis [57] and ulcerative colitis[58]. Lachnobacterium strains are capable to ferment 
sugars such as lactose and glucose into primarily lactic acid and minor amounts of butyric 
and acetic acids. Although these strains have characteristics similar to those of Lachnospira, 
they are metabolically highly equivalent to the common lactic acid-producing bacteria, i.e. 
Lactobacillus. The acidic environment that these bacteria create might on one hand avoid 
colonization by harmful invaders. On the other hand, lactic acid bacteria can modulate the 
dendritic cell and natural-killer cell interactions, shifting T-cell maturation towards Th1 by 
induction of IL-12 and IFN-y production, respectively [59-61]. Alternatively, lactic acid bacteria 
are able to modify the DNA methylation patterns of CD4+ T cells prompting enhanced immune 
activation at birth [61]. Moreover, an increased abundance of Lachnobacterium in infants 
at three to six months of age was linked to higher vitamin D levels directly after birth [62]. 
Although causality should be warranted, this may provide another explanation as vitamin 
D is an immune modulator that can induce synthesis of antimicrobial peptides such as 
cathelicidins and activate toll-like receptors (TLRs) [63, 64]. Asthma might be accompanied 
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by periods of acute worsening of the symptoms, named exacerbations, which are frequently 
triggered by viral infections. The latter is also related to subsequent allergic responses by 
increased production of pro-inflammatory cytokines like IL-17A [65]. The anti-viral actions of 
vitamin D together with the inhibition of IL-17A is thereby able to decrease the susceptibility 
to microbial infections and has been linked to reduced asthma exacerbations [66]. All in all, 
our study provides important insight to stimulate further analysis on this possibly pivotal 
bacterium.
  Although the pathogenesis of asthma may start in early in life [chapter 5], the actual 
diagnosis in the vast majority of children can only be made at 6 years of age and above. 
Wheezing can be recognized earlier, but only one third of wheezing preschool children 
will finally develop asthma [67]. Currently, a reliable biomarker to predict, which wheezing 
children will develop asthma is lacking and little is known about the association between 
the gut microbiota and asthma development in wheezing preschool children [68]. In chapter 
6, we therefore examined the gut microbiota in 202 wheezing children aged 2-4 years and 
50 healthy controls and the link with asthma at the age of 6 years. We observed that gut 
microbial diversity and overall community structure at this age were not associated with 
preschool wheezing or future childhood asthma. However, some bacteria were linked with 
wheezing and subsequent development of asthma. In particular, a high relative abundance 
of Escherichia was associated with an increased risk of asthma.
 Chapter 6 describes the first study that examined the microbiota in wheezing preschool 
children and its association with disease progression to asthma. In studies taking earlier time 
points into account, a general link between microbial diversity and asthma occurrence could 
indeed often not be observed [[55, 69, 70], chapter 5]. Moreover, despite the discrepancy 
between individual studies some earlier investigations had also reported an association of 
Escherichia with asthma risk [22, 71, 72]. In a large birth cohort study, infants with increased 
abundance of Escherichia (coli) developed IgE-mediated eczema [46]. Members of the genus 
Escherichia are able to produce compounds such as flagellae, fimbriae and endotoxin, which 
are potent stimuli of TLR receptors, increasing the risk of inappropriate inflammation which 
may in turn precede allergy development [73-76]. Alternatively, the higher abundance of 
Escherichia might indicate a delayed maturation of the microbiota as it has been shown that 
this bacterium dominates the composition in early infancy, and decreases thereafter gradually 
[chapter 3, chapter 5]. A delay in microbiota maturation has also recently been reported in 
children born to asthmatic mothers with later onset of asthma [22]. This delay might however 
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be partly influenced by decreased amounts of other bacteria such as Lactobacillus, which 
seems to be inversely related to Escherichia and thereby to exert a beneficial homeostatic 
effect in the gut [chapter 3, chapter 7]. Altogether, changes in the microbiota during infancy 
precede the development of allergic diseases and both the role of these bacteria as well as 
factors driving these bacteria warrant further investigation.
 In both chapter 5 and chapter 6, we attempted to link alterations in the microbiota 
composition to asthma development. The differences in the results of these studies not only 
rely on the fact that the asthmatic children were compared to different groups, but perhaps 
also on the age-window in which the microbiota composition was measured. Although in 
both studies the infants were clinically examined at school age (from 6 years), the preceding 
time points for microbiota assessment were mainly during the first year in the PAPS-study 
(chapter 5) and around 3 years of age in the ADEM-study (chapter 6). The modest microbiota 
perturbations described in chapter 6 suggest that the early microbial priming for life might 
have already been completed at this age. These findings are in line with the concept of the 
window of opportunity that takes place within the first months of life where the microbiota 
is suggested to have its strongest impact on tolerance development and immune maturation 
[77, 78]. Previous large longitudinal human cohort and animal studies observed that gut 
microbial alterations in individuals with allergic diseases indeed mainly occurred within 
this critical window in early life. This again underscores the importance of a good timing of 
biosampling and calls for studies with regular clinical examinations throughout infancy in 
combination with deep immunological phenotyping. 
Targeted manipulation of the gut microbiota
Oral administration of specific beneficial bacteria, named probiotics, might be a way for 
targeted manipulation of the gut microbiota to achieve clinical benefits, i.e. to decrease 
the incidence of infections and prevent the development of immune-mediated and 
inflammatory diseases such as allergies, asthma and in particular necrotizing enterocolitis 
(NEC). In chapter 7, we describe the influence of different interventions with Lactobacillus 
and Bifidobacterium strains on the microbiota in preterm neonates. We observed that the 
probiotics were linked to alterations of the microbial ecosystem and could in part persistently 
colonize after administration. The administration of probiotic bacteria, especially members 
of the genus Bifidobacterium, were inversely correlated with the abundance of pathobionts 
associated with NEC and with NEC incidence. Although this might not be unexpected at 
General discussion and summary
223
8
first sight, it should be noted that most probiotics do not colonize in adults [79]. Therefore, 
our study emphasizes that early infancy represents a critical period during which targeted 
manipulation of the gut microbiota might be possible and could confer a clinical benefit.
 The use of bacteria-rich fecal material to cure diseases has already been implemented in 
our society for thousands of years [80]. In the last decade, the essence of this ancient treatment 
has encountered a massive revival with a global increase in awareness. The use of these so-
called ‘fecal transplantations’ however needs to be tightly controlled as it is still unclear what 
exactly is introduced into the recipient and decent evidence of the health consequences on 
the long-term are lacking. For example, case reports described the transmission of multi-
resistant bacteria, which subsequently caused life-threatening infections [81]. Therefore, more 
personalized and precision medicine would be recommended rather than transplanting the 
complete fecal mass. The studies of this thesis, addressing the involvement of the microbiota 
in various diseases [chapter 5, chapter 6] and highlighting the valuable properties that 
certain pioneer bacteria exert [chapter 2, chapter 3, chapter 4, chapter 7], may contribute 
to further increase the awareness for precision medicine. For instance, specific members 
of the genus Lachnobacterium or Bacteroides could be of potential use to prevent allergic 
manifestations or delayed maturation after c-section delivery, respectively [chapter 5]. 
Moreover, many efforts in this respect have recently been made in which neonates born by 
c-section are directly exposed to the maternal vaginal microbiota upon delivery, named ‘vaginal 
seeding’ or ‘bacterial baptism’. Recent data however challenges the biological feasibility 
of this vaginal seeding to manipulate the neonatal gut microbiota as the key members of 
Bacteroides that differ by delivery mode seem to originate from the gastrointestinal tract 
rather than the vagina [36]. Although fecal transplantation might be an alternative strategy 
for vaginal seeding, concerns remain on the risks and uncertainties of this treatment. It is 
therefore crucial to first obtain detailed insight into the exact mechanisms, transmission 
routes and disturbing determinants before continuing with these attempts in restoring the 
baby’s intestinal microbiota. In accordance with this, the examination of specific bacteria, or 
perhaps more strongly, the identification of specific neonatal populations that will benefit 
most from certain microbiota manipulations is pivotal in order to support the development 
of more targeted interventions. This relates not only to those infants born by c-section but 
also to those infants that received antibiotic treatment or were susceptible to infections or 
necrotizing colitis for instance.
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Concluding remarks & future perspectives
There is a rainforest inside us, consisting of various microbial species that make up an entire 
complex ecosystem in the gut. The disturbance of such ecosystems could have dramatic 
implications and for the human intestinal microbiota this might impact health and disease. 
Since van Leeuwenhoek’s discovery 300 years ago, we are only starting to understand the 
impact and role of our little friends in this forest. The gut microbiota is an intrinsic element of 
our physiology, which starts to root and grow with birth. The microbial species that colonize 
first take a crucial part in the development of this ecosystem, possibly influencing the ultimate 
composition and functionality of the microbiota for life. The (lack of) establishment and 
expansion of these pioneer species are partly affected by maternal factors, medication, host 
characteristics, diet and environment. A better understanding of the interplay between the 
gut microbiota, our body’s physiology and the determinants interfering with the microbial 
development is important given its essential role in metabolic, immune and other processes. 
This thesis provided novel insight into specific factors driving the intestinal microbial community 
composition and inter-individual microbiota variations in early life and how changes in the 
microbiota composition and manipulation thereof relate to the onset of inflammatory diseases 
such as allergies.
 Together with previous studies, this thesis showed that different factors contribute 
to the variation of the gut microbiota composition between individuals and finally shape a 
stable microbial community that is as unique as one’s fingerprint. However, so far, we can 
only explain a minor part, and even identical twins sharing the exact similar genetics and most 
likely the same diet and environment exhibit major differences in their enteric microbiota. 
Therefore, host genetics appears to exert a low contribution to the microbiota variation as 
taken from twin studies [82, 83], whereas diet seems to contribute for only about 6% to the 
overall microbiota variation [84]. In total, the known determinants such as diet, drugs and 
lifestyle related factors account for less than 36% of the variation [85, 86], and although 
diet has the biggest relative proportional influence of all known determinants a large part 
of inter-individual microbiota remains still unexplained. This suggests that we either have 
overlooked important determinants or that other ecological processes such as historical 
contingency or stochastics effects play a major role in this unexplained inter-individual 
microbiota variation. For instance, it has been suggested that the order in which microbes 
arrive (historical contingency) impacts the community assembly and interactions as well 
[87]. This ‘first come, first serve’ principle could occur in early life and hence potentially alter 
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the development of the gut microbiota in babies including identical twins. Further research 
should take this ecological phenomenon into account, but also focus on unravelling other 
so far unknown factors that significantly contribute to the variation and acquisition of the 
microbiota, and thereby the vital biological processes in life.
 The use of big data might be useful in the search for these unknown factors. This 
comprises the combination of genomics, transcriptomics, and proteomics accompanied by 
extensive information on environmental exposure to not only unravel novel determinants but 
also to provide a more detailed functional insight. The latter calls for both large human birth 
cohort studies as well for well-controlled animal studies and perhaps in vitro experiments, 
preferably paralleling these to overcome the possible drawbacks of each. The emphasis 
on the link between the different biological systems, the metabolic pathways, immune 
responses and microbial interactions, which is until now often neglected, is crucial to further 
increase our understanding. Furthermore, the consideration and eventual proof of causality 
is of importance herein, i.e. causal inferences via mediation analyses that detect potential 
directions of association pathways. The archaea are for instance correlated with the asthma 
risk and influenced by consumption of milk products [chapter 4], but if and how this is 
exactly interconnected with each other remains unclear. A recommendation would be that 
this research field with many association studies should attempt to move towards more 
mechanistic and causative approaches albeit relationships may generate new hypotheses.
  We amongst others showed that cessation of breast milk profoundly influences the 
microbiota to a more mature composition during the initial years of life [chapter 3, chapter 
5]. The fact that breast milk is beneficial for the infant’s health has been widely accepted 
and the WHO recommends therefore to breastfeed up to 2 years. Is this however still the 
right duration in terms of the cooperative microbial, dietary and immune-mediated effects? 
Which signals contribute to finally complete the ultimate weaning transitions? Why is this time 
period non-redundant in light of the window of opportunity? Hence, studies are necessary 
to address these critical aspects also in order to support future targeted microbial therapies 
to prevent the risk of immune-mediated diseases in early life. In line with this, the selection 
and understanding of microbial manipulation and appropriate probiotics is pivotal and 
should rely on essential host-microbe interactions. In particular, increased knowledge on the 
microbes that are crucial for specific health outcomes may also promote the usage of certain 
drugs or diets to manipulate and “optimize” the microbiota. The potency of recovering the 
altered microbial colonization upon disturbance, especially upon antibiotic administration or 
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c-section delivery needs to be investigated. Lastly, further research is necessary to identify 
not only beneficial bacteria, but also their lasting long-term effect after administration and 
the components that impact these pioneer species.
 Moreover, the lack of certain microbes could be partly attributed to the lack of 
environmental exposure of children, spending more time in urban surroundings. Changes 
in lifestyle thereby could contribute to the increase in chronic inflammatory diseases 
such as obesity, asthma and allergies. The reduced exposure to nature might impede the 
beneficial health effects including the acquisition of bacteria, the maturation and balancing 
of immunological responses, and elevation of the vitamin D level. For instance, favorable 
(g-proteo)bacteria were detected in higher abundance in children living closely to non-
urban environments such as farms and forests [88]. Moreover, a ‘farm-like’ microbiota at 
home, originating from the outdoor environment and green areas around homes, decreased 
the incidence of asthma and allergy risk [89, 90]. Outdoor activity in a natural biodiverse 
environment may improve the microbial colonization, decrease the risk of allergies and asthma, 
and improve children’s general well-being. This concept of ‘microbiota re-wilding’ has recently 
been explored in a few animal studies. For instance, it has been demonstrated that laboratory 
mice released into an outdoor environment altered both the microbiota and enhanced the 
immune activation via the differentiation of T cell populations and circulating granulocytes [91]. 
In another study, the transplantation of embryos of lab mice into ‘wild’ mothers generated 
genetically defined offspring that harbor a microbiota that closely resembles that of wild mice 
[92]. The microbiota of these ‘wildlings’ was more resistant to environmental exposures such 
as diet and antibiotics and improved the immune regulation compared to the normal isolated 
lab mice. Conversely, the lack of microbes as reflected by germ-free mice results in a higher 
susceptibility to inflammatory disorders like allergies. Altogether, these studies support that 
a diverse microbiota derived from the wild outdoor contributes to greater stimulation of the 
immune system in free-living mammals. The mechanisms of the natural microbiota to induce 
these effects must be further investigated as it might explain the inter-individual differences 
in the predisposition to develop certain diseases. Future studies should also address the 
human interventional strategies if strengthening connections to nature as part of everyday’s 
life during infancy indeed exerts a protective effect. Perhaps we need to go back to our basic 
roots from ancient times, the original home of Homo sapiens, back to nature and into the 
wilds.
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 In conclusion, this thesis sheds further light on the relevance of specific host and 
environmental factors and first settlers in the maturing early life microbiota, seeing more 
and more the forest for the trees. By contributing to the growing knowledge on the nature 
and opportunities of the microbiota in early life, our research has provided new leads to 
further explore the precise mechanisms and determinants of microbiota development and 
its impact on the host. In order to support the development of personalized and targeted 
microbial therapies, I would recommend to further unravel these leads between diet, host 
factors, immune maturation and pioneer species. Additional functional studies integrating 
animal models or co-culture systems with findings or samples from extensive longitudinal 
human birth cohorts will aid in understanding the inter-individual microbiome variation and 
the onset of non-communicable diseases herein. The field of microbiology has long been 
focusing on methodologies within its own boundaries, but this thesis highlights that the 
microbial developmental interactions are complex and can only be determined by cross-
border research. The different fields of microbiology, immunology, and molecular biology 
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De samenstelling van de darmmicrobiota in de vroege kindertijd is zeer dynamisch en heeft 
een sterke invloed  op het immuunsysteem van de gastheer. Verstoringen in de totstandkoming 
van de microbiota tijdens deze kindertijd gaan gepaard met een inadequate ontwikkeling van 
het immuunsysteem en kunnen daarmee levenslange gevolgen hebben voor de gevoeligheid 
voor ontstekings- en immuun-gemedieerde ziekten. Daarom is een gedetailleerd inzicht in 
de ecologische factoren die de microbiota tijdens het vroege leven vormgeven van bijzonder 
belang.
In hoofdstuk 2 geven we een overzicht van de oorsprong en het belang van pionier bacteriën 
en de bekende evolutionaire factoren die de ontwikkeling van de darmmicrobiota in kinderen 
beïnvloeden. De microbiota ontplooit zich gedurende de eerste levensjaren tot een complex 
en divers ecosysteem onder invloed van een groot aantal omgevings- en maternale factoren, 
bijvoorbeeld de manier van bevalling, medicatiegebruik, moedermelk versus flesvoeding 
en andere voedingsfactoren. Deze microbiële volgroeiing is dus mede afhankelijk van de 
verspreiding van microben (dispersie) vanuit de omgeving en wordt verder beïnvloed door 
de volgorde waarin verschillende bacteriesoorten de darmen koloniseren (historische 
contingentie) en door factoren die een selectief voordeel bieden aan bepaalde bacteriën 
(habitat-filtering).
In hoofdstuk 3 hebben we de ontwikkeling en successie van bacteriën naar volwassenheid in 
zowel de dunne als de dikke darm van muizen nauwlettend gevolgd en hebben we onderzocht 
of er metabole factoren van de gastheer betrokken zijn bij dit maturatieproces. De bacteriële 
soortenrijkheid en diversiteit nam aanvankelijk af in zowel de dunne als de dikke darm binnen 
de eerste 24 uur na de geboorte. Dit illustreert het onvermogen om de neonatale darm 
permanent te koloniseren op dit tijdpunt. Verder was de algehele microbiota samenstelling 
zeer vergelijkbaar tussen de dikke darm en de dunne darm kort na de geboorte. De meest 
ingrijpende veranderingen, gekenmerkt door de totstandkoming van een orgaan-specifieke 
microbiota, werden waargenomen tijdens het stoppen van borstvoeding. Deze successie van 
bacteriën en de algehele volgroeiing van het microbiële ecosysteem zijn mede afhankelijk van 
variaties in de beschikbare substraten in de darm als gevolg van metabole veranderingen. 




acylcarnitines, glycerofosfolipiden, sfingolipiden en suikers op verschillende leeftijden gemeten. 
We identificeerden de galzuren als potentiële drijfveren voor de ontwikkeling van de microbiota 
samenstelling. De causaliteit van deze bevinding werd bevestigd door orale toediening van 
galzuren. De geselecteerde galzuren (bijv. tauro-β-muricholzuur en ursodeoxycholzuur) 
bevorderden in het bijzonder de groei van lactobacilli in de dunne darm. Deze snelle toename 
van lactobacilli na toediening van galzuren zou wellicht ook de bescherming tegen infecties, 
de zogenaamde kolonisatieresistentie, kunnen bevorderen. 
In hoofdstuk 4 toonden we aan dat onder omgevingsfactoren zoals hygiëne, medicatie, 
leefstijl en voeding de aanwezigheid van methanogene archaea (Methanobrevibacter smithii) 
in de ontlasting van  kinderen van 6-10 jaar positief gecorreleerd is met de consumptie van 
biologische yoghurt en melk. We hebben vervolgens bevestigd dat deze archaea aanwezig zijn 
in melkproducten hetgeen suggereert dat zuivelconsumptie de darmkolonisatie met archaea 
bij kinderen kan bevorderen. De kolonisatie van methanogene archaea is van belang vanwege 
hun vele gunstige (immune-modulerende) effecten en vanwege hun mogelijk beschermend 
effect tegen astma, atopische dermatitis en sensibilisatie voor allergenen zoals aangetoond 
in hetzelfde cohort. 
In hoofdstuk 5 hebben we de ontwikkeling van de darmmicrobiota bestudeerd in een cohort 
van pasgeboren kinderen op verschillende tijdstippen in het eerste levensjaar en eenmaal 
op de schoolleeftijd. We hebben aangetoond dat het stoppen met borstvoeding sterker 
samenhangt met veranderingen in de microbiële samenstelling dan de introductie van vaste 
voeding. We bevestigden verder dat Bacteroides het sterkst worden beïnvloed door de manier 
van geboorte. De lagere aantallen Bacteroïdes onder zuigelingen die via een keizersnede 
werden geboren bleef ook na een zorgvuldige aanpassing voor andere confounders, zoals 
het voedingstype, statistisch significant in onze studie tot op de leeftijd van 31 weken post-
partum. Uit ons [hoofdstuk 5] en eerder werk blijkt dat het voornamelijk deze Bacteroides-
stammen zijn die van moeder op kind worden overgebracht tijdens een vaginale bevalling. 
De verstoring van de microbiota in het vroege leven kan een oorzakelijke rol spelen bij het 
ontstaan van aandoeningen zoals chronische darmontsteking, obesitas en allergieën. De manier 
van bevalling heeft niet alleen een belangrijk effect op de darmmicrobiota van kinderen, 
maar verhoogd ook het risico op allergieën en astma, de meest voorkomende chronische 
kinderziekten. Deze bevindingen zijn echter meestal gebaseerd op dwarsdoorsnede onderzoek, 
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er zijn maar weinig studies die de ontwikkeling van de darmmicrobiota voorafgaand aan de 
openbaring van allergische klachten hebben bestudeerd. In hoofdstuk 5 hebben we vervolgens 
de veranderingen in de microbiota gerelateerd aan het ontstaan van allergieën en astma. 
We toonden aan dat de algehele microbiota samenstelling, de ontwikkelingstoestand en de 
hoeveelheid van specifieke bacteriesoorten geassocieerd waren met het risico op allergische 
aandoeningen op latere leeftijd. We vonden bijvoorbeeld met behulp van longitudinale analyses 
en zorgvuldige correctie van potentiële confounders dat de hoeveelheid van Lachnobacterium 
significant lager was gedurende de hele kindertijd in kinderen die atopische dermatitis of 
astma ontwikkelden. Een lagere hoeveelheid van Faecalibacterium was daarentegen indicatief 
voor een verhoogd risico op de ontwikkeling van atopisch eczeem.
Ondanks dat het ontstaan van astma in het begin van het leven kan beginnen [hoofdstuk 
5], kan een klinische diagnose bij de overgrote meerderheid van de kinderen pas gesteld 
worden vanaf 6 jaar en ouder. Het zogenoemde ‘piepen’ kan al op jongere leeftijd worden 
herkend, maar slechts een derde van de piepende kleuters ontwikkeld uiteindelijk astma. Een 
betrouwbare biomarker om te voorspellen welke piepende kinderen astma zullen ontwikkelen 
ontbreekt op dit moment. In hoofdstuk 6 hebben we daarom de darmmicrobiota bij 202 
piepende kinderen en 50 gezonde controle kinderen van 2-4 jaar en het verband met astma op 
6 jarige leeftijd onderzocht. De microbiële diversiteit en de algehele microbiële samenstelling 
op deze leeftijd bleken niet geassocieerd met een piepende ademhaling noch voorspellend 
voor de ontwikkeling van astma. Specifieke bacteriën, zoals Escherichia, bleken daarentegen 
wel geassocieerd met een verhoogd risico op de ontwikkeling van astma.
Zowel in hoofdstuk 5 als in hoofdstuk 6 hebben we geprobeerd om veranderingen in de 
samenstelling van de microbiota te koppelen aan de ontwikkeling van astma. In beide studies 
werden de kinderen klinisch onderzocht op schoolleeftijd (vanaf 6 jaar). Het belangrijkste 
verschil tussen deze studies was de leeftijd waarop de microbiota werd gekarakteriseerd. In 
hoofdstuk 5  bestudeerden we de darmmicrobiota in het eerste levensjaar, terwijl in hoofdstuk 
6 de microbiota op kleuterleeftijd werd bestudeerd. De matige microbiële verstoringen die 
zijn beschreven in hoofdstuk 6 suggereren dat de vroege microbiële stimulatie mogelijk 
op deze leeftijd al is voltooid. Deze bevindingen zijn in lijn met de zogenaamde ‘window 
of opportunity’, de kritische periode in de eerste levensmaanden waarin de microbiota 




nogmaals het belang van een goede timing van monsterverzameling en vraagt om studies met 
regelmatige klinische onderzoeken gedurende de kindertijd in combinatie met gedetailleerde 
immunologische fenotypering.
De orale toediening van specifieke gunstige bacteriën, genaamd probiotica, kan een manier 
zijn om de darmmicrobiota gericht te manipuleren om zo klinische voordelen te bereiken. In 
hoofdstuk 7 beschrijven we hoe het toedienen van verschillende stammen lactobacillen en 
bifidobacteriën de microbiota van prematuren beïnvloedt. We toonden aan dat het toedienen 
van probiotica geassocieerd was met veranderingen in het microbiële ecosysteem en dat 
ook na beëindiging van de toediening de probiotica-stammen deels blijvend koloniseren. De 
toediening van probiotische bacteriestammen, vooral bifidobacteriën, was gecorreleerd met 
een verlaging  van bacteriën die geassocieerd zijn met necrotiserende enterocolitis (NEC) 
alsmede de incidentie van deze dodelijke ziekte. Onze studie benadrukt dat de vroege kindertijd 
een kritieke periode is waarin manipulatie van de microbiota mogelijk is en gezondheid 
bevorderd kan worden. 
De studies in dit proefschrift, waarin de betrokkenheid van de microbiota in verschillende 
ziekten wordt beschreven [hoofdstuk 5, hoofdstuk 6] en waarin de waardevolle eigenschappen 
van bepaalde pionier-bacteriën worden benadrukt [hoofdstuk 2, hoofdstuk 3, hoofdstuk 
4, hoofdstuk 7], kunnen het bewustzijn vergroten om bacteriën te gebruiken als gerichte 
medicatie. Specifieke stammen van bijvoorbeeld Lachnobacterium of Bacteroides kunnen 
potentieel van nut zijn om allergische aandoeningen of vertraagde microbiota ontwikkeling 
van niet-vaginaal geboren kinderen te voorkomen [hoofdstuk 5]. 
Er is een regenwoud in ons dat bestaat uit verschillende microbiële soorten die een heel 
complex ecosysteem vormen in de darmen. De verstoring van dergelijke ecosystemen 
kan dramatische gevolgen hebben en wat betreft de menselijke darmmicrobiota kan dit 
onze gezondheid sterk beïnvloeden. Sinds de ontdekking van microbieel leven door van 
Leeuwenhoek 300 jaar geleden beginnen we pas net de impact en de rol van onze kleine 
vrienden in dit bos te begrijpen. De darmmicrobiota is een intrinsiek onderdeel van onze 
fysiologie, die begint te wortelen en te groeien vanaf de geboorte. De microbiële soorten 
die als eerste koloniseren spelen een cruciale rol in de ontwikkeling van dit ecosysteem en 
beïnvloeden mogelijk de uiteindelijke samenstelling en functionaliteit van de microbiota voor 
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de rest van ons leven. De vestiging van deze pioniers in het darmkanaal van zuigelingen wordt 
mede beïnvloed door maternale factoren, medicatie, gastheerkarakteristieken, voeding en 
omgeving. Een beter inzicht in het samenspel tussen de darmmicrobiota, de fysiologie van 
ons lichaam en de factoren die de microbiële ontwikkeling beïnvloeden is belangrijk gezien de 
essentiële rol van de microbiota op ons metabolisme, immuunsysteem en andere processen. 
Dit proefschrift gaf vernieuwend inzicht in specifieke factoren die de samenstelling van de 
microbiota in de darm beïnvloeden en bijdragen aan de variatie tussen individuen in het 
vroege leven. Tevens laat het zien hoe veranderingen in de microbiële samenstelling en de 
manipulatie daarvan verband houden tot het ontstaan van ontstekingsziekten zoals allergieën. 
 Het gebrek aan bepaalde microben zou deels kunnen worden toegeschreven 
aan het gebrek aan omgevingsblootstelling van kinderen die steeds meer tijd in de 
stedelijke omgeving doorbrengen. Buitenactiviteiten in een natuurlijke omgeving met 
een grote biodiversiteit kunnen de microbiële kolonisatie verbeteren, het risico op 
allergieën en astma verminderen en het algemene welzijn van kinderen verbeteren. 
Dit concept van ‘microbiota-rewilding’ is onlangs onderzocht in enkele dierenstudies. 
Deze studies ondersteunen dat een diverse microbiota afkomstig uit de wilde 
buitenomgeving bijdraagt aan een betere stimulatie van het immuunsysteem. Wellicht 
moeten we teruggaan naar onze oorsprong, terug naar de natuur en de wildernis in. 
 Concluderend, we zien steeds meer de bomen door het bos doordat dit proefschrift 
licht werpt op de relevantie van specifieke gastheer- en omgevingsfactoren en de eerste 
kolonisten in de ontwikkelende darm van het vroege leven. Door bij te dragen aan de groeiende 
kennis over de aard en de mogelijkheden van de microbiota in het vroege leven heeft ons 
onderzoek nieuwe aanknopingspunten opgeleverd om de precieze mechanismen van de 
microbiota ontwikkeling en de impact ervan op de gastheer verder te exploreren. Aanvullende 
functionele studies die diermodellen of co-cultuursystemen integreren met bevindingen of 
monsters van uitgebreide longitudinale menselijke geboortecohorten zullen helpen bij het 
begrijpen van de inter-individuele microbiële variatie en de invloed hiervan op het ontstaan 
van ziekten. Het onderzoeksgebied van de microbiologie focust zich al lange tijd op analytische 
methoden binnen de eigen grenzen, maar dit proefschrift benadrukt dat de microbiële 







Die Zusammensetzung der intestinalen Mikrobiota ist in der frühen Kindheit sehr dynamisch 
und hat einen starken Einfluss auf das Immunsystem des Wirtes. Störungen in der Bildung 
der Mikrobiota während dieser Kindheit sind mit einer unzureichenden Entwicklung des 
Immunsystems verbunden und können daher lebenslange Folgen für die Anfälligkeit für 
entzündliche und immunvermittelte Krankheiten haben. Daher ist ein detailliertes Verständnis 
der Faktoren, die die Mikrobiota während des frühen Lebens prägen, von besonderer 
Bedeutung.
Kapitel 2 beinhaltet einen Überblick über die Herkunft und Bedeutung von Pionierbakterien 
und die bekannten evolutionären Faktoren, die die Entwicklung der Darmmikrobiota bei 
Kindern beeinflussen. Die Mikrobiota entwickelt sich in den ersten Lebensjahren zu einem 
komplexen und vielfältigen Ökosystem unter dem Einfluss einer Vielzahl von Umwelt- und 
mütterlichen Faktoren, z.B. Art der Geburt, Medikamenteneinnahme, Muttermilch versus 
Flaschenernährung und andere Ernährungsfaktoren. Diese mikrobielle Reifung hängt zum Teil 
von der Verteilung der Mikroben (Dispersion) aus der Umwelt ab und wird darüber hinaus 
von der Reihenfolge in der verschiedene Bakterienarten den Darm besiedeln (historische 
Kontingenz) und von Faktoren die bestimmten Bakterien einen selektiven Vorteil bieten 
(Habitat-Filterung), beeinflusst.
In Kapitel 3 haben wir die Entwicklung und Sukzession von Bakterien bis zum Erwachsenenalter 
sowohl im Dünn- als auch im Dickdarm von Mäusen genau erfasst und untersucht, ob 
Stoffwechselfaktoren des Wirts an diesem Reifungsprozess beteiligt sind. Der bakterielle 
Artenreichtum und die Diversität nahmen zunächst sowohl im Dünndarm als auch im Dickdarm 
innerhalb der ersten 24 Stunden nach der Geburt ab. Dies verdeutlicht dass es nicht möglich 
ist den neonatalen Darm zu diesem Zeitpunkt dauerhaft zu besiedeln. Des Weiteren war 
die gesamte Mikrobiota-Zusammensetzung sich zwischen Dick- und Dünndarm kurz nach 
der Geburt sehr ähnlich. Die tiefgreifendsten Veränderungen während der Bildung einer 
organspezifischen Mikrobiota, wurden während des Stillens beobachtet. Diese Sukzession der 
Bakterien und die Gesamtreife des mikrobiellen Ökosystems hängen auch von Schwankungen 
der verfügbaren Substrate im Darm aufgrund von Stoffwechselveränderungen ab. Deshalb 
haben wir die Konzentrationen von Gallensäuren, Aminosäuren, biogenen Aminen, 
242
Addendum
Acylcarnitinen, Glycerophospholipiden, Sphingolipiden und Zuckern in verschiedenen 
Altersstufen gemessen. Wir identifizierten die Gallensäuren als potenzielle Treiber für die 
Entwicklung der Mikrobiota-Zusammensetzung. Die Kausalität dieses Befundes wurde 
durch orale Verabreichung von Gallensäuren bestätigt. Die ausgewählten Gallensäuren (z. 
B. Tauro-β-Muricholsäure und Ursodeoxycholsäure) förderten insbesondere das Wachstum 
von Laktobazillen im Dünndarm. Diese schnelle Vermehrung der Laktobazillen nach der 
Verabreichung von Gallensäuren könnte auch den Schutz vor Infektionen, die sogenannte 
Kolonisationsresistenz, fördern. 
In Kapitel 4 haben wir gezeigt, dass unter Umweltfaktoren wie Hygiene, 
Medikamenteneinnahme, Lebensstil und Ernährung, das Vorhandensein von methanogenen 
Archaeen (Methanobrevibacter smithii) im Stuhl von Kindern im Alter von 6-10 Jahren positiv 
mit dem Konsum von Bio-Joghurt und -Milch korreliert ist. Anschließend bestätigten wir 
das Vorhandensein dieser Archaeen in Milchprodukten, was darauf hindeutet, dass der 
Verzehr von Milchprodukten die Darmbesiedlung mit Archaeen bei Kindern fördern kann. 
Die Besiedlung mit methanogenen Archaeen ist wichtig wegen ihrer vielen vorteilhaften 
(immunmodulierenden) Wirkungen und wegen ihrer potenziellen Schutzwirkung gegen 
Asthma, atopische Dermatitis und Sensibilisierung auf Allergene, wie in der gleichen Kohorte 
von Kindern gezeigt wurde. 
In Kapitel 5 haben wir die Entwicklung der intestinalen Mikrobiota in einer Kohorte von 
Neugeborenen zu verschiedenen Zeitpunkten im ersten Lebensjahr und einmalig im Schulalter 
untersucht. Wir haben gezeigt, dass das Beenden des Stillens stärker mit Veränderungen in 
der mikrobiellen Zusammensetzung zusammenhängt als die Einführung von fester Nahrung. 
Wir bestätigten des Weiteren, dass die Bacteroide am stärksten von der Art der Geburt 
beeinflusst werden. Die geringeren Bakteroidzahlen bei den per Kaiserschnitt geborenen 
Säuglingen blieben in unserer Studie bis zum Alter von 31 Wochen postpartal statistisch 
signifikant, auch nach sorgfältiger Adjustierung für andere Confounder, wie z.B. die Art der 
Ernährung. Aus unserer [Kapitel 5] und früheren Arbeiten geht hervor, dass es hauptsächlich 
diese Bacteroid-Stämme sind, die während der vaginalen Geburt von der Mutter auf das Kind 
übertragen werden. Die Störung der Mikrobiota im frühen Leben kann eine kausale Rolle 
bei der Entwicklung von Erkrankungen wie chronischen Darmentzündungen, Adipositas 




Darmmikrobiota von Kindern, sondern erhöht auch das Risiko auf Allergien und Asthma, 
die am häufigsten vorkommenden chronischen Kinderkrankheiten. Allerdings beruhen 
diese Erkenntnisse meist auf Querschnittsuntersuchungen, nur wenige Studien haben die 
Entwicklung der Darmmikrobiota vor dem Auftreten allergischer Symptome untersucht. In 
Kapitel 5 haben wir darum die Veränderungen der Mikrobiota mit der Entwicklung von Allergien 
und Asthma in Verbindung gebracht. Wir haben gezeigt, dass die Gesamtzusammensetzung 
der Mikrobiota, der Entwicklungsstand und die Menge spezifischer Bakterienspezies mit dem 
Risiko auf allergische Erkrankungen im späteren Leben assoziiert sind. Zum Beispiel fanden 
wir mit Hilfe von Längsschnittanalysen und sorgfältiger Korrektur potenzieller Störfaktoren 
heraus, dass die Menge an Lachnobacterium während der gesamten Kindheit bei Kindern, 
die atopische Dermatitis oder Asthma entwickelten, signifikant niedriger war. Im Gegensatz 
dazu war eine geringere Menge an Faecalibacterium ein Hinweis auf ein erhöhtes Risiko, ein 
atopisches Ekzem zu entwickeln.
Obwohl Asthma bereits in den ersten Lebensjahren beginnen kann [Kapitel 5], kann eine 
klinische Diagnose bei der überwiegenden Mehrheit der Kinder erst ab dem 6. Lebensjahr 
gestellt werden. Das sogenannte „Wheezing“ kann schon in jüngeren Jahren erkannt werden, 
aber nur ein Drittel der keuchenden Kleinkinder entwickelt schließlich Asthma. Ein zuverlässiger 
Biomarker zur Vorhersage, welche keuchenden Kinder Asthma entwickeln werden, fehlt 
derzeit. Daher untersuchten wir in Kapitel 6 die intestinale Mikrobiota von 202 keuchenden 
Kindern und 50 gesunden Kontrollkindern im Alter von 2-4 Jahren und den Zusammenhang 
mit Asthma im Alter von 6 Jahren. Die mikrobielle Diversität und die gesamte mikrobielle 
Zusammensetzung in diesem Alter waren weder mit dem Keuchen assoziiert noch prädiktiv 
für die Entwicklung von Asthma. Es wurde jedoch festgestellt, dass bestimmte Bakterien, wie 
z. B. Escherichia, mit einem erhöhten Risiko für die Entwicklung von Asthma verbunden sind.
Sowohl in Kapitel 5 als auch in Kapitel 6 haben wir versucht, Veränderungen in der 
Zusammensetzung der Mikrobiota mit der Entwicklung von Asthma in Verbindung zu bringen. 
In beiden Studien wurden die Kinder im Schulalter (ab dem 6. Lebensjahr) klinisch untersucht. 
Der Hauptunterschied zwischen diesen Studien war das Alter, in dem die Mikrobiota 
charakterisiert wurde. In Kapitel 5 wurde die intestinale Mikrobiota im ersten Lebensjahr 
untersucht, während in Kapitel 6 die Mikrobiota im Vorschulalter untersucht wurde. Die in 
Kapitel 6 beschriebenen mäßigen mikrobiellen Störungen lassen vermuten, dass die frühe 
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mikrobielle Stimulation in diesem Alter abgeschlossen sein könnte. Diese Befunde stehen im 
Einklang mit der sogenannten „Window of Opportunity“-Hypothese, der kritischen Zeitraum in 
den ersten Lebensmonaten, in dem die Mikrobiota ihren stärksten Einfluss auf die Entwicklung 
des Immunsystems hat. Dies unterstreicht einmal mehr die Bedeutung eines guten Timings 
der Probenentnahme und fragt nach Studien mit regelmäßigen klinischen Untersuchungen 
im Kindesalter in Kombination mit einer detaillierten immunologischen Phänotypisierung.
Die orale Verabreichung spezifischer nützlicher Bakterien, so genannter Probiotika, kann eine 
Möglichkeit sein, die intestinale Mikrobiota gezielt zu manipulieren, um klinische Vorteile zu 
erzielen. In Kapitel 7 beschreiben wir, wie die Verabreichung von verschiedenen Stämmen von 
Laktobazillen und Bifidobakterien die Mikrobiota von Frühgeborenen beeinflusst. Wir konnten 
zeigen, dass die Verabreichung von Probiotika mit Veränderungen des mikrobiellen Ökosystems 
verbunden war und dass die probiotischen Stämme teilweise auch nach Beendigung der 
Verabreichung weiter kolonisieren. Die Verabreichung von probiotischen Bakterienstämmen, 
insbesondere von Bifidobakterien, wurde mit einer Reduktion der mit nekrotisierender 
Enterokolitis (NEC) assoziierten Bakterien sowie der Inzidenz dieser tödlichen Erkrankung 
in Verbindung gebracht. Unsere Studie unterstreicht, dass die frühe Kindheit ein kritischer 
Zeitraum ist, in dem eine Manipulation der Mikrobiota möglich ist und die Gesundheit 
gefördert werden kann. 
Die Studien in dieser Dissertation, in denen die Beteiligung der Mikrobiota an verschiedenen 
Krankheiten beschrieben wird [Kapitel 5, Kapitel 6] und in denen die wertvollen Eigenschaften 
bestimmter Pionierbakterien hervorgehoben werden [Kapitel 2, Kapitel 3, Kapitel 4, Kapitel 
7], können das Bewusstsein dafür schärfen, Bakterien gezielte als Medikamente einzusetzen. 
Spezifische Stämme von z. B. Lachnobacterium oder Bacteroides können möglicherweise 
nützlich sein, um allergische Erkrankungen oder eine verzögerte Entwicklung der Mikrobiota 
bei nicht vaginal geborenen Kindern zu verhindern [Kapitel 5]. 
In uns lebt ein Regenwald, der aus verschiedenen Mikroben Arten besteht, die im Darm ein sehr 
komplexes Ökosystem bilden. Die Störung solcher Ökosysteme kann dramatische Folgen haben, 
und was die menschliche Darmmikrobiota betrifft, kann dies einen großen Einfluss auf unsere 
Gesundheit haben. Seit der Entdeckung des mikrobiellen Lebens durch van Leeuwenhoek vor 




Freunde in diesem Wald zu verstehen. Die intestinale Mikrobiota ist ein fester Bestandteil 
unserer Physiologie, die von Geburt an Wurzeln schlägt und wächst. Die Mikroben Arten, 
die sich zuerst ansiedeln, spielen eine entscheidende Rolle bei der Entwicklung dieses 
Ökosystems und können die endgültige Zusammensetzung und Funktionalität der Mikrobiota 
für den Rest unseres Lebens beeinflussen. Die Etablierung dieser Pioniere im Darmtrakt von 
Säuglingen wird teilweise durch mütterliche Faktoren, Medikamente, Wirtseigenschaften, 
Ernährung und Umwelt beeinflusst. Ein besseres Verständnis des Zusammenspiels zwischen 
der intestinalen Mikrobiota, der Physiologie unseres Körpers und den Faktoren, die die 
mikrobielle Entwicklung beeinflussen, ist wichtig, da die Mikrobiota eine wesentliche Rolle in 
unseren Stoffwechsel, dem Immunsystem und anderen Prozessen spielt. Diese Dissertation 
gibt innovative Einblicke in spezifische Faktoren, die die Zusammensetzung der Mikrobiota 
im Darm beeinflussen und zur Variation zwischen Individuen im frühen Leben beitragen. Sie 
zeigt auch, wie Veränderungen in der mikrobiellen Zusammensetzung und deren Manipulation 
mit der Entstehung von entzündlichen Erkrankungen wie Allergien zusammenhängen. 
 Ein Mangel an bestimmten Mikroben könnte teilweise auf die mangelnde 
Umweltexposition von Kindern zurückzuführen sein, die immer mehr Zeit in der städtischen 
Umgebung verbringen. Aktivitäten im Freien in einer natürlichen Umgebung mit hoher 
Biodiversität können die mikrobielle Besiedlung verbessern, das Risiko von Allergien und 
Asthma verringern und das allgemeine Wohlbefinden von Kindern verbessern. Dieses 
Konzept des „microbiota-rewilding“ wurde kürzlich in einigen Tierstudien untersucht. 
Diese Studien unterstützen, dass eine vielfältige Mikrobiota, die aus der freien Natur 
stammt, zu einer besseren Stimulation des Immunsystems beiträgt. Vielleicht sollten 
wir zu unseren Ursprüngen zurückkehren, zurück zur Natur und in die Wildnis. 
 Abschließend sehen wir immer mehr Bäume im Wald, denn diese Dissertation 
beleuchtet die Relevanz von spezifischen Wirts- und Umweltfaktoren und den ersten Siedlern 
im sich entwickelnden Darm des frühen Lebens. Indem wir zum wachsenden Wissen über 
die Natur und die Möglichkeiten der Mikrobiota im frühen Leben beitragen, haben unsere 
Forschungsbemühungen neue Anhaltspunkte für die weitere Erforschung der genauen 
Mechanismen der Mikrobiota-Entwicklung und ihrer Auswirkungen auf den Wirt geliefert. 
Zusätzliche funktionelle Studien, die Tiermodelle oder Co-Kultursysteme mit Befunden 
oder Proben erweiterter longitudinaler menschlicher Geburtskohorten integrieren, werden 
helfen, die interindividuelle mikrobielle Variation und ihren Einfluss auf das Auftreten 
von Krankheiten zu verstehen. Das Forschungsgebiet der Mikrobiologie hat sich lange auf 
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Analysemethoden innerhalb der eigenen Grenzen konzentriert, aber diese Dissertation betont, 
dass die mikrobiellen Wechselwirkungen komplex sind und nur durch grenzüberschreitende 






The dramatically increasing prevalence of non-communicable diseases (NCDs) such as diabetes, 
obesity and allergies and related economic and societal impact is a worldwide public health 
burden [1]. NCDs are globally the primary cause of mortality with about 60% of deaths and 
still numbers are steadily rising [2]. Notably, atopic diseases including allergies and asthma 
are the most prevalent NCDs that arise in early life [3]. Atopic diseases often have relatively 
moderate disease courses, but the chronicity and high prevalence pursue in a large societal and 
economic impact. In order to support a sustainable health care system, the primary, secondary 
and tertiary prevention of chronic NCD’s is pivotal. These diseases are influenced by multiple 
environmental and genetical factors [3], and increasing evidence suggests that also the infant 
gut microbiota composition profoundly contribute to their etiology [5]. Although the genetic 
aspects of these conditions are unchangeable, the gut microbiota allows manipulation which 
makes it an intriguing target for new therapies to cure and prevent NCDs. Moreover, a better 
understanding of the natural dynamics of intestinal microbial maturation and subsequent 
insight into effective strategies to manipulate the microbiota could also be important for 
other diseases with an infectious component, i.e. necrotizing enterocolitis (NEC).
Firstly, this thesis studied the influence of host and environmental factors on early-life microbial 
colonization apart from the focus on a specific disease. These studies identified the neonatal 
subgroups with a disturbed microbiota, i.e. via caesarean birth, that might benefit most from 
a possible microbial treatment and could serve as a basis for personalized medicine. We 
further showed that the presence of methane-producing archaea in children was positively 
correlated with the consumption of organic yogurt and milk. Subsequently, it was confirmed 
that these archaea are indeed present in milk products and that dairy consumption can 
therefore promote the colonization of these microorganisms. Moreover, in addition to 
these dietary factors, bile metabolites appeared to have an important influence on the 
development of the small intestine microbiota of newborn mice, which was confirmed by 
oral administration of bile acids TCA and βTMCA. Importantly, this study was the first to show 
a causal role of host-derived metabolites in neonatal murine microbiota development and 
might have accelerated research into this area. Insight into these dietary and host factors that 
influence the colonization process could act as leads for future (nutritional) interventions.
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Secondly, this thesis described if manipulation of the neonatal microbiota indeed can be 
achieved in order to improve health. We showed that the administration of probiotics, 
especially bifidobacteria, to preterm infants was associated with a lower risk of developing NEC, 
a life-threatening intestinal inflammation. Therefore, this thesis confirmed and emphasized 
that early childhood is a critical period in which targeted manipulation of the intestinal 
microbiota is possible to promote a healthy future. 
Furthermore, the studies in this thesis also identified which factors influence the early 
development of the microbiota, and how changes in the microbiota during this life-phase 
relate to the onset of allergic diseases. For instance, the microbiota composition of children 
in two birth cohorts was investigated in relation to the development of asthma and allergies. 
Specific bacteria such as Lachnobacterium were reduced in children who subsequently 
developed atopic dermatitis and asthma, while a reduction in Faecalibacterium was indicative 
of atopic dermatitis. An increase in Escherichia was associated with an increased risk of 
asthma among children with pre-school wheeze. The examination of these specific bacteria 
is pivotal in order to both better understand the onset of these diseases and support the 
development of more targeted interventions. These commensal bacteria could serve as 
potential next-generation probiotics in the prevention of allergies or to protect against NEC, 
and the identified microbiota profiles of infants that did not develop such disease could be 
part of synthetic fecal transplants. Moreover, it also provides ways to explore new functional 
mechanisms in the pathogenesis of these diseases. The forthcoming interfering mechanisms, 
i.e. postbiotics, or the stimulation via probiotics may facilitate the development of low-cost 
and easy to handle treatments for affordable microbial therapies. 
These non-invasive supplements to promote intestinal immune-homeostasis would contribute 
to improved emotional impact as well, in particular in young vulnerable infants and their 
parents. In addition, the identified bacteria in this thesis could also be utilized for diagnoses in 
the early detection of these diseases such as asthma among wheezing pre-school children. In 
line with this, electronic home monitoring of these bacteria might perhaps be a revolutionary 
scope in the future.
Alltogether, the observation that certain conditions are associated with specific changes in the 




and personalized medicine. These findings will certainly increase the understanding of the 
establishing beneficial microbiota and will generate new leads for follow-up intervention studies 
to identify the infants that need it most and improve their gut health. Oral administration of 
the identified new leads (i.e. organic milk, Faecalibacterium, bile acids, etc.) might be a way 
for targeted manipulation of the gut microbiota to achieve clinical benefits, i.e. to decrease 
the incidence of infections by pathogens and prevent the development of immune-mediated 
diseases. The neonatal window may provide the best opportunity for targeted manipulation 
of the microbiota, potentially even with long-lasting positive health consequences which 
time will tell.
Importantly, the impact of this thesis on the environment is remarkable. The thesis has only 
been printed for specific delegates and thereby about 50% less paper is used compared to 
the average common orders. Furthermore, it has been printed on ‘ paper’ consisting of 85% 
to 100% of agricultural waste. The latter resulted in a reduction of 20% CO2 and 47% lower 
eco-footprint (general environmental impact) compared to common FSC-certified paper. The 
improved environmental impact comprises eco-toxicity to soil and water, particulate matter, 
human toxicity, influence of land use, ozone layer degradation, smog formation, depletion 
of fossil raw materials, and acidification of soil.
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This is it! The official end of my student-era. A collorfull chapter in life, from which I gained 
a lot. An international journey full of stunning experiences, challenges, but also some 
heavy disappointments. I learned to deal with these aspects and to keep believing in my 
oppurtunities and the path ahead. 
This journey, together with all people mentioned below that took part in it, developed me 
into becoming the researcher I’m today and I’m very thankfull for that.
Als eerste dank aan alle kinderen die een prachtige ingekleurde tekening hebben bijgedragen 
voor dit proefschrift: Elin, Raf, Elif, Emre, Paul, Nicolas, Julia, Noa en mijn eigen dochter 
Maya. Jullie vrolijke en bonte illustraties maken het boekje helemaal af! 




John, tie your ears (not ‘nuts’): je was letterlijk de beste supervisor die ik me ooit had kunnen 
voorstellen. Je motiveerde en inspireerde me met je passie voor goed wetenschappelijk 
onderzoek en je haalde echt het beste uit mezelf. Zonder je betrokkenheid, oog voor detail 
(mits de juiste cameralens mee) en het altijd ontvankelijk zijn voor vragen en kritiek was mijn 
promotietraject niet ontplooid zoals het nu is. Het zette ‘the points on i’. Je wist de perfecte 
balans te vinden - behalve op skilatten - tussen professionele aansturing en slechte humor. 
Dank voor de slapeloze nachten, zowel tijdens alle roadtrips door je gesnurk, als op het lab 
tussen de muizen (figuur - credits: John).
Mathias, I really appreciated you as my doctor-father, although you sometimes didn’t make 
my PhD easier when you suggested a new project topic almost every week. I enjoyed our 
lengthy intellectual discussions, the freedom you gave me and the way you tried to push 
everything to the highest level. 
Paul, thanks for guiding me all these years, for your fresh input and thinking along with me. 
Furthermore, I would like to thank all co-authors for their contribution to the studies included 
in this thesis. I learned a lot from doing research together in a collaborative manner, with 
collegues from different backgrounds, as well as the writing process.  
To my colleagues in Aachen: Shahed, Alina, Martina, Nour, Aline, Ambre, Regina, Maike, 
Stefan, Johannes, Annika, Natalia, Fine, Kaiyi and all others, thank you for the nice work 
environment (despite the green), the endless journal clubs, all the support and the weekly 
cakes. I really enjoyed being there with you right from the start, at a  time we all could still 
fit in one office, and being involved in all developments. 
Martina, thanks for your technical support and especially all the quality time and conversations 
we had about our wonderful lives. You understood me completely and always thought 
further ahead despite me being a bit chaotic at times. I feel privileged to be able to work 
close together with you and will definitely miss this fun. 
Thanks to all colleagues in Maastricht, including Erik, Christel, Charlotte, Carla, Chris, Mayk, 
Kevin, Gianluca, Brian, Liene, Melissa, Nader, Birke, Casper, Julius, David, Heike, Judith, Lars, 
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Mattew, Tessa, Wesley, Giang, and the rest of the MMB-department for all cosy (coffee-)
moments and keeping up my cafeïne-level despite the terrible coffeemachines. Mayk, dank 
voor je strakke illustraties voor de publicaties behorende bij dit proefschrift (chapter 2 & 
chapter 5) waarmee ik op veel congressen kon pronken. 
A special thanks to my(former) roomie’s Brian, Gianluca and Liene who could handle my 
distracting attitude. Gianluca, thanks for letting me steal your awfull coffee when needed and 
working together with you on two shared first-author master-pieces. Brian, mijn ‘back2back’-
kamergenoot, fijn dat ik altijd met je kon sparren over van alles. Liene, het was enorm fijn 
om met je samen te werken, te reizen en te bouwen aan het LucKi-project. Ik heb genoten 
van onze toffe tijd in New York, Canada en Ierland, maar ook tot laat op kantoor met warme 
persoonlijke gesprekken en toekomstvisies. Hoewel mijn stinktrui jou prikkelde, hield je mij 
juist scherp door vooral je structurele manier van werken (waar ik nog steeds jaloers op ben). 
Dank voor al het plezier dat ik met je heb gehad door o.a. je vrolijke verschijning, uitlachen 
om John’s uitglijders en de slappe lach tijdens keynote-sessies op conferenties (InVivo). En 
ik blijf dromen over je zwembad!
Aan mijn lieve paranimfen: Heike, dankje dat ik altijd bij je terrecht kon, zowel op UM als 
bij je thuis in Aachen. Van gezellig kletsen over je nieuwste tatoage’s en geklaag over lijn 
350 tot complete brainstorm-sessies. Ik waardeer dat je altijd stond te springen (behalve op 
de trampoline op onze bruiloft) om nieuwe projecten en ideeën te bedenken en hoe je dit 
stiekem ijverig op tientallen memo's schreef. En ook dank dat ik je 'bus-office' excuus mag 
gebruiken! Casper, dank dat je telkens voor me klaarstond. Althans, voor de koffie-pauze’s, 
Tripel Karmeliet, organiseren van (kerst)evenementjes en de ontelbare vrijmibo’s - onze 
gedeelde passie. Thembi was vaak nog niet eens open of we zaten er al. Ik prijs je attente 
karakter: geen proost-gelegenheid - van carnaval tot zakelijke plenaire sessies - ging aan je 
voorbij. We hebben meer bitterballen op dan dagen dat ik aan mijn PhD heb besteed, en 
ik appreciëer je lef om toch altijd de laatste te pakken. Dank ook voor je samenwerkingen 
met muffin-onderhandelingen en het niet ondersteunen (mislukken) van mijn Dry January. 
Max, Claudia, Alex, Svenja, Leslie, Thomas, Carmen, Camiel, Sanne, Joël, Mirella, Mick, 
Loes, Mandy, Roger; vrienden voor het (MLW)leven. Jullie bedankt voor de (studie)basis, 




festivals en ons eigen Postival/Maria-Hopeloos geen overlevingskans voor mijn PhD. Max & 
Carmen, dank voor alle mooie koffie-momenten op de uni en vooral het delen van elkaar’s 
PhD-belevenissen de afgelopen jaren. Mick & Joël, onze gezamenlijke Duitse avonturen 
waren prachtig; van torens bouwen tijdens carnaval tot alle minibars leegdrinken tijdens de 
retreat. Joël, wat mis ik onze ooit dagelijkse gesprekken nu al; je ongezouten (sterke) mening, 
trance-updates en gestoei met het Duitse systeem. Mick, eeuwig bedankt dat je me hebt 
overtuigd over de grens te gaan werken!
Melih, vielen Dank voor de mega-gezellige autoritten. Het was me een waar genoegen om 
telkens met je op en neer naar Aachen de pendelen en anders niet gelukt zo vaak de grens 
te passeren! Ik waardeer ook je enthousiaste deelname samen met Marlies, Emre & Elif aan 
de studies, maar natuurlijk vooral de vriendschap die daaruit is ontstaan.
Lieber Reiner & Monika, danke auch an euch für die Unterstützung und alle Ratschläge. 
Ich danke es zum Teil auch euch, dass ich mich für diese Aachener Route überhaupt erst 
entschieden habe.
Lieve mama en papa, dank dat jullie mij de mogelijkheid hebben gegeven deze ‘hobby’ 
te laten uitgroeien tot deze mijlpaal. Alleen met jullie steun en gegeven vrijheid heb ik 
het zo ver kunnen schoppen! Sven, broertje, je was de beste uitlaatklep tijdens mijn 
promotie-traject, inclusief de (de)motiverende peptalks en Duvelse dilemma’s. En dankzij 
je groene invloed en kijk op de wereld is de ‘nature’ uit de titel mede aan jou te danken. 
 
Johanna, dank voor álle hulp bij vooral de vele keuzes en dat je altijd in me bent blijven 
geloven (bijv. dat ik het levende bewijs ben dat domme vragen wél bestaan). De gedeelde 
liefde voor ontwikkeling van natuur en kinderen hoop ik nog lang met je te exploreren.
Lastly, I would like to thank ‘Thesaurus’ ! I could never have made it till the end without you. 
I can’t imagine how the language in my thesis would look otherwise. You made this thesis to 
be the crown of my work; the cherry on the cake.
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